Spring 2024 Intern Articles
A collection of articles authored by Scleroderma United’s Spring 2024 Intern cohort
sclerounited.us
About
This publication compiles a series of articles authored by Scleroderma United’s Spring 2024 Intern Cohort. These articles were written as part of an educational program intended to encourage and guide student interns in learning about scleroderma and related medical/healthcare topics.
The information presented in these articles should not be considered as a substitute for professional medical advice, diagnosis, or treatment. Readers are strongly encouraged to consult with qualified healthcare professionals regarding their individual medical conditions, as inaccuracies may inadvertently be present in intern articles. The content is not intended to endorse any medical treatments or approaches. Readers are advised to independently verify information and seek professional advice before making any decisions based on the content of this publication.
Authors
We are very happy to publish articles authored by the following interns: Aania Garg, Anaiya Khan, Analiese Godin, Angela Liu, Alex Nguyen, Anika Deshmukh, Anoushka Bellum, Anusha Rahman, Aryan Krti Iyyappan, Christina Zhu, Christopher Yeow, Davia Williams, Diya Joshi, Elma Cesic, Elyse Da Costa, Franny Khine, Heqing Feng, Imaan Mehmood, Isha Parikh, Jadey Ding, Jaguar Ngo, Jia Hui Lin, Jisara Wuttikreekiat, Joy Wei, Kaitlyn Flanagan, Karson Yuen, Liya Khan, Liyana Haque, Martin Nguyen-Khoa, Medha Nandikur, Mia Szczesniak, Minhanh Nguyen, Mya Silveyra, Nathan Morales, Navya Dubey, Nichu Shibu, Nithusha Ranjith, Nuzhat Azim, Prisha Phatnagar, Sarika Rahman, Sehrish Hirani, Shria Ajay, Sonia Lee, Sonal Jain, Sophia Neuenhaus, Sophie Choi, Sophie Citron, Tharmitha Ramkumar, Tisya Mahajan, Tonique Swaby, Valeria Bianchi, and Valeriia Svyrydova.
Scleroderma's Silent Battle: The Importance of Understanding Neuropsychiatric Symptoms
By Aania Garg from New York City, USA
Beyond the Visible
Scleroderma, a complex autoimmune disease, systematically affects multiple organs in the human body, including the lungs, heart, and gastrointestinal tract, leading to a wide range of symptoms that vary significantly from patient to patient. While the external changes in scleroderma, such as hardening of the skin and Raynaud’s phenomenon, are the most visible and often the initial indicators for diagnosis, patients frequently endure neuropsychiatric symptoms, which although less apparent, are profoundly debilitating and significantly impair their quality of life.
These psychological effects often receive less attention in clinical settings compared to the physical aspects of the disease. The reasons for this oversight are manifold but largely stem from a historical focus on visible symptoms that are more easily quantifiable. However, the spotlight should be shifted onto these hidden struggles, and a holistic approach to scleroderma treatment that acknowledges and addresses the full scope of scleroderma’s impact is crucial for providing comprehensive care and improving overall patient outcomes.
Scleroderma United
Spring 2024 Intern Articles
Understanding Neuropsychiatry
Neuropsychiatric symptoms refer to mental health problems that occur in conjunction with chronic illnesses, including cognitive dysfunction, mood disorders, and anxiety. These symptoms arise as a direct consequence of the disease’s impact on the body and are compounded by the emotional strain of living with a chronic, visibly altering condition. The persistent pain, significant lifestyle adjustments, and the social stigma associated with physical changes can trigger or exacerbate these psychological issues.
Research indicates that approximately 60% of scleroderma patients experience depressive symptoms, with a similar percentage reporting anxiety disorders. This high prevalence highlights the significant impact of scleroderma on mental well-being. Biologically, the chronic inflammation and immune system dysregulation common in scleroderma are believed to influence neurotransmitter functions and brain chemistry, potentially leading to neuropsychiatric conditions. Psychologically, the constant stress of managing a chronic illness and the fear of social rejection due to physical symptoms contribute significantly to mental health declines.
Resources for Support
Many patients affected by scleroderma have found strength and practical help through various support systems and coping strategies, which have proven to be critical components of managing both the symptoms of the disease and the psychological stress it can induce.
Online communities and support groups are particularly valuable resources. These platforms offer a space where patients can share experiences, treatment tips, and emotional support from others who truly understand the realities of living with a rare chronic illness. For example, the Scleroderma Foundation’s online forums provide a structured environment where patients can connect, share information about managing symptoms, and discuss coping strategies such as meditation, exercise, and diet modifications tailored to their needs. Additionally, reaching out to family and friends for support can help significantly. Even though it might be tough, loved ones are only there to support you, and can offer practical help, emotional support during tough times, and
Scleroderma United
Spring 2024 Intern Articles
and emotional support from others who truly understand the realities of living with a rare chronic illness. For example, the Scleroderma Foundation’s online forums provide a structured environment where patients can connect, share information about managing symptoms, and discuss coping strategies such as meditation, exercise, and diet modifications tailored to their needs. Additionally, reaching out to family and friends for support can help significantly. Even though it might be tough, loved ones are only there to support you, and can offer practical help, emotional support during tough times, and assistance in navigating the complexities of healthcare appointments and treatments. Further, educating friends and family about scleroderma can foster a deeper understanding and more meaningful support.
The Role of Integrated Care
Medical experts should increasingly advocate for integrated care models that treat scleroderma not just as a physical ailment but as a condition that affects all aspects of a patient's health. These models should propose the inclusion of mental health professionals in routine care teams to ensure that psychological support is available as part of regular patient care. By fostering an environment where mental health care is as accessible and routine as physical health care, we can ensure that patients receive the full spectrum of support needed to navigate the challenges of this disease. This includes regular screenings for mental health issues, ongoing support through therapy and counseling like cognitive behavioral therapy, and the inclusion of mental health professionals in treatment teams. Studies supporting integrated care demonstrate that patients receiving both physical and mental health care exhibit better overall health outcomes, fewer hospitalizations, and improved quality of life.
A Call for Comprehensive Care
The traditional focus on physical manifestations has often overshadowed the urgent need for comprehensive mental health care, leaving many patients to struggle in silence. However, as our understanding of the interplay between mental and physical health deepens, the medical community is called upon to adopt a more holistic approach to effectively manage scleroderma. Together, we can
Scleroderma United
Spring 2024 Intern Articles
transform the landscape of scleroderma treatment and truly empower our patients in their journey toward wellness.
Scleroderma United
Spring 2024 Intern Articles
Exploring Challenges in Diagnosing Scleroderma
By Anaiya Khan from Newark, Delaware, USA
Scleroderma is a rare autoimmune disease with skin thickening as its hallmark that can also affect internal organs and, potentially, shadow your entire body Scleroderma is challenging to diagnose due to differences in symptoms that may imitate other diseases. No tests can confirm scleroderma so the diagnosis relies on individual evaluation and testing. However, diagnostic uncertainty can result in a lengthier delay in appropriate treatment of up to one’s entire body.
Diagnosing scleroderma poses challenges for medical professionals because of understanding the difficulties associated with diagnostic uncertainty, such as the many symptoms and the absence of definitive tests, we seek to uncover potential solutions. The goal for the future is to advocate for improved diagnostic approaches to ensure timely and accurate identification of scleroderma, to ensure the patient is getting the right treatment and medications.
The symptoms of scleroderma can range from coughing to Arithisis. Scleroderma symptoms vary widely and can affect different parts of the body physically and mentally. This variability makes diagnosis challenging because symptoms may not always be clear or consistent due to the lack of specific diagnostic tests. There are no specific markers or tests that definitively diagnose scleroderma, adding to the difficulty of accurately
Scleroderma United
Spring 2024 Intern Articles
identifying the condition. The only tests to identify scleroderma are lung health tests, blood tests, skin biopsy, etc. According to John Hopkins medicine, “There is no single test for scleroderma. It is a clinical diagnosis that requires a thorough exam and history by the doctor”(John Hopkins).
Scleroderma shares symptoms with many medical disorders and diseases, making it challenging to distinguish from other illnesses. For example, the symptoms could match with Scleromyxedema, Rheumatoid Arthritis, Systemic Lupus, etc.
The diagnostic journey starts with an initial consultation, where medical history and symptoms are evaluated. Tests like blood tests and imaging studies are then chosen to help with the diagnosis. However, due to scleroderma's complexity can make selecting the right tests can be tricky. This often makes the patient go to a different specialist. Several factors can influence the diagnostic reasoning in scleroderma. These include the variability of symptoms, patient history, and the need to differentiate from other autoimmune disorders and medical conditions. Additionally, the limitations in available diagnostic tools can impact the diagnostic process and time. Real-life cases highlight the difficulties of diagnosing scleroderma as they can showcase the diverse symptoms, delays in diagnosis, and the impact on patients' lives. By examining these cases, we gain insight into the challenges faced by both patients and medical professionals in identifying and managing scleroderma.
Current diagnostic tests for scleroderma often lack precision and may produce false results, complicating the diagnostic process. These limitations highlight the need for more reliable and accurate testing methods to improve diagnostic accuracy. Medical biases, such as those about scleroderma or unfamiliarity with its symptoms, can influence diagnostic decisions and lead to misdiagnosis or delayed diagnosis. Addressing these biases through education and awareness is crucial for improving diagnostic outcomes and ensuring timely intervention for patients.
In seeking clarity for scleroderma diagnosis, it's important to embrace collaboration and the establishment of specialized centers dedicated to this difficult disease. By bringing together specialists, we can ensure evaluation and treatment plans for patients. Furthermore, advocating for a broader approach to differential diagnosis is crucial, recognizing that scleroderma
Scleroderma United
Spring 2024 Intern Articles
can present with varied symptoms Using advanced diagnostic techniques can help diagnosing some more accurately. Through case studies showcasing we can learn valuable insights, informing best practices and guiding future approaches to scleroderma diagnosis. By prioritizing collaborations, we can navigate the complexities of scleroderma diagnosis with clarity and confidence, which can improve outcomes for individuals affected by scleroderma.
Navigating the diagnosis of scleroderma presents an intense journey, as shown in many personal narratives of individuals impacted by the disease. These stories reveal the challenges patients encounter while seeking an accurate diagnosis and effective treatment. From misdiagnoses to delayed treatments, patients often face challenges in accessing proper care. However, patient support groups and advocacy organizations play a crucial role in empowering individuals to advocate for themselves and others. Through shared experiences and collective efforts, many groups raise awareness about scleroderma, drive changes in healthcare practices, and offer invaluable support to those navigating the difficulties of the disease.
As we reflect on the journey of scleroderma diagnosis, it's evident that significant progress has been made, yet there remain important gaps to address. While diagnostic tools have advanced and understanding have improved patient outcomes, there is still much work to be done. It's a call to action for healthcare providers, researchers, and policymakers to collaborate in closing these diagnostic gaps. By prioritizing research funding, strengthening medical training, and implementing standardized diagnostic protocols, we can strive towards improved diagnostic outcomes for individuals with scleroderma. However, amidst these efforts, it's crucial to center our focus on the patient experience. Patient-centered care must remain at the forefront, recognizing the unique challenges and needs of those affected by the disease. Ultimately, it's the collective dedication to ongoing advancements and the unwavering commitment to diagnostic clarity that will shape a brighter future for all individuals impacted by scleroderma. Together, let us remain committed to driving progress, promoting early detection and ensuring that every individual affected by scleroderma receives the care and support they deserve.
https://www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/scleroderma-diagnosis
Scleroderma United
Spring 2024 Intern Articles
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412724/ https://newsnetwork.mayoclinic.org/discussion/hold-for-zebra-evergreen-needs-image-text-connect-link-x-2-reviews-consumer-health-what-do-you-know-about-scleroderma/ https://www.aad.org/public/diseases/a-z/scleroderma-symptoms https://scleroderma.org/ https://patient.boehringer-ingelheim.com/more-than-scleroderma/understanding-scleroderma/testing-for-scleroderma/blood-and-urine-tests
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Discovering Hope: The Positive Aspects of a Scleroderma Diagnosis and the Benefits of Support Groups
By Analiese Godin from Lancaster, Pennsylvania, USA
What comes to mind when thinking about rare diagnoses? For some people, it's easy to dwell on the negative aspects and the difficulties of managing. Naturally, being diagnosed with a rare disease is a shocking, devastating, overwhelming, and life-changing event; however, it is vital to have an optimistic outlook and to embrace the positive aspects. Many individuals diagnosed with Scleroderma have done just that, and it has changed not only their outlook on their "new" life but has given them the opportunity to find their purpose.
Positive Aspects
Scleroderma is a rare, terminal autoimmune disorder that can have a significant impact on diagnosed individuals' quality of life, causing physical symptoms as well as emotional and psychological effects. The symptoms range in severity from hardening and thickening of the skin to various effects on the internal organs. Despite the challenges that come with this disease, many individuals have found ways to manage their symptoms which has led to them living fulfilling lives. These individuals have learned to embrace the positive aspects of their diagnosis, such as developing increased self-awareness and self-care. They have achieved this greater level of self-care by listening more closely to their body's needs and prioritizing their health,
Scleroderma United
Spring 2024 Intern Articles
both physically and mentally. By embracing their Scleroderma diagnosis, many individuals have learned to embrace gratitude, pursue everything they are capable of doing, and experience new things. This shows that many individuals are taking advantage of their changed lives to develop a mindset shift that is more positive and more appreciative. Because of this, many individuals have learned to change their perspectives in life and their priorities for the better. Diagnosed individuals also have the opportunity to connect with others who are going through similar experiences and the chance to raise awareness about rare diseases. This has resulted in improved relationships and social support for many individuals.
Shared Experiences
In fact, many individuals with Scleroderma have shared about their changed lives and newfound positivity from their diagnosis. For example, Amy Gietzen, who was diagnosed with Scleroderma in 2011, has written many articles focusing on how her diagnosis has led to her finding her purpose in life. She said that in the beginning, being diagnosed was naturally one of the scariest moments for her; however, now it "has become the single greatest factor" in her life, helping her find her "true self" (Gietzen, 2023). Looking at the positive side of things is crucial for patients' mental health and also in understanding that everything happens for a reason, especially when dealing with health challenges. Amy even states that "Scleroderma has carved out an identity" for her (Gietzen, 2023). Yogita Sharma, who was diagnosed with Scleroderma in 2016, also shared about her experiences with Scleroderma United. She discussed that since her diagnosis, she has learned to count her blessings, live life to the fullest, and fully express herself. Prior to her diagnosis, she was more of an introvert; however, Scleroderma has given her the opportunity to come out of her shell (Scleroderma United, n.d.). It is truly inspiring to hear stories from diagnosed individuals like these who are coping positively with their diagnosis and looking at their lives through an optimistic lens despite their disease and its challenges.
Support Groups
Another key component to staying positive is support and communication. Because of this, many people have found support groups and organizations to be highly beneficial in positive outcomes. One of the most important aspects of support groups is that they offer a sense of community and belonging. Scleroderma patients often feel isolated and misunderstood, and support groups can offer a space where they can connect with others who
Scleroderma United
Spring 2024 Intern Articles
understand first-hand what they are going through. Amy shared in her article that after being diagnosed, she began connecting with others who were diagnosed, joined organizations, and began educating others about Scleroderma. From this, she said she felt like she "became part of a broader community" and "wasn't alone anymore" (Gietzen, 2023). Scleroderma support groups have proven to be a safe and supportive environment where individuals can share their experiences, challenges, and successes with others who are going through similar situations, which can help many stay positive and motivated despite their disease. These support groups can be found online, through social media, or in many communities across the globe.
While living with a Scleroderma diagnosis can certainly be challenging, it is inspiring to see how individuals can transform their experiences into opportunities for growth, self-improvement, and positivity. It is important to acknowledge the positive effects that come with a diagnosis; hence, it is crucial to encourage those diagnosed with Scleroderma or other rare diseases to develop a positive outlook on their "new" life as well as encourage these patients to seek support and connect with others who share similar experiences. By discovering hope through an overwhelming and difficult time, many individuals can learn to navigate their journey effectively and find their purpose in their "new" life.
References
Gietzen, A. (2023, July 26). How a scleroderma diagnosis changed my purpose in life |... Scleroderma News. https://sclerodermanews.com/columns/how-scleroderma-diagnosis-changed-purpose-life/%20
Gietzen, A. (2023, March 15). Accepting all of my feelings about scleroderma | Scleroderma News. Sclerodermanews.com. https://sclerodermanews.com/columns/accepting-all-my-feelings-scleroderma
United, Scleroderma. Yogita Sharma - Scleroderma United. (2023, September 23). https://www.sclerounited.us/yogita-sharma/
Scleroderma United
Spring 2024 Intern Articles
Methotrexate and Emerging Treatments for Juvenile Localized Scleroderma
By Alex Nguyen from Scarborough, Ontario, Canada
The condition known as scleroderma is linked to an overabundance of collagen synthesis, which results in fibrosis of the skin and other organs involved. Systemic sclerosis (SSc) and localized scleroderma (LS) are the two primary types; LS is six to ten times more frequent in children. Dermatologists also commonly refer to LS as morphea. Life-threatening conditions such visceral organ fibrosis and vasculopathy are common in SSc patients, whereas they are rare in LS patients. However, extracutaneous involvement of LS patients can result in significant deformity and functional disability.
Treatment for juvenile localized scleroderma (jLS) is dependent on the severity of the condition. A pediatric rheumatology research network subgroup (CARRA) has generated classifications for the disease severity. Low-severity is diagnosed in patients with morphea that is not associated with subcutaneous atrophy or scalp hair loss. These patients are given topical medications (corticosteroids, tacrolimus, imiquimod, vitamin D analogues) or phototherapy as treatment. Patients with deeper tissue involvement and all other subtypes fall under the category of moderate to high severity. Clinical exams might not be able to identify this, and low-severity cases may develop this later.
Pediatric rheumatologists and dermatologists did a randomized treatment of methotrexate in combination with corticosteroids on patients with
Scleroderma United
Spring 2024 Intern Articles
moderate to high severity jLS. The goal of this treatment is to suppress inflammation and reduce the risk of major morbidity development. It might be difficult for dermatologists to identify flare-ups or treatment effectiveness in children who have entered the pubertal growth spurt since they may be in remission from the medication. Because 15% to 53% of jLS patients experience relapses, long-term monitoring is typically required.
Additionally, it was discovered that certain jLS patients who did not exhibit methotrexate tolerance benefited from mycophenolate mofetil. In adults, phototherapy is successful; however, no evidence was found for individuals at a premature age. As alternatives for nonresponders, several immunomodulators—including biologic agents—are being investigated. Surgery can be used to treat atrophy and other abnormalities in emergency situations, but it should only be taken into consideration when the illness has become inactive as a result of post-operative flare-ups.
Despite being thought of as self-limiting in the past, juvenile localized scleroderma are now more often acknowledged as chronic relapsing-remitting illnesses that call for ongoing care and long-term monitoring. There is evidence for the use of biologics and small molecules in scleroderma in addition to corticosteroids, mycophenolate mofetil, and methotrexate. In order to lower long-term morbidity, extracutaneous symptoms must be recognized. Unfortunately, there do not seem to be any other known medications that can stop juvenile scleroderma from getting worse. Additional outstanding study has unveiled the therapeutic arsenal that targets adult tissue fibrosis. In the near future, new methods and technology will be needed to assess how well these therapies work on children.
Scleroderma United
Spring 2024 Intern Articles
Navigating Scleroderma: Psychological Impact and Coping Strategies
By Anika Deshmukh from Melbourne, Victoria, Australia
I. Introduction
Scleroderma, a rare, chronic autoimmune disease, most commonly affects adults aged 20-50. The disease, in which there is an excess of collagen and connective tissues within the body leads to the hardening of skin due to a change of cellular structure and vascularization of the body's tissues. Despite not being an inherited condition, a trend of genetic predisposition is seen in some individuals who have associated family members with the same condition.
Emotional and psychological impact upon individuals remains an often uncharted area within Scleroderma research. Major themes emerging from live interviews of patients afflicted with scleroderma were a deep change in personal identity, including mental readjustment and processing of grief through the loss of mobility and changes in physical facial features. Australia’s limited research on this facet due to a preference for a purely biological approach often pathologizes and minimises the experience of grief in individuals, generating difficulty for individuals in accessing community and maintaining a tangible sense of autonomy. Women remain disproportionately affected in this regard, their condition often causing further difficulties navigating culturally idealised body image and
Scleroderma United
Spring 2024 Intern Articles
appearance.
II. The Psychological Impact on Individuals' Careers and Livelihoods
Recent studies have illustrated the profound impacts of autoimmune diseases upon individual’s livelihoods and careers. Galetti. I’s literature review, (2021) found that as scleroderma progresses, work and social activities decrease, subsequently impacting the psychological and economic livelihoods of patients as individuals are forced to change their working hours, change professions or remain unemployed. This idea is reiterated in Scleroderma United’s interview with Raele Robinson, who relays that the largest adjustment has been stamina levels. Finding that she can only work 4-5 hours a day, energy becomes a focal obstacle towards career progression and maintenance for many scleroderma patients. Furthermore, individuals face difficulty in accessing proper healthcare services. Galetti’s review found that an autoimmune disease so complex requires management in centres of expertise which implements both existing clinical practices alongside the more holistic requirements unique to scleroderma patients. In certain regions, including Italy there remains a scarcity of centres, forcing patients to travel >100 km to obtain support.
III. Impact on Families and Functioning
The impact of scleroderma extends beyond individuals to families and loved ones, who often become caregivers for scleroderma patients. Milette K (2019)’s scientific journal found repeated themes of misunderstanding, disconnection and emotional distress between patients and their families that had the potential to exacerbate suffering and increase difficulty coping. Despite evident effort from family and loved ones in understanding the diagnosis, patients regularly described their overwhelmed reactions and scepticism of the patient’s abilities and limitations. 71 year old Scleroderma patient River asserted that she had avoided communication and obtaining support from loved ones to stay mentally grounded and socially active due to caregivers, struggling with a lack of resources and communal understanding on the issue becoming frightened enough to state: ‘I can’t go with you. I can’t take you. I’m too scared. You’re too much responsibility.’
IV. Coping Strategies and Finding Strength
Despite challenges posed by scleroderma, individuals demonstrate remarkable resilience in navigating the condition. In the same scientific journal (2019) three key strategies were reported in helping to tackle physical and mental difficulties. In particular, patients examined the importance of mental relaxation in the face of perceived challenges. 44 year old patient
Scleroderma United
Spring 2024 Intern Articles
Toby reported that maintaining clear headedness when feeling overwhelmed helped him maintain clarity when making important decisions about treatments or interacting with their loved ones and health care professionals. The verbal expression of scleroderma experiences, both in person and through social media was also seen as imperative in assisting loved ones and caregivers in maintaining clear communication and empowering the patient’s autonomy in concurrence with their diagnosis, leading to decreased emotional distress. Similarly, connecting to other individuals with Scleroderma as well as SSc societies and reputable organisations, not only leads to accessing greater information, emotional support and strength against daily struggles, but generation of funding for clinical research on the condition.
V. Gender Perspective: Coping with Changes in Physical Appearance
Women remain disproportionately affected by scleroderma and as such, face unique challenges related to changes in physical appearance. Amin K’s (2011) scientific journal, focusing on body image concerns in systemic sclerosis, found in a study of 489 patients (432 female, 57 male,) that dissatisfaction with appearance alongside social discomfort was strongly correlated with the extent of skin involvement. The standardised regression coefficients were = 0.02, p = 0.001; 0.02, p = 0.020, respectively), as was skin involvement in the face (0.18, p = 0.016; 0.23, p = 0.006, respectively). Additionally, greater social discomfort was increasingly associated with younger age (-0.017, p<0.001) and upper-body telangiectasias (0.32, p = 0.021), relaying severe concern for the psychological wellbeing of young women with Scleroderma growing into adulthood in regards to social functioning and self esteem. Dissatisfaction with appearance was associated with hand contractures (0.07, p = 0.036,) symptoms that occur typically as a result of Raynaud's syndrome, reveal how body image concerns in women with Scleroderma must be further investigated and prioritised in treatment, alongside consideration of how overwhelmingly appearance correlates with identity and autonomy in contemporary society. Cultivating self compassion and challenging societal beauty standards remains a cornerstone to empowering women to navigate such challenges with resilience and emotional release.
VI. Conclusion
Scleroderma presents significant challenges to patients' psychological well-being and that of their families. Through examination of the psychological impact of the disease and the implementation of targeted strategies, both health professionals and caregivers can support patients in coping with
Scleroderma United
Spring 2024 Intern Articles
symptoms and maintaining a sense of resilience.
Citations
Galetti, I.(2021) Living with systemic sclerosis: the point of view of patients, Current Medical Research and Opinion, 37:sup2, 1-4, DOI: 10.1080/03007995.2021.1992369
Milette.K, Thomb. BD, Maiorino.K, Nielson W.R, Körner.A, & Peláez.S (2019) Challenges and strategies for coping with scleroderma: implications for a scleroderma-specific self-management program, Disability and Rehabilitation, 41:21, 2506-2515, DOI: 10.1080/09638288.2018.1470263
Jewett LR, Hudson M, Malcarne VL, Baron M, Thombs BD; Canadian Scleroderma Research Group. Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis. PLoS One. (2012) doi: 10.1371/journal.pone.0033281. Epub 2012 Mar 23. PMID: 22457749; PMCID: PMC3311623.
K. Amin , A. Clarke , B. Sivakumar , A. Puri , Z. Fox , V. Brough , C.P. Denton , E.M. Peter & M.D. Butler (2011) The psychological impact of facial changes in scleroderma, Psychology, Health & Medicine, 16:3, 304-312, DOI: 10.1080/13548506.2010.540250
Scleroderma United
Spring 2024 Intern Articles
Understanding Social Support Needs of Scleroderma Patients: Insights from a Recent Study
By Anoushka Bellum from Folsom, California, USA
Abstract
In the journey of living with a rare disease like scleroderma, support and understanding from close relationships can make an immense difference. It is important to delve into the social support needs of scleroderma patients, shedding light on their experiences and the crucial role of support networks. By highlighting these ideas, scleroderma patients will feel more comfortable to share their struggles and gain more information on how to live with this condition.
Patient Perceptions
One poignant instance from an article from the National Library of Medicine encapsulates the emotional impact of diagnosis: "‘I’m so sorry, you’re so young, you have scleroderma,’ turned out to be the second most impactful statement on my life... ‘I’m giving her 6 months and that’s pushing it’...turned out to be the first." These words, spoken by a doctor, marked the beginning of a transformative journey for the patient, highlighting the shock and uncertainty that often accompany a rare disease diagnosis. The study revealed that patients often receive various forms of support from their close relationships, including emotional, informational, and instrumental support. Emotional support emerged as particularly crucial, providing patients with
Scleroderma United
Spring 2024 Intern Articles
strength and resilience in the face of adversity. However, the study also underscored the importance of relational factors, such as communication style and active engagement, in shaping the support received.
Moreover, the study emphasized the need for interventions that address scleroderma as a collective challenge. By harnessing the support of close relationships and empowering both patients and their supporters with relevant information and skills, healthcare professionals can optimize rehabilitation efforts to improve patient outcomes. The journey of living with scleroderma is not without its challenges, but with the support of knowledgeable healthcare professionals and understanding from close relationships, patients can navigate this journey with resilience and hope. As the patient in the study aptly stated, "She is clothed in strength and dignity and she laughs without fear of the future," embodying the courage and determination to face the unknown.
Social Support
Another article by Taylor and Francis Online delves into the social support dynamics experienced by people living with scleroderma, looking at how patients perceive and use support from their close relationships to cope with the physical and psychological challenges of the condition. The study's focus group conversations with 19 patients illustrate the complex nature of social support, which includes emotional, informational, and instrumental aspects. Emotional support is highlighted as especially important, highlighting the value of empathy, understanding, and friendship in managing the intricacies of scleroderma. The study also highlights relational aspects such as communication style, active participation, and complementarity that influence the effectiveness of support received.Honest communication, careful selection of support sources, and strong connections defined by motivation and involvement are regarded as improving support, whereas avoidance of interaction and misunderstanding impede it.
The findings highlight the importance of targeted therapies that promote communal coping skills among scleroderma patients. Understanding patients' complex experiences within their social networks allows rehabilitation specialists to better promote successful support systems. Key techniques for rehabilitation experts include encouraging patients to seek out supporting individuals with specific knowledge and abilities, establishing open communication, and providing resources to both patients and their
Scleroderma United
Spring 2024 Intern Articles
close relationships.
Conclusion
In conclusion, the studies offer valuable insights into the social support dynamics of scleroderma patients. By recognizing the multifaceted nature of support and addressing relational nuances, healthcare professionals can better assist patients in navigating the challenges posed by this rare disease.
Scleroderma United
Spring 2024 Intern Articles
Juvenile Systemic Scleroderma - Importance of Family in Time of Need
By Anusha Rahman from Queens, New York, USA
Julia was only 5 years old when her parents noticed something peculiar about their daughter’s body. “I said something to our pediatrician like her toes are blue,” her mother explained, “That’s not normal.” Julia, who was once a bright bubbly child, became so weak it became hard for her to enjoy her favorite hobby, gymnastics. And the cause of it all? Scleroderma.
For background, scleroderma is a very chronic autoimmune disease, affecting 20 people out of every 1 million and is even rarer in children, with only 2 cases out of 100,000. It results in thickened skin from a collagen overproduction and depending on each case, can spread to vital organs such as the lungs, kidney, and heart, limiting movement and functionality. Juvenile Systemic Scleroderma is when thickening tissue spreads in an adolescent's inner body with the possibility of fatality and is exactly what Julia had to endure.
Children with JSSC usually first show signs with Raynaud’s phenomenon. This is when fingertips and toes are particularly sensitive to the cold and turn blue, but in warmth are red and painful. Weakness is also common, since as tissue thickens in the muscles, it can hinder joint mobility. Julia’s mother recalls Julia not being able to do a simple bike ride they’ve done a number of times
Scleroderma United
Spring 2024 Intern Articles
saying, “She's like I can't pedal anymore my legs are so tired.” Drastic weight loss and decreased appetite from the inability to swallow food are also common. Sudden changes in a child’s ability to perform movement such as loss in flexibility, decreased stamina, rashes on fingers, complaints of always feeling tired, and not being able to stand up without help are significant indicators of scleroderma in children.
Diagnosing a child with scleroderma starts with consulting with a rheumatologist. The processes that would follow include a physical examination to analyze the skin thickening, a conversation on family background, a skin biopsy, an electrocardiogram or echocardiogram to monitor the heart, pulmonary function tests to monitor the lungs and a gastrointestinal tract exam to track esophagus and stomach function. The purpose of these tests are to see if the thickened skin is damaging the organs so it’s vital that parents act quickly.
Juvenile Systemic Scleroderma confines little ones to their homes. Simple tasks like brushing your teeth or using a spoon becomes difficult and lack of social activities are detrimental to the child’s way of life. This is why family is essential to nurture and support them. To begin, exercise is crucial for the first step back to proper health. Simple stretches and walks help to slow down thickening of tissue and help to relearn how to move again. Second, continuous aid and supervision is key. Friends and families should help the child with tasks that might seem like second nature and that way, everyone learns how to live cooperatively. Lastly, the barrier with social interaction can be bridged with other forms of communication. Calls between friends and visits to their houses are still very much possible and a great way to interact and get support.
It’s also still very possible to still be creative and enjoy hobbies. Julia, for example, was able to express creativity and her experience through songwriting and singing. Her mom described that meeting Julia being able to meet with a songwriter to publish her own song was “a really meaningful experience”. Parents similarly should continue to encourage and support their children through their ambitions.
Living with Juvenile Systemic Scleroderma may seem difficult at first. However with a strong group of support and the right actions, anything can be possible.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma United
Spring 2024 Intern Articles
Exploring the Impact of Muscle Involvement in Scleroderma
By Aryan Krti Iyyappan from Toronto, Ontario, Canada
Introduction
Living with scleroderma brings about a host of challenges, from the tightening of the skin to complications affecting our internal functions. Yet, among these concerns, we often overlook the impact that scleroderma can have on our muscle health. Recent research regarding skeletal muscle abnormalities in the bodies of scleroderma patients has discovered a new area of research for systemic sclerosis that can help to further understand the severity of the disease and potentially lead to discovering more in-depth muscle involvements and newer treatments.
This article explores the complexities of muscle problems in scleroderma, analyzing their impact, significance, and solutions for patients diagnosed with the autoimmune disease to use in their daily lives.
Understanding Muscle Problems in Scleroderma
Not only does scleroderma heavily affect the skin of patients, but it can continue downwards past the skin and damage the areas underneath, such as blood vessels, joints, and muscles.
Scleroderma’s muscle involvement in patients is extremely complex and can be subtle.
Scleroderma United
Spring 2024 Intern Articles
Despite being subtle, the health and mobility of the muscular system are crucial for our overall well-being. Thus, it is important to invest time and effort into check-ups of muscle function to maintain personal well-being. Common experiences can include body weakness and fatigue.
Spotting the Signals of Muscle Problems
Some indications of muscle problems in scleroderma include weakness, fatigue, joint stiffness, muscle pain, decreased mobility, increased creatine kinase levels, muscle atrophy, and Raynaud's phenomenon. When experiencing any of these symptoms, it's important to talk with a healthcare professional as early as possible because detecting muscle issues early is key to effective treatment.
Consequences of Untreated Muscle Issues
If left untreated, muscle problems in scleroderma can lead to more complications, like myositis and Sjögren's syndrome, which can seriously affect our long-term health. Thus, identifying early symptoms and arranging for regular check-ups are vital for keeping things under control and maintaining a healthy lifestyle. It's important to prioritize our health and speak more openly about body irregularities in order to achieve a healthy and active life.
Dealing with Muscle Challenges in Daily Life
Adapting to muscle issues in our daily lives takes some adjustment and support. Whether it's changing our routines or using assistive personal devices, finding ways to maintain our independence and comfort is crucial. Even if changes to your daily life are difficult, prioritizing your well-being and bodily health take a higher priority. However, if one is feeling the mental stress of a sudden change in their lifestyle, take the time to reach out to health professionals or supportive virtual groups.
Future Research and Solutions
It's worth noting the emerging research into the role of physical activity and exercise in managing muscle involvement in scleroderma. While it may seem unreasonable to participate in more constant physical activity when battling muscle problems, studies suggest that exercise routines can improve muscle strength, function, and overall quality of life for scleroderma patients.
Scleroderma United
Spring 2024 Intern Articles
Working closely with healthcare professionals to develop safe and effective exercises can be a valuable part of managing muscle problems in scleroderma. By integrating more physical activity into our daily lifestyles, patients can further enhance their ability to deal with the challenges created by muscle involvement in scleroderma.
Conclusion
In summary, muscle problems in scleroderma are a significant yet often overlooked part of the condition. Understanding, detecting, and managing these issues early on can lead patients to take better care of themselves and improve their quality of life. By raising awareness, seeking early treatment, and taking more open approaches to health, scleroderma patients can make life better for themselves and may even find unexpected happiness from newly discovered activities.
Scleroderma United
Spring 2024 Intern Articles
Understanding Scleroderma: The Impact on the Body
By Christina Zhu from Brooklyn, NY, USA
Introduction
The chronic autoimmune disease, known as scleroderma, causes skin and connective tissue tightening and hardening. This condition affects many organs and systems in the body and can cause a wide range of symptoms and issues. Understanding the many body areas affected by scleroderma is essential for effective management and treatment.
Skin
One of the major aspects of scleroderma is how it affects the skin. Individuals diagnosed with scleroderma usually exhibit skin that is thicker, harder, and has a glossy appearance. This condition can affect any area of the body, commonly called “scleroderma skin,” but it primarily affects the arms, fingers, hands, and face. The discomfort, decreased range of motion, and aesthetic modifications resulting from skin tightening can significantly impair an individual’s quality of life.
Gastrointestinal Tract
Scleroderma causes damage to the gastrointestinal (GI) tract, which can cause a variety of digestive issues. Heartburn, dysphagia, and acid reflux are a few signs of esophageal dysfunction, a frequent condition. Diarrhea, constipation, bloating, and abdominal pain are all symptoms of intestinal and stomach motility problems. Extreme cases can lead to complications such as hunger and weight loss.
Scleroderma United
Spring 2024 Intern Articles
Cardiovascular System
Scleroderma may affect the cardiovascular system, leading to various complications. Increased blood pressure in the arteries supplying the lungs defines pulmonary arterial hypertension (PAH), one of the most difficult conditions. Untreated PAH can lead to fatigue, shortness of breath, chest pain, and fainting, affecting both life expectancy and quality of life. Two more cardiovascular symptoms of scleroderma are arrhythmias and pericarditis, or inflammation of the sac surrounding the heart.
Conclusion
A complicated autoimmune condition, scleroderma, can affect many bodily systems and organs. Its effects on the gastrointestinal tract, cardiovascular system, musculoskeletal system, and skin can cause a wide range of problems and symptoms that lower the prognosis and quality of life for people who are affected. Patient outcomes are enhanced by early diagnosis, multidisciplinary care, and focused therapy, which lessens the effects of scleroderma on the body.
Scleroderma United
Spring 2024 Intern Articles
Social Life and Scleroderma
By Christopher Yeow from Singapore, Singapore
How many times has this happened to you: you make plans with your friends, but on the day, you are struck by an illness- whatever it is, and are forced to cancel your plans. You’re not just upset to have to cancel, but also worried that your friends will think less of you and may not invite you to things in the future. For patients with scleroderma, these feelings are all too common.
Let’s slow down a sec though: What is scleroderma you may ask? Scleroderma- or systemic sclerosis, is an autoimmune disease that causes the hardening and tightening of one’s skin. To the layperson, this is often where their understanding of Scleroderma ends. In reality however, Scleroderma- like many other chronic illnesses, causes a plethora of other physiological symptoms. Such symptoms often have no correlation to each other: ranging from generalised discomfort and fatigue to more targeted issues like gastrointestinal and even cardiovascular complications. Due to a lack of understanding and assumptions, these symptoms, which are already a physiological nightmare, often end up causing social complications for patients; who may develop a reputation as a bad friend or lazy colleague without understanding or empathy for the hardships they could be facing, or why they are acting the way they are. This article seeks to highlight some examples of misconceptions that patients with scleroderma have had to tackle in order to highlight the importance of education and understanding
Scleroderma United
Spring 2024 Intern Articles
when interacting with people with scleroderma, and any other chronic illnesses. The reality is; patients of Scleroderma want more than anything to uphold any semblance of normalcy that they can muster. If things have to change due to their condition, they feel worse than anyone else.
Flakiness:
The biggest issue with Scleroderma is that symptoms can be unpredictable. Jovana Placido highlights that even if she feels good earlier in the day, her symptoms could suddenly flare up later in the day. Because of this- though she is somebody who likes to plan ahead, Jovana has been forced to accept that she would not be able to predict how she will feel beforehand. This often causes Jovana, and other people like Nayanashree Sanikop and Alayna Roberts some dismay when they have to cancel plans with friends at the last minute due to worsening symptoms. While they are lucky to have compassionate and understanding friends, Yogita Sharma on the other hand shared her experience dealing with people who are less understanding, some of whom even give her nasty comments about her appearance. While these things may seem trivial, nobody with Scleroderma: or any chronic illness for the matter, wants to let their condition affect their social life. In fact, most of them, when reflecting on how they cope with their condition, list support from family and friends as a major protective factor for them (Maslow et al., 2012; Racine et al., 2016). When these patients; already struggling with their symptoms, are seen as “flaky” or “unreliable” by their friends, their confidence in their friends waver and they become prone to shutting them out. This removes a huge point of support for them, which could end up really affecting their ability to cope with stressors and in turn end up worsening their condition. A little understanding can go a long way however. In contrast to some of the negative experiences from Yogita, Jovana mentions how the understanding and compassion shown to her by her loved ones served to really strengthen her resolve and is one of the reasons she is doing so well in spite of her symptoms.
Unprofessional:
While it is easy to see patients of a chronic illness as just patients, as mentioned earlier, people suffering from scleroderma want nothing more than for life to retain some normalcy. This means that most scleroderma patients, as long as their condition allows it, continue to work at their jobs. Keeping busy often helps patients to deal with their symptoms, which not only improves physical health, but also improves mental health in patients
Scleroderma United
Spring 2024 Intern Articles
who would otherwise be left to ruminate with their thoughts. For patients, however, a point brought up by Luisa Ruiz Kulig that I think is important to bear in mind is that unlike something obvious like a broken bone for example, most effects and symptoms of scleroderma are invisible to everybody that isn’t the person suffering from it. These symptoms often cause scleroderma patients to miss work or be unable to keep up with work. Luisa recounts this in her testimony, highlighting that people would not believe her when she spoke about her symptoms as she was not bleeding, or displaying any symptoms that would be visible to an onlooker. This pushed her to do things like not drink water throughout the day so she wouldn’t have to use the toilet as her colleagues, who did not believe she was being affected by her symptoms, would not accommodate her laboured movement to or from the toilet. She was also met by much doubt when she told her colleagues that she was unable to come into the office because her symptoms were too bad. She eventually had to give up work altogether, as her symptoms became too much for her to handle. Conversely, Elaine Wiley details how her employer has provided her many resources which she can use freely to make her working life easier. She is also allowed to work from home, which allows her the flexibility to plan her medical checkups.
Whether it involves unprofessionalism, flakiness, or any other negative association you may have, the assumptions we make about people with scleroderma can have incredibly negative effects on their mental health. While it is easier to be ignorant and turn a blind eye, let me encourage you to choose kindness over impatience, and to educate yourself before making assumptions. Nobody wants to be a burden, and assuming the worst in those around us, especially those who are struggling will only serve to hurt them.
Scleroderma United
Spring 2024 Intern Articles
Unveiling the Xist Ribonucleoprotein Complex: Unraveling Sex-Biased Autoimmunity
By Davia Williams from Wylie, Texas, USA
Abstract
Autoimmune disorders, encompassing conditions where the immune system mistakenly attacks the body's own tissues, pose a significant burden on individuals' health and healthcare systems globally. Despite considerable advancements in understanding these disorders, there remains a notable gap in comprehending why certain autoimmune diseases exhibit a marked sex bias in both prevalence and severity. This discrepancy has spurred researchers to delve deeper into the intricate mechanisms underlying autoimmune pathogenesis, with a particular focus on the role of the Xist ribonucleoprotein complex.
Understanding the Xist Ribonucleoprotein Complex
The Xist ribonucleoprotein complex, traditionally recognized for its involvement in X chromosome inactivation, has emerged as a key player in autoimmune disorders. This complex, critical for achieving gene expression balance between males and females by silencing one of the two X chromosomes in the latter, has garnered attention for its potential implications beyond chromosomal regulation. Recent studies have unveiled its association with autoimmune pathogenesis, suggesting a broader role in immune system dysregulation.
Study Findings: Unveiling the Role in Sex-Biased Autoimmunity
Scleroderma United
Spring 2024 Intern Articles
In a groundbreaking study published in Cell, researchers investigated the role of the Xist ribonucleoprotein complex in driving sex-biased autoimmunity. Departing from the typical pattern observed in females, the researchers induced the expression of Xist in male mice. Remarkably, these male mice exhibited autoantibody production and pathological features reminiscent of autoimmune diseases, indicating a direct involvement of the Xist complex in driving autoimmune responses. Moreover, analysis of human serum samples revealed reactivity against Xist-associated proteins, further bolstering the link between this complex and autoimmune disorders in humans.
Clinical Implications
The implications of these findings are profound, particularly in the clinical realm. Xist-associated proteins have emerged as promising candidates for biomarkers in disease screening, offering a non-invasive means for early detection and intervention (Dou 2023). Additionally, unraveling the mechanisms underlying sex disparities in autoimmune disorders is paramount for designing targeted therapeutic approaches tailored to individual patients. By elucidating the intricate interplay between genetics, sex, and immune dysregulation, researchers aim to develop more effective diagnostic tools and therapeutic strategies, ultimately improving outcomes for individuals afflicted with autoimmune diseases.
Therapeutic Strategies
However, while targeting the Xist ribonucleoprotein complex holds promise for intervention, it also presents challenges in drug development. The complex regulatory network involved necessitates careful consideration to avoid unintended consequences. Nonetheless, personalized medicine approaches, which leverage sex-specific mechanisms, offer hope in revolutionizing autoimmune disease treatment. By tailoring interventions to individual patients based on their genetic and sex-specific profiles, researchers aim to maximize therapeutic efficacy while minimizing adverse effects.
Conclusion
In conclusion, the study unraveling the role of the Xist ribonucleoprotein complex in sex-biased autoimmunity marks a significant milestone in autoimmune research. It underscores the need for further exploration into the intricate mechanisms governing autoimmune pathogenesis, particularly with regard to sex disparities. Through continued research and innovation, the ultimate goal is to develop more precise diagnostic and therapeutic strategies that can effectively mitigate the burden of autoimmune diseases and improve the quality of life for affected individuals.
Scleroderma United
Spring 2024 Intern Articles
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., Li, R., Yu, B., Srinivasan, S., Abe, B. T., Kraft, K., Hellström, C., Sjöberg, R., Chang, S., Feng, A., Goldman, D. W., Shah, A. A., Petri, M., Chung, L. S., Fiorentino, D. F., … Chang, H. Y. (2024). Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell, 187(3), 733–749.e16. https://doi.org/10.1016/j.cell.2023.12.037
Scleroderma United
Spring 2024 Intern Articles
A Parent’s Guide To Tackling Pediatric Scleroderma In Their Child
By Diya Joshi from Weston, Florida, USA
What is Scleroderma?
Scleroderma is a rare autoimmune disease, meaning that an individual’s cells mistake themselves as foreign invading cells, which then causes the cells to attack themselves. This causes inflammation and destruction in different areas on the skin and adversely affects internal organs and blood circulation.
Since this is a chronic disease, the pain only worsens over time. Unfortunately, because there isn’t a cure for it, all of the treatments/medications that are taken to combat it, are targeted to weakening and slowing down the development of Scleroderma within an individual.
Types of Scleroderma
There are two main types of Scleroderma and they have their own subcategories of areas they impact. Localized Scleroderma is far more common in children than Systemic. Localized targets only the skin in different ways, while on the other hand systemic affects the whole entire body. Here is a more detailed description of the two:
Scleroderma United
Spring 2024 Intern Articles
Scleroderma in Children
As stated by the National Institutes of Health, Scleroderma is most commonly seen in individuals who are anywhere from 30 to 50 years of age. In fact around 2% of people with it happen to be younger than 10 years of age and 7% are 10-19 years of age.
Since there are only about 5,000 to 7,000 children in the United States with this medical condition as said by experts at Cleveland Clinic, many parents that have a child with this medical condition are unsure what the next step may be and how to deal with this as a parent.
It is understandingly hard to accept that your child has such a harmful disease, especially when it is this rare. According to Stanford Medicine, gene and environmental factors may play a role in why your child has Scleroderma but the cause is primarily unknown.
Although this condition, like all, comes with many extremities and implications, it is not nearly as limiting as many other conditions and there are many ways to comfort your child if they are struggling with it through various medications and treatments. Children are strongly encouraged to play sports with Scleroderma, to improve their mobility and flexibility as their skin is prone to tighten over time.
Scleroderma United
Spring 2024 Intern Articles
Common Symptoms
Scleroderma can affect individuals in varied intensities with varied symptoms so it can be hard to detect if your child has it, especially since it is such a rare disease. These are a few common symptoms seen in patients with this medical condition are the following:
If your child has been exhibiting some of these symptoms, it is strongly advised that they are taken to see a doctor and there they may be referred to see a rheumatologist or dermatologist depending on the severity of the symptoms. There they will be properly diagnosed, supervised, and given special treatment for the kind of medical condition they have.
Antibody, blood & urine, skin biopsy, echocardiogram, and pulmonary function tests may be taken in order to determine specifically what kind of Scleroderma your child has and what area it is specifically targeting in your child’s body, as stated by Columbia University Irving Medical Center.
Treatments & Medications
Unfortunately, there is no cure for Scleroderma yet, but there are some treatments and medications that can be used to tackle it. A few of them include the following:
Scleroderma United
Spring 2024 Intern Articles
Medications aid patients differently based on the type of symptoms present, severity of the symptoms, and type of Scleroderma they have. It is advised to start off with one to two of these treatments/medications and progress as needed.
Works Cited
Scleroderma United
Spring 2024 Intern Articles
Scleroderma research: What the research of the antifibrotic protein, Cathepsin L, tells us
By Elma Cesic from Chicago, Illinois, USA
What is Scleroderma?
Scleroderma is an autoimmune disease that causes inflammation and fibrosis (thickening) in the skin as well as other areas of the body. This abnormal growth of connective tissue, not only thickens the skin, but can also lead to internal organ damage.
Scleroderma can be broadly divided into two major types. Localized scleroderma only affects the skin and the structures directly under the skin. Its localized skin lesions and sores can get better or even go away completely. It is the more moderate type of this disease.
Systemic scleroderma, the more severe type, tends to affect many systems in the body including the skin and many different organs. Systemic scleroderma may cause joint pain, inflammation in the joints and muscles, and cause one’s fingers to turn white. This type of scleroderma tends to be deadly and most often damages internal organs.
As of today, scleroderma has no cure. As researchers study the disease, they have been able to uncover and connect different relationships that can make finding a cure more feasible in the upcoming decades.
Scleroderma United
Spring 2024 Intern Articles
Cathepsin L Scleroderma Research Findings
The Medical University of South Carolina’s (MUSC) research team made such a discovery when they approached their Scleroderma research differently than those in the past have. Instead of studying the increased number of proteins promoting fibrosis, they instead measured the levels of an antifibrotic protein, Cathepsin L, in Scleroderma patients. Amid their research, they noticed two critical components. They realized that, one, patients with scleroderma had reduced levels of Cathepsin L and that, two, the Cathepsin L that they did have was packaged in an non-functional state. This is significant because it tells us that patients with scleroderma have more profibrotic proteins than antifibrotic ones, effectively shifting the balance of these proteins in favor of fibrosis.
Researchers also discovered that Cathepsin L was reduced in the fibroblasts, or the cells responsible for fibrosis, of scleroderma patients. In general, fibrosis occurs when excess collagen gathers around surrounding cells as the rate at which the collagen is degraded is extremely low. This discovery in general helps explain why fibrosis occurs in the skin and internal organs of patients with scleroderma. Drugs have not been proven to stop this fibrosis, only merely delaying it, making discoveries like these pivotal role in addressing this component of the disease.
This study, specifically, is incredibly important as it provides a new lens for both doctors and researchers to utilize when studying scleroderma.
What does this research tell us?
Most plainly this research informs the general public about the significance of antifibrotic proteins and their relationship to the symptoms scleroderma patients experience. Research like this allows further medical and scientific professionals to draw their own conclusions and conducts related research that advances this issue further.
This research also does an incredible job of narrowing down the scope of scleroderma research by providing researchers further tools and ideas that can better shape what they study. This dwindling effect allows the research community more specific and catered resources that they can use to hopefully deduce the issue of a scleroderma cure to a focal point. With this we can develop a method of treatment for scleroderma in the upcoming decades, not centuries.
Scleroderma United
Spring 2024 Intern Articles
Although such advancements are incredible, it is also clear that further research is needed and attention to this research is also greatly important. Simply, the more of us that understand the advancements being made in this field, the more of us there are to fight for the same cause.
Further study
Further study of scleroderma related issues, can include understanding other protein behaviors that are impacted by Cathepsin L. This can include research into endostatin, another antifibrotic protein, that is released by Cathepsin L. It too helps reduce fibrosis when functioning correctly, so it too can have important significance in this field. Another path for further research can be the exploration into the genetic components for the lack of Cathepsin L in scleroderma patients. By understanding the genetic stressors, precursors, and risks associated with this protein, researchers can be further aware of what exactly can be done to reverse such occurrences. Both of these methods are great first steps that build off of this research that has already been conducted.
Research, in all fields, is vital to sustain and uphold as it helps us understand the inner workings of complex phenomena and concepts. It's vital we continue such steps and advance the field in positive ways as it will benefit generations of people and families that are affected by scleroderma.
Equally as important is the notion that people keep up with these advancements and understand them as they happen. An informed public on this issue will not only allow scleroderma to be more publicized in our media, but research like the one discussed here can continue to be done. It's up to us to do what we can to advance this cause, and there is so much that can be done!
What you can do
Scleroderma United
Spring 2024 Intern Articles
Scleroderma United
Spring 2024 Intern Articles
Healing is Pain: The Battle of the Scleroderma Warriors
By Elyse Da Costa from Toronto, Ontario, Canada
Scleroderma is a rare autoimmune disease characterized by the thickening and hardening of the skin. Despite the ambiguity surrounding the disorder, there exists numerous non-for-profit organizations that have been developed to spread awareness about the disease. Grassroot organizations such as Project Scleroderma, the National Scleroderma Foundation, and the Scleroderma Research Foundation have all pioneered their own set of advocacy strategies to illuminate the stories of those fighting against ongoing symptoms. Some Scleroderma symptoms could include tightening of the skin in such a way that grasping becomes difficult. Other side-effects could include progressive damage to internal organs such as the heart, lungs, kidneys and respiratory tract. Despite the detrimental byproducts of Scleroderma, there is unfortunately no cure. Although some might see this diagnosis as the “start of the end,” many Scleroderma patients are proving the exact opposite. On the contrary, these survivors are channeling their pain by facing it head-on!
The Artists’ Guidebook to Life
Scleroderma is a disease associated with a spectrum of different side-effects, from shortness of breath to crippling joint movements. Due to such
Scleroderma United
Spring 2024 Intern Articles
symptoms, it is often difficult for patients to complete daily tasks, some of which include:
What is astonishing however is that despite this obvious lack of mobility, many Scleroderma warriors have opted out of the painless, easy route. To put it simply, some patients are using outlets both to (1) advocate for Scleroderma and (2) cope with the illness that on the flipside causes them to face many of these challenges on a daily basis. Art-based therapy is just one of these outlets.
Whether painting, crocheting, or knitting, Scleroderma warriors worldwide aren’t letting their calloused skin get the better of them. Using art-based therapy, many advocates are using their craft as a tool of awareness as well as healing. An example of this can be seen in several published Scleroderma Stories, such as the story of Mercedes Howard, a woman who used knitting to help her open-up the tightening skin of her hands. It was through this form of natural healing that Mercedes was able to improve her own health. In her story, Mercedes remarked that although medication did provide relief, it was only for “some of the symptoms, not all.” Her profound reason to keep knitting despite the pain was because it “pushed her to do new things as a reminder that she still can.”
Another artists’ story includes her battle with progressive loss of limb coordination, including the spontaneous curling inward of the fingers. Nineteen-year-old Amy Gietzen from Buffalo, US. is a passionate painter and quilter, and has used this form of creativity to train her hands to accompany a larger range of movement. Younger Scleroderma Warriors such as Las Angeles' future artist, 11-year-old Angela Fernandez , uses painting as a stress reliever. Angela’s scleroderma symptoms include a combination of different side-effects including difficulty concentrating, fatigue, and insomnia. Anglea is using her love of painting and drawing to relieve tension that accompanies the difficulties of the autoimmune disease. It is through this craft that Angela can dream of a better and brighter future, more importantly, as the owner of
Scleroderma United
Spring 2024 Intern Articles
her own art gallery!
Through these mediums, many artists have found a way to cope with debilitating symptoms while taking care of their own mental wellbeing. Facing illness with a courageous and headstrong attitude allows Scleroderma patients all over the world to use their talents to the best of their ability. It speaks volumes on the artist's mentality of perseverance: “I can, so I will.”
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
What is CREST syndrome?
By Franny Khine from Brooklyn, New York, USA
Every year, 300,000 people, aging from ages 30 to 50 years old are diagnosed with Scleroderma, a disease formed by the rapid growth of fibrous tissue. One form of scleroderma is CREST syndrome. CREST is an acronym for calcinosis, raynaud’s phenomenon, esophageal dysmotility, and sclerodactyly, which are all clinical features seen in a patient with this disease.
Calcinosis is the act of calcium depositing in the skin and subcutaneous tissue. It may be caused by dystrophic calcification and is associated with calcium and phosphorus levels.
Raynaud’s phenomenon is the spasm of blood vessels in response to cold or stress. It decreases the blood flow in the fingers and in other parts of our body.
Esophageal dysmotility causes acid reflux and a decrease in the motility of our esophagus. It makes the process of passing food and water more difficult, which causes problems when swallowing.
Sclerodactyly is the creation of tension through the thickening and tightening of the skin on the fingers and hands.
Telangiectasias is the dilation of capillaries, which causes red marks on the surface of skin. Although they can be associated with diseases, they are
Scleroderma United
Spring 2024 Intern Articles
completely harmless.
A Hidden Curse
Why is there no cure for CREST syndrome? Despite being present in over a quarter of patients, and having over half a million cases per year, many doctors yet to know what this phenomenon is. There is no stopping the overproduction of collagen, but there are many medications that may prevent complications. Some medications include blood pressure medication, immune system suppressants, and pain relievers.
An article of a scleroderma patient, Tom Fry from Scleroderma United, said “I had probably two or three years worth of appointments in about only six months”. Tom had 15 different blood tests, was incorrectly prescribed, and almost died of renal failure a month later. In the end, he was saved by a doctor who specializes in Scleroderma.
Never the End
At the start, many patients may feel numb and abnormal, even left out, but that shouldn’t be the reason as to why we stop living our best life. Consider working on what you can access instead of what you can’t. Meet up with a friend and don’t be afraid to seek support. Having scleroderma shouldn’t indicate that we live a “dreadful” or “irrelevant life”, instead it means expanding our horizons and stepping out.
About the author
Franny Khine is a freshman at Brooklyn Technical High School, and an intern for the nonprofit organization, Scleroderma United. Since the start of high school, she curated a goal of being involved in the medical field. Luckily, Scleroderma united came along her path, and was given an unforgettable opportunity to advocate for an undermining disease (scleroderma). This article was a contribution to all Scleroderma patients and the overlooked battles that they have to face. She hopes that after having read this article, that maybe one more person would be willing to make a difference too.
Sources:
https://medlineplus.gov/ency/imagepages/19507.htm
Scleroderma United
Spring 2024 Intern Articles
Embracing Beauty: Navigating Makeup and Skincare for Facial Changes
By Heqing Feng from Nashville, Tennessee, USA
Scleroderma, a complex autoimmune condition, can profoundly affect an individual’s skin. Excessive collagen production leads to progressive thickening and hardening of the skin, further resulting in tightness and stiffness in facial features. Some scleroderma individuals may also experience microstomia, which is tightness around the mouth, and blepharophimosis, the narrowing of the eyelids. It can be uneasy to witness one’s facial skin alter as the symptoms progress, constantly reminding themselves and others of the presence of their disease. So, how about putting on some makeup?
While makeup is not necessary if you are comfortable with your skin, it can be a helpful tool if you find yourself struggling with the changes in your appearance – feeling embarrassed to be seen in public, weary of others' stares or questions about your skin – while also grappling with concerns about whether makeup might worsen your skin condition or whether you are “psychologically weak” by trying to hide your skin conditions. This article will guide on applying makeup for individuals with scleroderma.
The Power of Makeup and Skincare
Scleroderma United
Spring 2024 Intern Articles
First and foremost, there is no need to feel ashamed about wanting to wear makeup. Everyone experiences moments of self-consciousness about their appearance, especially when they feel different from others. Wanting to enhance one's appearance and cover imperfections is entirely natural. However, it can indeed be challenging to find makeup products tailored specifically for individuals with scleroderma and to learn techniques for applying them effectively to achieve a polished look. Here are some tips to improve your skin appearance:
There are also plenty of online resources to support individuals with scleroderma to improve their skin conditions.
SRUK (Scleroderma & Raynaud's UK): Skin Camouflage offers guidance on using camouflage techniques to conceal skin changes due to scleroderma. It provides tips on selecting appropriate products and techniques for effective coverage, and also advice on maintaining skin health and managing self-esteem.
Changing Faces supports individuals with visible differences, such as those from medical conditions like scleroderma, by providing counseling services, peer support, and practical advice.
American Academy of Dermatology (AAD): Scleroderma Self-Care also
Scleroderma United
Spring 2024 Intern Articles
provides comprehensive information on mitigating skin symptoms of scleroderma through self-care, including advice on skin care routines, protective measures, and suitable skincare products to reduce the discomfort from scleroderma.
Thriving with Scleroderma
Fighting scleroderma is a long and arduous battle, so it is crucial to maintain a healthy mindset. Beyond skincare and makeup, finding supportive communities and online forums can provide comfort and encouragement. You are not alone in the battle, and connecting with others through platforms like Scleroderma United will help foster a sense of belonging and acceptance. Also, engaging in hobbies like outdoor adventures, arts and crafts, or culinary not only adds excitement to life but also shifts your focus from what you are losing due to the disease to what you are accomplishing. By embracing a comprehensive approach to wellness, you will be empowered to navigate the complexities of living with scleroderma with resilience and positivity.
Scleroderma United
Spring 2024 Intern Articles
Diagnosed with Scleroderma: What’s Next? Ways of Taking Care of Your Mental Health
By Imaan Mehmood from Ajax, Ontario, Canada
What is Scleroderma?
Scleroderma is an autoimmune disease that can impact many aspects of your life. Scleroderma can come in two main forms: system (SSc) or localized. SSc is the form of scleroderma which typically impacts the skin as well as the organs and systems within the body. Its progression is characterized by blood vessel abnormalities, overproduction of collagen, and immune system dysfunction. SSc can manifest in a number of ways: Raynaud phenomenon, telangiectasias, esophageal dysfunction, pulmonary fibrosis, high blood pressure, kidney damage, decreased gut motility, calcinosi, and pulmonary hypertension. Localized scleroderma, as the name suggests, affects limited and localized areas of skin. As a result, scleroderma has the potential to impact the entire body. This can have implications on your relationships, career, education, and hobbies as well. Such a drastic, life changing diagnosis may also impact your mental health.
The Connection Between Scleroderma and Mental Health
There is a strong connection between chronic physical illness, depression, and anxiety. The physical constraints that come with scleroderma undoubtedly become a strong driving force for adapting new lifestyle
Scleroderma United
Spring 2024 Intern Articles
changes. Consistent physical pains, financial difficulties, and major disruptions to social life and work are changes that may come with scleroderma that are correlated with declines in mental health. In addition, this diagnosis comes with a lot of uncertainty. Patients often describe not understanding what exactly their diagnosis will mean for them, and how it will manifest in their body. This uncertainty stems from the "the unknown cause of scleroderma, the unpredictability of this disease, and the variability of this disease course from patient to patient”, which is an added stressor that many patients face. Amongst all this uncertainty, there is one thing you can be sure about: we all have the potential to take charge in our medical journey and make the best of what we have.
Keeping your Mind Healthy
Taking care of your mind alongside your body is crucial for combatting this disease. Firstly, your relationship with your doctor matters. Finding a doctor that will share in your concerns and figure out innovative ways of managing the disease is incredibly important. Also, building a strong support system is crucial for being able to express what you are going through. There are a number of local and international organizations that are built around a strong and supportive community. In fact, many scleroderma patients feel a great amount of empowerment and confidence through advocacy work and involvement within their community. This often becomes a means of forming long-lasting relationships as well. Importantly, mindset is extremely important. Many people with scleroderma around the world are combatting this disease with sheer strength of mind, alongside keeping their physical health in check. Yogita Sharma, an associate consultant living in Delhi, India, was diagnosed with systemic sclerosis in her late teen years. Yogita emphasizes how having support and developing a strong mindset were crucial in battling her declining self-esteem following the onset of the disease. She stresses that people with scleroderma should still “go anywhere and do anything” that they want to the best of their abilities. Yogita actively works in an NGO to support others with scleroderma at a global level. There are many Scleroderma Stories of inspiring individuals that have implemented unique ways of not only coping with the disease, but thriving despite it. As always, if you are experiencing negative thoughts, difficulty coping with the disease, and other symptoms related to your mental health, this is completely normal. Make sure to reach out to a professional that can understand your struggles and help you navigate these tough times.
Scleroderma United
Spring 2024 Intern Articles
Having scleroderma does not mean you will have to stop doing what you love. It is important to find encouragement and enable ways for yourself to continue pursuing your passions and interests despite the difficulties that come with the disease. With the right care, support, and choices, there is no doubt that your life can be fulfilling and active.
Scleroderma United
Spring 2024 Intern Articles
The Further Impact of Chronic Physical Illnesses
By Isha Parikh from Plano, Texas, USA
My name is Isha Parikh, and I found a lot of interest in the connection between mental and physical health disorders. The fact that both chronic illnesses can cause mental health disorders to form and vice versa stood out to me. Through this, I further researched how mental health disorders can originate and ways to combat them. This article can help spread information about dealing with mental health disorders that can impact someone's life.
A chronic physical illness is a lasting health problem that will never go away and can be managed but not cured. Not only can it not be cured, but chronic physical illnesses require a lot of medical attention and can limit activities of daily life. Some examples include diabetes, asthma, arthritis, scleroderma, and even cancer. These illnesses can range from something that's life-threatening to something that's just life-altering. Despite this, people who have chronic physical illnesses tend to have a higher chance of getting depression or anxiety, further worsening their condition.
The American Psychiatric Association found that anxiety disorders make up 30% of all mental health disorders. When you think of anxiety, what comes to your mind? Maybe anxiousness and worry, but that's not all. Anxiety is when the nervous feelings don’t go away, which can make it hard to cope with daily living or do simple things like taking tests, talking to people, or waiting for results. Whether one has Generalized Anxiety Disorder (GAD) or Panic
Scleroderma United
Spring 2024 Intern Articles
Disorder, any type of anxiety can impact a person’s mental health and attitude. According to Forbes Health, another considerable mental health disorder that impacts about 280 million people worldwide is depression. Depression is more than just feeling sad or overwhelmed; it’s a condition that can affect your physical and mental well-being. Depression can cause a constant feeling of sadness and a loss of interest, which can interfere with a person’s daily life. Anxiety disorders and depression are only a few examples of mental health disorders, but they can change someone’s attitude and life because of the lack of compassion from other people or significant changes in their life.
How do these mental health disorders originate in people with chronic physical illnesses though? Living with these illnesses usually results in a loss of independence or the feeling of being misunderstood. In addition to this, receiving news as big as having a disease that will impact the rest of one’s life can affect a person if they don’t have people around them to help. Without understanding or compassion, a feeling of loneliness is created, further intensifying the negative impact on their mental health. Not only do mental health disorders originate after being diagnosed with a chronic physical illness, but they can also lead to some. For example, depression increases the likelihood of developing heart conditions or diabetes. With a mental health disorder, a person with a chronic illness may find it harder to go outside, eat a proper amount of nutrients, exercise, or do other things that can better their well-being.
Now that we’ve talked about the mental health disorders that are associated with chronic physical illnesses and their impacts, how can we combat these disorders? The American Psychological Association says that being surrounded by understanding and friendly people can lift your mood by 15%. For people with chronic physical illnesses, there are a lot of support groups that can help. A lot of other things that can help boost your mood are going to therapy, breathing exercises, talking to someone you trust, keeping track of your day in a diary, and pursuing a hobby. Overall, chronic physical illnesses can crucially impact a person’s physical health, but with an adequate amount of help, a person’s day or even life can be changed.
Scleroderma United
Spring 2024 Intern Articles
Are COVID-19 Vaccines Effective for People with Scleroderma?
By Jadey Ding from Melbourne, VIC, Australia
Vaccines have always been a heavily debated topic in the medical field, some promoting their efficacy, some heavily against them due to reported adverse effects. But what about the efficacy of COVID-19 vaccines for people with scleroderma? As of 19/03/2024, 70.6% of the world population has received a COVID-19 vaccine1, but this number is not reflected in people with scleroderma, specifically systemic sclerosis (SSc). SSc is a rare chronic disease that causes internal organ damage and skin abnormalities. There are two subtypes of systemic sclerosis: limited cutaneous and diffuse cutaneous.
Multiple studies have found that patients with SSc had a higher risk of moderate-to-severe COVID-19 infection and death 2,3. This was particularly apparent in those with SSc-ILD (interstitial lung disease associated with systemic sclerosis) as they were highly impacted by COVID-19. ILD is a group of disorders that causes progressive scarring of lung tissue, affecting one's ability to breathe and obtain enough oxygen. The damage of ILD renders individuals unable to regain full use of their lungs.
When a vaccine is injected into an individual, the weakened/inactive fragments of the organism and included parts of the antigen (disease) will trigger an immune response4, involving the body producing specific antibodies to attack the antigen. Many COVID-19 vaccines, especially Pfitzer,
Scleroderma United
Spring 2024 Intern Articles
Moderna and AstraZeneca require at least two doses to ensure the individual has long-term memory and protection of antibodies against COVID-19 and allow the continuous development of memory cells. As autoimmune diseases already decrease one's immune system due to less leukocytes, COVID-19 vaccines may be doing more harm than good for individuals with SSc.
People with scleroderma are given immunosuppressants as treatment for their skin thickening caused by the overproduction of collagen. An immunosuppressant is a class of medicine that can either “inhibit or decrease an immune response’s intensity”5 and reaction rate.
Specific immunosuppressants, such as Mizoribine, can inhibit the proliferation of lymphocytes6. Lymphocytes play a key role in antibody production, meaning it directly influences one’s response to vaccines. Hence, a person who is immunocompromised is unlikely to adapt to the abnormal immune response caused by the vaccines, causing them to not only be unprotected due to the reduced immune response, but feel more uncomfortable. It is important to know that “death may also occur”7 due to a weakened immune system, as the body cannot withstand any more damage due to the little immune cells available to tackle additional unknown pathogens.
People with SSc may also enter a renal crisis following the vaccination. One patient after their first dose of Pfizer (a common COVID-19 vaccine) developed persistent headaches, nausea, and sudden acute vision loss with extreme high blood pressures8. After- effects of COVID-19 vaccines can also include rapid progression of skin thickening9, which was seen from a 70 year old man after receiving the first dose of AstraZeneca. As there are new COVID-19 vaccines constantly entering the market, there are many unexpected and unfound detrimental aftereffects, such as relapses10 or stable patients after vaccinations. Other adverse reactions include physical pain, such as sore arm, muscle ache and joint pain, as well as chills and fevers11, which builds on top of the pain and discomfort of SSc patients.
It has been suggested that SSc Covid-19-infected patients can consider TCZ infusion if they are undergoing other treatments and experiencing mild symptoms12. TCZ is a recombinant humanised anti-interleukin-6 receptor monoclonal antibody, which has a main use in the treatment of rheumatoid arthritis. In infected hospitalised SSc patients, preventive anticoagulation (substances that prevent blood clots)12 is advised. Other methods of lowering the chance of infection for SSc patients include social distancing, washing hands often, and wearing masks in crowded spaces.
Scleroderma United
Spring 2024 Intern Articles
Substantial amounts of data have proven COVID-19 vaccines to be effective, however, health officials and professionals must consider the individual’s health first. Therefore, for SSc patients, it is not the vaccine itself being ineffective, but the fact that they are immunocompromised, meaning they cannot produce the maximum number of antibodies from the vaccine. As a result, their immune reaction to the vaccine is smaller compared to a healthy individual, hence why they would have less protection against COVID-19, making the vaccine less effective.
Sources
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Empowering Oneself in the Face of Scleroderma
By Jaguar Ngo from Brisbane, Queensland, Australia
Introduction
When first starting my internship at Scleroderma, little did I know I would embark on a journey that would change not only my perception of the disease but chronic diseases themselves. When first beginning the internship, we were tasked with reading profiles and stories of patients with Scleroderma. From what I already knew, I perceived Scleroderma to be a debilitating disease – one that stalled the life of the person diagnosed. However, as I continued to research patient profiles and stories, I was amazed at both the optimism and the empowerment each person diagnosed showed for the future. In the words of one Scleroderma warrior, “Scleroderma was definitely not in the plans, but I have it, and it is now a passenger in my life.”
Understanding Scleroderma
For those who do not know, Scleroderma is an autoimmune disease associated with the overproduction of collagen and immune system dysfunction. There are two main types of Scleroderma: systemic sclerosis and localized Scleroderma. Common symptoms of Scleroderma are Raynaud’s syndrome, oesophageal issues as well as telangiectasias. It can also complicate into pulmonary fibrosis, kidney disease, and bowel disease. While the specific cause of Scleroderma remains unknown, genetic and
Scleroderma United
Spring 2024 Intern Articles
environmental factors are thought to contribute to its development.
The Emotional Impact
Given the severity of the disease, initial diagnosis is often difficult on patients. Not only is the physical toll exhausting, but the chronic nature of the disease can also affect an individual both emotionally and financially.
In my reading of Scleroderma Stories, patients often discussed difficult truths of overcoming depression, anxiety surrounding the disease, and uncertainty for their future.
However, what was most inspiring was learning the ways in which people overcame such adversity through community and connection.
Through groups like Scleroderma United, fellow patients with Scleroderma could share their experiences with the disease and ways they have dealt with their symptoms. They share treatment tips, provide emotional support, and work together to build a strong Scleroderma community.
Other individuals opened up to their families and friends who stood as a beacon of hope and support for those diagnosed.
One example is that of a patient who initially felt isolated and alone following her diagnosis. However, through her participation in a charity walk for Scleroderma she discovered the existence of a supportive community, which dispelled her sense of isolation and invited a newfound sense of belonging and resilience.
Taking Control
These articles not only highlighted to me the importance of making oneself vulnerable and being open to connecting with others, but they also served as a reminder that extending a hand of support can make an incredible difference in someone’s life.
As I continued to learn more about the disease and the stories of individuals diagnosed, I was also impressed by the sheer number of patients who refused to be defined by the disease.
As part of the Art & Business Project, my role was to identify patients who were either artists or small business owners and to promote their endeavours on the Scleroderma United website. In doing so, I was inspired by the feats people had achieved in spite of such a severe disease like Scleroderma.
From aspiring models and bloggers to talented musicians and artists, these individuals not only pursued their passions but also thrived despite the challenges posed by Scleroderma. Many have started their own entrepreneurial ventures, offered invaluable services, and enriched the lives of others through their expertise and creativity.
While each of these patients still live each day trying to minimise the effect
Scleroderma United
Spring 2024 Intern Articles
Scleroderma has on their life, they thrive in achieving their goals and doing amazing things.
Thank You Warriors
In closing, my time as a Scleroderma United intern has taught me so much. It taught me the emotional, physical, and financial toll that chronic diseases like Scleroderma can have on individuals. It taught me the transformative power of community in overcoming adversity. But most of all, it taught me that regardless of the circumstances one faces, the empowerment to shape one’s destiny and future is within reach to all.
To all the Scleroderma warriors out there, your enduring resilience and courage continues to inspire us all.
Sources
https://www.niams.nih.gov/health-topics/scleroderma
https://sclerodermawarriors.org/
Scleroderma United
Spring 2024 Intern Articles
How the Scleroderma patient experience is reflected in the stages of Grief and the Biopsychosocial Model; protective and risk factors as patients proceed through the stages of grief.
By Jia Hui Lin from Melbourne, Victoria, Australia
What is Scleroderma?
Scleroderma is a rare autoimmune disease that causes the skin and internal organs to thicken. In Australia, 6000 individuals have scleroderma, compared to 2.8 million people with eczema.
The five stages of grief
Kubler-Ross’s model proposed that individuals proceed through 5 stages (denial, anger, bargaining, depression and acceptance) when dealing with grief. While it has its merits, this model could be applied to patients with Scleroderma.
How patient experience reflects the five stages of grief
Scleroderma stories share insights about the sentiments of Scleroderma patients from pre-diagnosis to the onset of disease, and finally, life adjustments and management of the condition to live a fulfilling life despite the disease.
Scleroderma United
Spring 2024 Intern Articles
Through qualitatively coding the Scleroderma stories (identifying key themes and messages in the stories), an identifiable pattern emerged that aligns with the five stages of grief.
Patients commonly experience feelings of denial due to the prevalent misdiagnosis and rarity of the disease among those receiving the diagnosis: patients experience anger due to disruption of lifestyle accompanied by disease. For example, patients have increased difficulty participating in active hobbies and work due to the hardening of skin; patients attempt to manage the disease via bargaining, making compromises such as time off work to manage symptoms, or engaging in new coping mechanisms; patients experience depression due to complex treatment (immunotherapies), co-morbidities such as cardiovascular diseases, infection) and isolation due to having to sacrifice work given the symptoms; finally, patients accept the disease and use their unique ways to pursue a meaningful life, for example, engaging in advocacy to empower patients with similar experiences and maintaining mobility.
Protective and risk factors associated with the five stages of grief
Having identified that patients proceed through the stages of grief, it is important to consider what are some protective factors and risk factors associated with how fast patients proceed through these stages to best support patients navigating the disease following diagnosis.
A protective factor may be social network support. A consensus protective factor highlighted in literature and Scleroderma stories is the importance of the social support network. As it is a rare chronic condition, patients tend to feel isolated. Therefore, building a support network with loved ones, family, friends, and other patients may encourage patients to accept the disease. Psychoeducation for carers and family members of patients with Scleroderma could enhance this.
A risk factor prohibiting patients from proceeding through the cycle of grief may be the financial burden accompanied by the disease. Many patients can no longer work due to the condition, and the increase in medical bills and other expenses, such as specific dietary requirements, may deter patients from seeking support such as counselling. The financial instability may make it difficult to continue certain treatment options, which are expensive and also impact quality of life, making it harder for patients to come to acceptance of the disease.
Scleroderma United
Spring 2024 Intern Articles
This risk factor could be addressed by initiatives developed to support patients with chronic illnesses, such as the Health Care Card in Australia and the Social Security Disability Insurance in the United States. Healthcare professionals should also consider the patient's financial situation when developing treatment plans to ensure it is long-term financially feasible for the patient.
Importance of holistic approach to a rare chronic disease
As a chronic illness, Scleroderma has a holistic impact on patients. Aside from biological symptoms, scleroderma is also accompanied by a mental health toll and social interruptions for patients. Therefore, when developing treatment options and long-term care plans for patients with scleroderma, medical professionals and allied health practitioners should adopt a holistic approach to ensure these different factors are considered, as they all are important considerations for patients' quality of life.
The theory underpinning this is the biopsychosocial model, which suggests that illness is an interaction between biological, psychological and social factors. This could be addressed in a clinical setting by incorporating patients into developing the treatment plan to ensure patients' needs are accurately and adequately addressed. Another way to apply it in a clinical setting would be using a multidisciplinary treatment team to provide comprehensive patient support.
It is also important to note that each patient’s financial situation, values, support level needed, and disease severity are different. Therefore, doctors should tailor treatment methods to each patient. A fixed treatment plan for all patients would fail to address that.
Scleroderma United
Spring 2024 Intern Articles
Pediatric Scleroderma: Scleroderma in Children
By Jisara Wuttikreekiat from West Vancouver, BC, Canada
Scleroderma is an autoimmune disease that causes inflammation and fibrosis (thickening) in the skin and other areas of the body. While the condition itself is rare in adults, it is possible for children to develop the disease, which leaves a significant impact on families when their child is diagnosed with an unfamiliar disease. Therefore, understanding the distinct clinical features, diagnostic approaches, and therapeutic considerations specific to pediatric scleroderma becomes a discussion that could not be ignored.
Overview
Pediatric scleroderma includes two major groups of clinical entities, systemic sclerosis and localized scleroderma. Localized scleroderma often affects only the skin and not major organs. On the other hand, systemic scleroderma affects the skin and may affect the tissues under it, including blood vessels and major organs. This implies that those diagnosed with systemic scleroderma are more likely to be fatal. According to the National Library of Medicine, although both are uncommon in children, the estimated annual incidence of localized scleroderma is 1–3 per 100,000 children while systemic scleroderma is 1 per million children.
Scleroderma United
Spring 2024 Intern Articles
Clinical Features
The most common clinical feature presented on children diagnosed with scleroderma is thickened or hardened skin, often in a symmetric distribution. Another common feature is changes of color in fingers or toes in responding to stress or cold. Although more difficult to spot on children, symptoms such as joint pain, stiffness, and swelling can be developed as a result of skin tightening. However, for systemic scleroderma, the child might experience affects in their internal organs such as gastrointestinal, respiratory or cardiac symptoms. Those symptoms include: abdominal pain, bloating, diarrhea, constipation, shortness of breath, cough, and chest pain.
Diagnostic Approaches
The first step is to recognize the symptoms and head to a clinic for a professional to do physical examinations for the conditions present. After that, depending on the results, laboratory tests might be necessary to provide experts with the information needed to confirm their diagnosis. Blood tests are used to elevate inflammatory markers, autoantibodies such as anti-nuclear antibodies, anti-Scl-70 antibodies, and anti-centromere antibodies. Moreover, imaging scans may be used to evaluate internal organ involvement such as lung fibrosis in the case of systemic scleroderma. It is extremely important to let an expert or a professional to provide accurate diagnosis and information regarding the treatments moving forward.
Therapeutic Considerations
Unfortunately, there is currently no cure for this disease and as a result, patients are encouraged to undergo therapy. Medications are used to alleviate symptoms, control inflammation, and prevent organ damage while physical therapy helps with joint contractures, mobility, and in general, improving life’s qualities. Overall, with current technologies, there are not a lot of treatment options for scleroderma, let alone pediatric scleroderma.
In the end, given the rarity of scleroderma and the panic it often causes in adults who aren't familiar with it, imagine the added worry for parents when their child is diagnosed. Therefore, the purpose of this article was to ease this stress, by explaining the signs of scleroderma in children, what it can do, and how it can be treated.
Scleroderma United
Spring 2024 Intern Articles
Linear Scleroderma in Pediatric Patients: What It Is, How We Can Treat It, and Why It’s Important
By Joy Wei from Forest Hills, New York, USA
Introduction: What is Linear Scleroderma?
Linear scleroderma is a kind of scleroderma that presents a distinct problem in pediatric dermatology and rheumatology: unlike the more well-known diffuse type of scleroderma, which usually affects adults with broad skin involvement and/or internal organ issues, linear scleroderma mostly affects children and adolescents. This form of the condition is characterized by localized skin thickening along linear tracks. These all mean that this condition's pathogenesis, clinical manifestations, and management strategies are significantly different from those of its counterparts, or other subtypes. Thus, linear scleroderma requires a focused understanding and approach. The importance of early detection/specialized care in managing linear scleroderma (particularly in children) means that not only clinicians, but also the general public, should recognize and address it in order to mitigate its potential impact on growth, development, and overall quality of life.
Diagnosing Linear Scleroderma:
Linear scleroderma in younger patients has a specific clinical profile, including thicker skin bands, joint stiffness, and the possibility of growth disruption. In contrast to the diffuse or systemic types of scleroderma that are
Scleroderma United
Spring 2024 Intern Articles
more common in adults, linear scleroderma is characterized by localized skin involvement and limited systemic symptoms. The linear distribution of skin thickening along with joint stiffness distinguishes this subtype, often affecting specific areas on the body such as the limbs, face, or trunk. Moreover, the potential for growth disturbances in affected areas further underscores the unique nature of linear scleroderma in children. Despite these distinguishing characteristics, however, the diagnosis of linear scleroderma in pediatric patients is still extremely difficult (because of the disease's rarity, as well as its symptoms overlapping with other rheumatic illnesses). For example, the Children’s Hospital of Philadelphia states that linear scleroderma is often mixed up with Parry-Romberg syndrome because both conditions are characterized by the same progressive loss of subcutaneous fat, and both occur in childhood. Therefore, these diagnostic difficulties highlight the need for a comprehensive evaluation by an experienced team (for example, a medical team comprising of pediatric specialists, rheumatologists, and dermatologists) in order
to accurately differentiate linear sclerosis from other conditions and enable prompt management!
Treatment for Linear Scleroderma:
When treating linear scleroderma, a team-based approach guarantees thorough evaluation, precise diagnosis, and customized treatment regimens catered to the specific requirements of the child. Regular evaluations of skin involvement, joint mobility, and growth factors, along with close observation of the disease's course, allow for prompt modifications to treatment plans aimed at maximizing benefits and reducing drawbacks. There are also many therapeutic options available for treating children with linear scleroderma including topical treatments, systemic medicines, and physical interventions.
In the end, though, it's critical to weigh the benefits and drawbacks of each
Scleroderma United
Spring 2024 Intern Articles
course of treatment in relation to the child's overall health and the severity of the illness.
Psychosocial Aspects:
A comprehensive approach to care that takes into account both the medical and psychological/social elements of the condition is also very important, since linear scleroderma can have a significantly negative influence on both a child's physical and mental health. The need of giving children and their families continuing assistance and counseling is underscored by the physical changes and possible functional limitations that may have an impact on social interactions, body image, and self-esteem. As Rheumatology Advisor mentions, psychosocial therapies, such peer support groups and cognitive-behavioral therapy, can help kids be resilient and manage the emotional difficulties brought on by their conditions. Furthermore, advocating for social inclusion and educational adjustments as well as creating a supportive atmosphere at home and at school are crucial elements of holistic care for kids with linear scleroderma.
Conclusion:
Children with linear scleroderma have a wide range of long-term prognoses, which are influenced by factors such as therapy response, extracutaneous symptoms, and the degree of skin involvement. With early and active treatments, some children may have illness remission or stabilization; however, other children may have complications, including joint contractures, disparities in limb length, or functional impairment, which require continuous monitoring and care. Frequent follow-up appointments and care are necessary to identify any problems early, correct them, and modify treatment plans as necessary. Ultimately, even though children with linear scleroderma will likely face many obstacles, their long-term prognosis and outcomes can definitely be improved with early detection, prompt management, and comprehensive treatment!
Sources:
https://www.sruk.co.uk/scleroderma/understanding-scleroderma/scleroderma-systemic-sclerosis-diffuse/
Scleroderma United
Spring 2024 Intern Articles
Scleroderma United
Spring 2024 Intern Articles
Exercise and Scleroderma Patients: Biological Functioning Improvement
By Kaitlyn Flanagan from Toronto, Ontario, Canada
The diagnosis of the autoimmune disease Scleroderma can bring on many daunting perceptions, but exercise is the answer. The progression of Scleroderma can leave individuals searching for treatment options to better their bodies and regain some of the physical strength they had before diagnosis.
Many symptoms are brought on through the diagnosis of Scleroderma, posing a need for physical treatment options to make patients feel better about themselves. Individuals in the study for Identifying barriers and facilitators observe that rehabilitation is a challenge due to the involvement of the skin, musculoskeletal system and internal organs for patients.
The pathology of this autoimmune disease generates an unpredictable nature in which patients can improve. In 50-60% of Scleroderma patients, it is indicated that there is a consistent usage of a physical therapist for a period of time. This deciphers that although the disease is rare, a non-pharmaceutical intervention like exercise can be conducted at home as a safe way to improve circulation and therefore promote better biological functioning.
Scleroderma United
Spring 2024 Intern Articles
The management of pain and need for improved mobility makes a great difference in biological functioning when physical activity is engaged in. The range of exercise is endless, but the starting point for all should be low impact activities. Scleroderma patients not only feel better moving their bodies physically, but their mental clarity will also improve.
So what low impact exercises can I start doing today?
As a newly diagnosed patient it is very important to get into a physical routine to avoid the arisal of any new symptoms, particularly build up of scar tissue or fibrosis.
However the following physiotherapy workouts were designed through Scleroderma & Raynaud's UK, an incredible source for patients to combat their diagnosis right away:
Face: lifting eyebrows, winking eyes individually, frowning your forehead and grinning without showing teeth
Back: sit on a chair and twist, lie on your back and twist knees to both sides and stretching your arms behind you
Neck: tilt your head to each shoulder and rotate your head to each side
Wrists: extending or flexing wrist by placing palms together and lowering or raising them down the chest
Shoulders: standing up hold a stick and face upwards until you feel a stretch
Furthermore, higher impact exercises are also available for those that feel they need greater strides in mobility to fit their specific needs. One individual demonstrated the way in which your body can improve over the course of engaging in multiple marathon runs through his Run Greg Run campaign. The evident love for running can be translated to all Scleroderma patients looking to better their bodies.
What exercises are next if those are too easy for me?
The consultation of a physician before pursuing strenuous exercise is highly encouraged, as it is always best to know your limits and stay within them. Experimenting with the following aerobic exercises can improve symptoms significantly:
Scleroderma United
Spring 2024 Intern Articles
Although any activities described can have positive effects on patients, the best way to allow biological function improvement comes down to a daily routine to stick by. Setting a routine can be hard when fluctuations in physical limitations occur due to the flare ups of symptoms linked to the disease. These challenges make it especially important to move your body in any way you can without being too hard on yourself.
The important takeaway is that the progressive symptoms are proven to become suppressed when diagnosed Scleroderma patients are actively engaged in physical activity. Learning to incorporate exercise into a routine will have exponential effects on those impacted by Scleroderma of all forms.
Scleroderma United
Spring 2024 Intern Articles
Close Relationships Promote Internal Healing In Scleroderma Patients
By Kaitlyn Flanagan from Toronto, Ontario, Canada
The diagnosis of Scleroderma can create an uncomfortable atmosphere for the one affected and others surrounding. The importance of close relationships in the promotion of internal healing is the best way to connect your mind and body together. Surrounding yourself with those who care about you can lift your spirits and create a place of growth.
At first diagnosis, patients may find it hard to connect with those around them as their life feels so removed from what they once knew. Not knowing who to talk or turn to can create a divide causing a disconnect in the individuals intrapersonal relationship with themselves. This poses the need for those diagnosed to seek out ways in which they can be listened to, but also provide reassurance in return.
Healing internally comes from expressing to the external world, particularly through interpersonal relationships. The use of these bonds with others is highlighted within Conversation, activities reduced SSc patients' loneliness where opening up about your disease improved quality of life.
Normalizing that the diagnosis is now a part of your life makes it easier to interact with others. Those diagnosed should not feel the need to hide because the internal processes of one’s mind still behave the same, making
Scleroderma United
Spring 2024 Intern Articles
them the same person.
Individuals diagnosed can go about meeting their emotional needs in many ways. There are many Support Groups in Scleroderma totalling over 175 in North America alone. These groups are led by peers who share their experiences and can ignite a new way of viewing your diagnosis. Ultimately, proposing a new outlook on life while living with the autoimmune disease Scleroderma.
How can I express my emotional needs to combat the learning curve of my diagnosis?
Taking the first step into mending interpersonal relationships can be a tricky one, but the best place to start is to be open with friends and family. Being vocal about your health struggles can improve the way a loved one views Scleroderma, as your assuredness can make peace with it for them. The following guide can help those diagnosed mend a learning curve:
What will I get out of the various forms of interpersonal relationships?
The progression of normalcy will propel you into a better way of living as the disease will no longer feel as though it is running your life. There are many Reasons for attending support groups and they can be described below:
The most powerful way to combat the diagnosis emotionally is to make peace with it. Creating a safe space with those around you will promote so much internal healing that the disease will become background noise. Finding the light at the end of the tunnel will make everything easier in your healing process and this is done through the communications with others.
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Navigating the Complexities of Chronic Illness through the Lens of a University Student: Understanding the Connection between Physical Health and Mental Well-being
By Karson Yuen from Toronto, Ontario, Canada
Living with a chronic illness presents a unique set of challenges that extend beyond the realm of physical health, often intertwining with one's mental well-being. For university students grappling with chronic conditions, the journey is multifaceted, encompassing not only the management of symptoms but also the emotional upheaval that accompanies the chronicity of their health condition. In this article, we'll explore the relationship between chronic illness, anxiety, and depression, shedding light on the complexities faced by students navigating these intersecting realms. Moreover, we'll explore practical strategies and resources aimed at fostering resilience and promoting holistic well-being within the university setting.
The experience of living with a chronic illness as a university student is akin to traversing a labyrinth, fraught with twists and turns that demand adaptation and resilience. From managing coursework and extracurricular activities to attending medical appointments and coping with fluctuating symptoms, the balancing act can be overwhelming. However, what often remains unseen is the toll that chronic illness takes on mental health, manifesting in the form of
Scleroderma United
Spring 2024 Intern Articles
anxiety and depression.
Anxiety is a prevalent companion for many university students contending with chronic illness. The uncertainty surrounding the trajectory of their health condition, coupled with the pressure to excel academically, can amplify feelings of worry and apprehension. The fear of experiencing symptom flare-ups during crucial academic deadlines or missing out on social engagements due to health constraints can contribute to heightened anxiety levels, further exacerbating the challenges of student life.
Similarly, depression casts a shadow over the lives of students navigating chronic illness, permeating their daily existence with feelings of sadness, hopelessness, and despair. The relentless nature of the illness, coupled with the disruption it imposes on academic and social pursuits, can erode one's sense of identity and purpose. The struggle to maintain academic performance amidst the ebb and flow of symptoms can fuel self-doubt and exacerbate feelings of worthlessness, compounding the burden of mental distress.
Acknowledging the Connection of chronic illness, anxiety, and depression is essential in fostering a supportive environment for university students. Cultivating awareness and understanding among faculty, peers, and healthcare providers can help destigmatize discussions surrounding mental health and create avenues for meaningful support. Additionally, integrating mental health education and resources into university curricula can empower students to recognize the signs of distress and access appropriate support services.
In addition to institutional support, students can benefit from cultivating coping strategies to navigate the challenges of chronic illness and mental health. Utilizing mindfulness and relaxation techniques, such as deep breathing exercises and guided meditation, can help alleviate stress and promote emotional well-being. Moreover, seeking peer support through student-led organizations or online communities can foster a sense of belonging and solidarity, reducing feelings of isolation and fostering resilience.
Professional intervention, including therapy and medication management, plays a crucial role in addressing anxiety and depression among university students with chronic illness. Cognitive-behavioral therapy (CBT) in particular
Scleroderma United
Spring 2024 Intern Articles
offers practical tools for challenging negative thought patterns and developing adaptive coping mechanisms. Additionally, psychotropic medications, prescribed under the guidance of a healthcare provider, can help alleviate symptoms of anxiety and depression, enhancing students' ability to engage fully in academic and social pursuits.
In conclusion, the journey of university students grappling with chronic illness is marked by intricacies that extend beyond the confines of physical health. By recognizing the interplay between chronic illness, anxiety, and depression and implementing comprehensive support strategies within the university setting, we can empower students to thrive academically and emotionally. Through collaborative efforts and a commitment to holistic well-being, we can cultivate a university environment that nurtures resilience and fosters the growth and development of all students, irrespective of their health status.
Additional resources if you need support:
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Supporting Scleroderma through Stories
By Karson Yuen from Toronto, Ontario, Canada
Scleroderma, a condition that involves the hardening and tightening of the skin and connective tissues, is more than a medical term; it's a reality that thousands live with every day. While scientific definitions provide clarity, they often fail to capture the human experience behind the diagnosis. It's through personal stories that the true impact of scleroderma comes to light, presenting the emotional and physical journey of those affected. By exploring these stories, it sheds light on the courage, challenges, and resilience that define the lives of individuals with scleroderma.
In Issue 5, we feature a tapestry of personal stories from those battling scleroderma. Each narrative offers a unique perspective, from the shock of initial diagnosis to the rollercoaster of emotions that ensues. These stories are not just about the struggles but also the victories, big and small, that punctuate this journey. Through them, we gain a deeper understanding of the day-to-day realities and the indomitable spirit of those living with scleroderma.
No one should navigate scleroderma alone. The stories we've gathered underscore the vital role of support systems—family, friends, and specialized scleroderma communities. These networks not only provide emotional solace but also practical advice for managing daily challenges. Shared experiences forge a bond that empowers individuals, highlighting the
Scleroderma United
Spring 2024 Intern Articles
transformative power of community in the face of adversity.
Amid personal anecdotes, a wealth of medical and therapeutic insights emerge. From cutting-edge treatments to tried-and-true home remedies, our storytellers share their journeys through the medical landscape of scleroderma. These narratives vividly demonstrate the importance of ongoing research and innovation in improving the quality of life for those with scleroderma, showcasing the hope that new discoveries bring.
Raising awareness about scleroderma is a recurring theme in the stories we've collected. Individuals and groups alike are championing the cause, seeking to enlighten the realities of living with this condition. Their advocacy efforts aim to improve care, boost research funding, and ensure that no one faces scleroderma in the shadows. This section highlights the pivotal role of advocacy in driving change and fostering a more understanding and supportive community.
Perhaps the most inspiring aspect of these stories is the resilience and hope that shine through. Despite the undeniable challenges, individuals with scleroderma find ways to grow, change perspective, and uncover joy in life's moments. This section celebrates the strength and optimism that fuel the journey, offering encouragement and inspiration to us all.
The mosaic of personal stories presented in this article reflects a collective strength and courage that transcends scleroderma. These narratives are a testament to the human spirit's ability to confront adversity with resilience and hope. As readers, we're called to support scleroderma research, raise awareness, and join the community in solidarity. Together, we can make a difference in the lives of those touched by this condition.
Scleroderma United
Spring 2024 Intern Articles
Empowering Wellness Through Movement: Navigating Scleroderma Through Physical Activity
By Liya Khan from Newmarket, Ontario, Canada
Physical activity is the cornerstone of a healthy lifestyle, offering a multitude of benefits that extend beyond just physical health. Maintaining our physical health through fitness is essential for maintaining our body's natural chemistry, to support organ function and vital processes such as circulation, digestion, and immune function, ultimately promoting overall well-being and longevity. Due to the scope of physical activity, it is accessible to all but may present as restrictive to those living with chronic diseases.
According to the National Scleroderma Foundation, scleroderma is an autoimmune disease, meaning that the immune system's ability to distinguish foreign bacteria and viruses from self is compromised, causing immune cells to attack the body’s own tissues.
Understanding the spectrum
There are two primary forms of scleroderma, systemic sclerosis, which affects internal body systems and organs, and localized scleroderma, affecting parts of the skin. Systemic sclerosis (SSc) can manifest as skin thickening on the hands, arms, torso, thighs, lower legs, and feet depending on the cutaneous form.
Scleroderma United
Spring 2024 Intern Articles
Patients living with SSc are at a greater risk of developing pulmonary hypertension, pulmonary fibrosis, kidney, and bowel disease due to scar tissue obstructing the lungs, elevated blood pressure, and lack of mobility in the stomach. SSc also causes blood vessel abnormalities, damaging internal organs, and immune system dysfunction - impairing the balanced function of B cells, T cells, and macrophages. Patients also commonly experience acid reflux, heartburn, the Raynaud phenomenon and telangiectasias.
Localized scleroderma can manifest as thickened patches, lines and spots of skin on local body parts, such as the limbs or face. It can be characterized by the unbalanced formation of collagen, made up of fibroblasts, which are unnecessarily being activated, causing tissue damage and the malfunction of certain organs and body parts.
Investigating the Impact
A study showed that due to factors such as joint pain, limited range of motion, fatigue, dyspnoea, and abdominal pain, individuals with scleroderma tend to have relatively low levels of daily physical activity. These factors are the result of the experienced inflammation, lack of blood circulation and compromised organ systems.
Exercise is progressively being regarded as a non-pharmaceutical rehabilitation intervention for patients with scleroderma, as regular fitness may lead to anti‐inflammatory benefits, improve circulation, help maintain a range of motion and improve overall functioning to support daily activities.
A systematic review conducted by Sophie Liem and colleagues, examined randomized controlled trials and observational studies which compared different forms of exercises and their effects of body functions; oxygen uptake, aerobic capacity and muscle strength. The participants were 18 years of age and older with scleroderma.
Studies found that mobility hand exercises done at home for 50 minutes, 5 days/week, improved hand functional capacity, mobility, and grip strength through significant improvements in the Dreiser’s index, HAMIS, and Cochin hand function scale (all tools for hand function assessment). Orofacial exercises, such as mouth-stretching and oral-augmentation exercises, for 6-20 minutes, twice daily, were shown to significantly improve oral aperture by approximately 10.7 mm.
Scleroderma United
Spring 2024 Intern Articles
Studies that focused on aerobic training, showed that treadmill walking, high-intensity-interval training followed by brisk passive recovery, and ergometer cycling for approximately 20-30 minutes at moderate to high intensities can increase values of VO2 peak, peak exercise oxygen saturation and metabolic equivalents. Muscle-strengthening exercises showed that resistance training with optimal repetitions 30-50 minutes, 2-3 days a week, can eventually improve values of VO2 peak, improve muscle strength, function and endurance, time to exhaustion, resting heart rate, and reduce fatigue. Individuals who engaged in both aerobic and muscle-strengthening exercises, showed converging benefits and reported greater quality of life.
Scleroderma Chronicles: Navigating My Personal Health Journey
Through reading Scleroderma Stories issues 4 and 5, physical activity is represented as a realistic therapeutic intervention, promoting overall well-being and improving quality of life for individuals across all spectrums of health. Many of the interviews highlight routines of hand exercises to maintain hand mobility and reduce tractions, and walking exercises to keep active.
Santos, a scleroderma warrior, shared how yoga and consistently working out clinically benefitted her lungs. Other individuals share how they replace higher intensity activities, like running, with moderate intensity activities, like walking, to stay active in a safe manner. It's important to note that not every condition is the same and individuals with scleroderma have compromised organs and functional capacities to different severities, affecting their level of ability to exercise.
There are many stories similar to Iddon and Romero, of individuals living with scleroderma that had to stop exercising upon disease onset or unaware of how to incorporate practical fitness in their routine but want to. When starting your fitness journey from scratch, it's important to start with finding your current “why”, take time to improve your fitness knowledge, set realistic goals and slowly work towards them. Cohen notes that physical activity, from a mental health perspective, plays a significant role in a healthy and positive mindset. You should also start your fitness journey with a similar positive mindset to set proper and lasting intentions.
Scleroderma United
Spring 2024 Intern Articles
Although the benefits of physical activity look clear, it's important to consider specific ways individuals with scleroderma can pragmatically incorporate it into their lifestyle. Whether it's simply taking walks or doing hand exercises consistently, it's important to make sure your body is being heard and to take steps in finding a fitness regimen that is fitted for you.
Scleroderma United
Spring 2024 Intern Articles
Examining Exercise Therapy and Mental Health in Patients with Scleroderma
By Liya Khan from Newmarket, Ontario, Canada
Individuals with scleroderma (SSc) can benefit greatly from conventional therapeutic interventions, such as achievable fitness regimens, to support their unique health needs. These interventions can help reduce feelings of social alienation by promoting community engagement and shared activities tailored to their abilities, sustaining pre-SSc symptoms behavior. By incorporating structured exercise into their routine, individuals can adapt to lifestyle changes upon onset and sustain overall health and well-being.
Scleroderma is characterized by a complex interplay of fibrosis, inflammation, vascular damage, and immune system dysfunction. SSc can affect the ability to engage in physical activity due to joint stiffness, fatigue, and potential organ involvement causing pulmonary challenges, cardiovascular strain, and abdominal constraints, which may limit range of motion, mobility, and endurance.
Systematic literature reviews, particularly investigating the effect of different types of exercise therapy, such as hand exercises, orofacial exercises, aerobic and muscle-strengthening exercises, and uniform management of physical impairment are required to design and assess treatment modalities for patients with scleroderma.
Scleroderma United
Spring 2024 Intern Articles
Mental and Physical Health Concerns for Optimal Well-Being
Through reviews evaluating psychiatric symptoms and quality of life (QoL) among patients with SSc, it was found that psychological distress was associated with physical HRQoL, perceived physical health, and quality of life. Regression analyses revealed that a low level of SOC, a measure of an individual's resilience confronting stress and coping capacities, was associated with high levels of psychological distress and depressive symptoms in SSc.
A systematic review found that orofacial exercises (e.g. mouth-stretching and oral-augmentation exercises), mobility hand exercises, aerobic training (e.g. treadmill walking, ergometer cycling), and muscle-strengthening exercises may improve oral aperture, hand functionality, oxygen uptake, resting heart rate and overall strength respectively. Rehabilitation therapy, such as fitness, has resulted in improved quality of life for decreasing disabilities. It was particularly noted that evidence on the effect and safety of exercise therapy in SSc is relatively limited.
Scleroderma Interviews: About Natasha Sisodiya
“My name is Natasha Sisodiya, and I turned 51 in February. I have been married for 26 years and have two boys, Shaan (19) and Taran (16) and was born in India and raised in Saudi Arabia and Canada before moving to San Francisco in 1992. In August of 2022, my family and I moved to Los Angeles. By profession, I am an accountant but am currently not working.
I have a passion for hiking, exercising, and cooking healthy food. After being diagnosed with scleroderma, my passion for cooking arose as I had to watch my diet carefully. It led me to create an Instagram page (@bytesofyum) to share my healthy cooking and support me during my journey.
I am still passionate about hiking and would love to hike somewhere overseas like Kilimanjaro in Africa someday.”
Natasha was diagnosed with systemic scleroderma in 2012 but still explores her fitness journey with a conventional approach. She has been actively engaged in aerobic activities, particularly walking/hiking, 4-5 times a week and strength training 3-4 times a week, for almost 3-5 years respectively. Upon scleroderma onset, she describes having to reduce overall fitness
Scleroderma United
Spring 2024 Intern Articles
intensities, and frequency, recognizing intense forms of cardio as an unsuitable method.
As someone with scleroderma, she describes walking and hand exercises as positive health outcomes and physical relief bearing. With the fitness goals of improving strength and maintaining leanness, Natasha continues to engage in aerobic, muscle-strengthening, and hand exercises. Concerning self-regarded mental health in association with maintaining athleticism, Natasha regards physical health as a huge helping factor in maintaining feelings of strength and positivity.
Scleroderma Interviews: About Sarah Bryant
“I'm Sarah. I'm 36 and live in BC Canada. I was diagnosed with diffuse systemic scleroderma 8 years ago (March 2016). I have interstitial lung disease (ILD) and Raynaud's as well. When first diagnosed I was very depressed and thought my life was over. I've learned to appreciate the small things, and enjoy each day. Spend as much time as I can with my son. We love to explore. Try new restaurants. Camping, walks, nature, and road trips around BC.
I'm followed by the wonderful scleroderma specialists at St. Paul's Hospital. I love to attend annual walks to support scleroderma patients and meet others like me who understand what I'm going through. I work part-time and love it. I am currently on CellCept and rituximab infusions every 6 months to keep my disease stable and so far progression has slowed.”
Upon disease onset, Sarah describes a decline in her physical functionality, particularly the inability to walk inclined with her ILD and to engage in skiing or winter activities due to Raynaud's disease. She emphasizes the importance of taking things slower and being mindful of her body. Not being able to physically keep up with her friends or child, sensitivities to cold weather, and restrictive mobility, are something Sarah finds mental health impacting concerning the ability to maintain levels of physical activity with scleroderma. Sarah currently engages in light-moderate aerobic and flexibility activities, such as walking and stretching, as an essential part of maintaining overall mobility.
Acknowledgements
Special thanks to Natasha Sisodiya and Sarah Bryant for sharing their experiences and insight regarding scleroderma and athleticism, to encourage more visibility on this topic. The purpose of sharing interviews is to display personal navigation of physical health with scleroderma, to present a scope of associated impacts in essence.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma: A Molecular Analysis of Commonly Experienced Symptoms
By Liyana Haque from Toronto, Ontario, Canada
Scleroderma is an autoimmune disease that causes fibrosis and inflammation in the skin and other areas of the human body. This is due to the immune system's response triggering tissues to think they are injured, leading to an overproduction of collagen. Collagen is a protein required for healthy connective tissues that support and hold human organs in place. Scleroderma can be divided into two categories: systemic sclerosis and localized. Systemic sclerosis affects multiple systems within the human body and induces damage to blood vessels and internal organs including the heart, lungs, and kidneys. In comparison to localized scleroderma which only affects the skin and structures directly beneath the skinny causing fibrous, waxy patches on the skin.
Medline Plus defines the family of genes associated with developing this autoimmune condition as the human leukocyte antigen (HLA) complex. This complex is located on the short arm of chromosome 6 and transports processed peptide antigens which use alloantibodies to fight against leukocytes. The Yonsei Medical Journal illustrates the HLA complex to assist the human immune system by differentiating between the body’s proteins and proteins produced from unknown sources including bacteria and viruses. In addition, each HLA gene consists of different normal variations to
Scleroderma United
Spring 2024 Intern Articles
fight a wide range of unknown proteins, and these normal variations increase the risk of producing scleroderma. Examples of these genes include IRF5 which influences diffuse cutaneous systemic scleroderma and STAT4 which influences limited cutaneous systemic scleroderma.
We strive to engage the audience in complications related to being diagnosed with scleroderma at the molecular level. Two common compilations caused once a patient is diagnosed with Scleroderma include Raynaud’s Phenomenon (RP) and Scerldeorma Renal Crisis (SRC).
Raynaud’s Phenomenon
Raynoud’s phenomenon (RP) is when small arteries that supply blood to the skin begin to narrow. This results in areas of the body including fingers and toes to respond to cooler temperatures and stresses by feeling numbness. By limiting blood flow to affected areas, we develop cold-induced vasoconstriction: a physiological process to redirect blood flow and protect the body from excessive heat loss. The Front Pharmacol Journal describes that this constriction is controlled by the reflex sympathetic release of norepinephrine and results in RP when it is exaggerated. RP involves local, neuronal, and hormonal mediators that contribute to the over-exaggeration of blood-carrying arteries in response to norepinephrine. Norepinephrine binds to adrenergic receptors (ARs) on the vascular smooth muscle cells (VSMCs) to evoke effects. There are three ARs: α1, α2, and β2 in which α1 and α2 are responsible for mediating cold-induced vasoconstriction. Moreover, exacerbating these ARs can lead to RP.
Scleroderma Renal Crisis
Scleroderma renal crisis (SRC) is a complication of scleroderma (specifically systemic sclerosis) that causes severe hypertension and progressive renal failure, hypertensive encephalopathy, congestive heart failure, or microangiopathic hemolytic anemia. The National Library of Medicine has found that 10%-25% of patients diagnosed with diffuse scleroderma experience this disease and 75% of diagnoses for this condition are made as soon as the first 8 months of developing scleroderma. Most models of pathogenesis suggest that SRC is associated with vascular endothelial injury and changes in cellular/humoral immunity. Moreover, scleroderma has antibodies including T helper lymphocyte type-2 (TH-2) activation, cytokine
Scleroderma United
Spring 2024 Intern Articles
production, and excess collagen collection. These antibodies allow vasculopathy to develop. Vasculopathy occurs when a thrombus forms inone’s artial lumen and compromises blood flow. The presence of these autoantibodies and the development of vasculopathy contribute to being the potential cause of SRC. In addition, the International Journal of Rheumatology identifies that 85% of those diagnosed with scleroderma have anti-endothelial cell antibodies that induce endothelial cell apoptosis (cell death). This results in vascular injurieis such as inflammation and disturbing exchange between the bloodstream.
Treatments Options
Many patients believe being diagnosed with scleroderma-induced diseases including Raynaud’s phenomenon (RP) and Scleroderma renal crisis (SRC) mark the end of the world. However, many treatments are available for these conditions to ensure one can live healthy and prosper daily!
For moderate cases of Raynaud’s phenomenon, there are medications including alpha-1 blockers, dihydropyridine calcium channel blockers, topical nitroglycerin ointment, and vasodilators. These medications work differently to alleviate constriction and tension in blood vessels and improve blood flow. However, for more severe cases nerve surgeries including sympathectomy can be performed. Johns Hopkins Medicine describes this procedure as clamping together the sympathetic nerve chain running along the spine. This procedure prevents the brain from sending signals to areas that influence blushing or reacting to cooler temperatures.
In contrast, Scleroderma renal crisis (SRC) depends on activating the renin-angiotensin-aldosterone system (RAAS), and a rise in blood pressure (BP). Moreover, when someone is diagnosed with this condition they are hospitalized and begin angiotensin-converting enzyme inhibitor (ACEI) therapy. ACEI assists with lowering blood pressure by providing the patients with a beginner dosage of inhibitors including captopril. This initial dosage is immediately titrated to lower systolic BP by 20 mm Hg in 24 hours which causes the overall BP to become 120/70 mm Hg within 72 hours of treatment. Once the desired BP and dosage level are achieved, ACEI therapy continues by receiving equivalent doses. The National Liberty of Medicine indicates that 1-year deaths among those diagnosed with this condition have dropped from 85% to 24%.
Scleroderma United
Spring 2024 Intern Articles
Privilege, scleroderma, and running a marathon – it’s the little things that matter
By Martin Nguyen-Khoa from Melbourne, Victoria, Australia
“There was an inevitability about their road towards one another which encouraged meandering along the route.”
– Zadie Smith
Something that has defined my 20s so far – despite still being 3 months from 22 – is this pervasive, hypersensitive awareness of my privilege. Almost everything that has contributed to who I am now has been a result of privilege. There are the more obvious signs: attending both a private and a selective school during my secondary years, having financial support from my parents even to this day, being able to afford non-essential luxuries.
But there are also the more subtle ones which I argue are the most significant. For one, I have the privilege to decide. To decide what I want to do with my life and what I want to use my privilege for. And I don’t ever want to sound conceited in saying this, as if privilege is some divine purpose that I’ve been granted. I’m still getting used to the language I use when discussing this. But I feel so lucky and so fortunate every single day to live the life that I live.
And I want to dedicate my life to using this privilege for good – within my own
Scleroderma United
Spring 2024 Intern Articles
life and within the wider community.
Scleroderma? What’s that?
Like most people, I had never heard of scleroderma prior to beginning my internship at Scleroderma United. I began to learn that it was a rare autoimmune disease that’s brought about by excessive collagen production, which causes a thickening of the skin around the body. Beyond limiting movement and noticeable cosmetic differences, I further learned that scleroderma often severely impacts the health and wellbeing of the diagnosed individual. Patients can experience shortness of breath, hypertension, fatigue, mood alterations, reduced vascular system functioning and if severe enough, fatal organ failure.
I knew that if I was going to raise awareness and raise funds around this debilitating disease, I needed to do something that actually challenged me. So I asked my friends to donate, because for every $10 that was donated, I’d run a kilometre. I thought people would donate in smaller amounts. I’d raise maybe a maximum of $100. Running 10 kilometres would be a good challenge anyways, considering the last time I ran 100 metres was four years ago. $100 all donated to Scleroderma United’s noble missions. That’s great, right?
I raised $732 within 48 hours. I was going to be running exactly 73.2km. That’s a full marathon and a bit. Why didn’t you instead promise one push up for every $10? Why didn’t you promise 1 kilometre of bike riding for every $10? Naturally, I was worried, and my close friends were worried – not just for my health and wellbeing – but about whether I was going to have the time to do this right and to see it through to the last kilometre.
And then I watched Greg Cohen’s documentary, ‘Run Greg Run’.
Can’t stop, won’t stop
Greg Cohen was an avid fitness-enthusiast, being both an NCAA Division 1 wrestler and a CrossFit trainer. One day, he couldn’t feel his left hand at all. He was initially diagnosed with bilateral carpal tunnel, and then Hashimoto’s disease (an autoimmune thyroid disease). Eventually, he was diagnosed with limited systemic scleroderma.
For all of the symptoms of scleroderma, even just from the ones I listed earlier,
Scleroderma United
Spring 2024 Intern Articles
fitness at Greg’s level should’ve been a long-lost venture. But then, he signed up to run four marathons within a year.
If that wasn’t inspiring enough, this comment in his interview to the Daily Express US might seal the deal:
“[And] I think the other thing is I think about people that aren't as fortunate as me, who are in worse positions with the illness, whether they have severe lung involvement and they have to be on oxygen or their body doesn't allow them to do the things that I'm able to do. I run for those people as well.”
A reminder of how to be great
I never knew about Greg before choosing to run for my own fundraiser. But as you can imagine, his documentary deeply resonated with me. Not because I was also running to raise funds and awareness, but because he was also willing to use his position to do good. To help others and to really challenge himself for this cause.
I’m in no way placing myself at Greg’s level of commitment and dedication. To be able to acknowledge that there are people less fortunate than himself even while suffering with a debilitating disease is awe-inspiring; running four full marathons with scleroderma might elevate him to the status of a god.
But for someone like myself, who is healthy and able-bodied, it is a stark reminder that I have the privilege to decide what I want to do with my life and how I’ll give back to people more disadvantaged than me.
And luckily for me, I can decide how to do that while running 73.2 kilometres.
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Methotrexate: Is it really the right drug for me?
By Medha Nandikur from Frisco, Texas, USA
Scleroderma, also known as systemic sclerosis, is an autoimmune disease and there is no known cure for this terrible disease. However, there are ways patients of Scleroderma or other Autoimmune diseases treat the disease to reduce symptoms. One of these ways is using a commonly known drug known as Methotrexate.
Methotrexate is a drug that is in the antimetabolie family and it treats different types of immune system problems and it is also used to treat cancer. It is usually prescribed by a dermatologist or rheumatologist and it is given in the form of a pill or an injection. The pill form is small and yellow and it is taken from 5mg to 25 milligrams a week by Autoimmune patients. If patients take high amounts of this drug, that would be because this drug is mostly a chemotherapy drug that is used to treat cancer
The other form of Methotrexate patients take is in the form of an injection. The injection is usually from 7.5 to 25 mg similarly to the pill and it is injected underneath the skin. A study from Verywellhealth randomly assigned 384 patients with a methotrexate pill or injection after a 24 day period, patients who took the injection show that they prefer the injection over pill due to a better experience in taking it and having to take in less of a dosage
Scleroderma United
Spring 2024 Intern Articles
compared to the pill.
However, both the injection and the oral pill can have both pros and cons to it. For some patients, this pill is a lifesaver while other patients experience horrible side effects. So if you decide to take the pill or not, be aware of the effects of this drug and decide if methotrexate is really the best thing for you.
A lot of the time, Methotrexate is a game changer for patients with autoimmune disease. For example, an article written on bezzyRA by Alexis Rochester says that after taking methotrexate for one month Alexis saw benefits regarding her joints in which she was able to move them with ease. Alexis saw that her swelling was getting better as well. Methotrexate is also said to reduce body inflammation as well as kill cancer cells since this drug is often used to treat cancer. Elaine from Elaine’s autoimmune adventure says that methotrexate helped her reduce her hair loss and made her hair a lot healthier and stronger.
Even though it helped Elaine through her autoimmune journey, some patients do experience hair loss along with other normal or life-threatening side effects as well. Aimee’s article by Versus Arthritis discusses how methotrexate made her very sick and unable to sleep. “I had lots of physio and occupational therapy to help me regain movement in my ankles and wrists” says Aimee. She did not have a good experience with methotrexate in which she decided it was not the drug for her. Other patients experience different side effects such as seizures, increased swelling, vomiting and/or more.
Remember, every body is different and every Autoimmune patient experiences different things. Some patients may experience multiple side-effects and some may experience nothing at all. Everyone has different experiences and perspectives of Methotrexate like shown in this article. Whether you take methotrexate or not depends entirely on your experience of this drug.
Summary:
Methotrexate is a drug that autoimmune patients take to relieve their symptoms. However, this drug has both pros and cons. Patients should talk to their specialist to discuss if methotrexate is really the right drug for them.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Lessons learned from Scleroderma Warriors
By Mia Szczesniak from New York, New York, USA
Scleroderma is an autoimmune condition in which the body’s immune system attacks its own tissues: There are medications to slow down disease progression and help with symptoms, right now there is no cure for scleroderma.
There are two types: systemic sclerosis, SSc - affecting internal organs, and localized; that affects a local area of skin. Localized, has two types: Linear and Morphea. There are also two major types of systemic sclerosis or SSc: limited cutaneous SSc and diffuse cutaneous SSc. In limited SSc, skin thickening only involves the hands and forearms, lower legs and feet. In diffuse cutaneous disease, the hands, forearms, upper arms, thighs, or trunk are affected. The face can be affected in both forms.
Localized- Linear scleroderma consists of a line of thickened skin down an arm or leg on one side. The fatty layer under the skin can be lost, so the affected limb is thinner than the other one. In growing children, the affected arm or leg can be shorter than the other. Morphea consists of patches of thickened skin that can vary from half an inch to six inches or more in diameter.
There are many symptoms: hard, thickening, or tight skin. This trait is what
Scleroderma United
Spring 2024 Intern Articles
gives scleroderma its name. Hair loss and less sweating, Dry skin and itch, Skin color changes, Salt-and-pepper look to the skin, Stiff joints and difficulty moving them, Muscle shortening and weakness, Loss of tissue beneath the skin. Unfortunately, the cause of scleroderma is unknown. There are many clues that define susceptibility developing scleroderma.Scleroderma may affect some Native Americans and African Americans more severely than Caucasians and women are more likely to get it.
During my research, I had an honor to read some articles and understand the story of people that are facing this terrible disease, and I would like to introduce and recognize some of them in this article.
Tom Fry, shares his journey about scleroderma, a rare autoimmune disease. His initial symptoms were stiffness and swelling in his hands and feet. Despite multiple doctor visits and misdiagnoses, he was eventually correctly diagnosed with systemic scleroderma. Despite the challenges, Thomas found strength through faith, and his friends’ support. He has become an advocate for scleroderma awareness, using social media, and personal interactions to spread awareness and offer support to others facing similar disease. He encourages others to seek support, communicate their limitations, and engage in advocacy efforts. Tom's story reflects resilience, determination, and a commitment to making a positive impact despite facing significant difficulty.
Evamarie Gilbes-Cole, a 53-year-old New Yorker, shares her journey with scleroderma spanning over 16 years. Initially misdiagnosed with lupus, she eventually received the correct diagnosis of CREST Syndrome. Since then, she has faced various symptoms such as skin tightness, joint pain, as well as financial pressures due to medical expenses. Despite these challenges, Evamarie remains proactive in her treatment, participating in clinical trials and advocating for better insurance coverage for chronic illnesses. And, as a mother with scleroderma, Evamarie has navigated unique challenges, feeling guilt and frustration over her physical limitations. But she was able to see the opportunities to educate others about scleroderma and feels a strong connection to the scleroderma community, considering fellow patients as close friends and family. She remains active in advocacy efforts, targeting to raise awareness and ultimately find a cure for scleroderma. Despite the challenges, Evamarie finds joy in hobbies like gardening, reading, and spending time at the beach, emphasizing the importance of staying active and positive despite the limitations imposed by scleroderma.
The patients’ stories I have been reading are very interesting, sad and most
Scleroderma United
Spring 2024 Intern Articles
importantly touching . However, I am impressed with all those patients, how brave they are , and how strong they are. They are all trying to enjoy their life to the fullest , and in between all kinds of doctor visits , and medical treatments, still enjoy their time with family and friends with a big smile on their faces .
Greg Cohen is a resident of Studio City, California, originally from New York. As a former college athlete and current fitness industry worker, he actively engages in marathon running and promoting a healthy lifestyle. Cohen was diagnosed with scleroderma at the age of 36, experiencing earlier symptoms such as numbness in his hands and gastrointestinal issues. Despite the diagnosis, he continues his fitness pursuits but must adapt to challenges associated with the disease, such as fingertip ulcers. He supports the scleroderma community, inspiring them to remain active and positive despite adversities. Cohen emphasizes the importance of self-care and stress management for individuals with chronic illnesses, encouraging proactive steps toward improving quality of life.
In conclusion, the personal stories of individuals living with scleroderma are both inspiring and touching. Despite the challenges they face, they demonstrate remarkable resilience and courage in their pursuit of a fulfilling life. Through advocacy, support networks, and personal determination, these individuals are making a positive impact within the scleroderma community and beyond.
By conducting extensive research on scleroderma, I have explored into the multifaceted aspects of this autoimmune disease, going from its clinical displays to the deep impact it has on individuals' lives. Through the study of medical literature, personal testimonies, and clinical studies, I have gained a deeper understanding of the challenges faced by patients and the resilience they show in their journeys with scleroderma.
My research has highlighted the importance of raising awareness about scleroderma, not only to raise understanding among the general public but also to advocate for better resources, support networks, and research initiatives for those affected by the disease. By shedding light on the experiences of individuals like Tom Fry, Evamarie Gilbes-Cole, and Greg Cohen, I humanize the condition, scattering misconceptions, and inspiring empathy and action within the broader community.
Scleroderma United
Spring 2024 Intern Articles
Guide to systemic scleroderma’s number 1 symptom; Gastrointestinal problems
By Minhanh “Mimi” Nguyen from Charlotte, NC, USA
Systemic scleroderma is one of the two major groups of scleroderma that is categorized by the excess production of collagen within the internal organs. This in turn causes the muscles, skin, and organs to harden and become scarred and therefore this internal structures to become weakened or even paralyzed. The biggest symptom of systemic scleroderma patients being gastrointestinal issues, expressed in an episode of one Scleroderma Education podcast.
According to a study published in 2010 by the National Institute of Health, found that around 97% of systemic scleroderma patients had a combination of both upper and lower GI. These GI issues are caused by scleroderma when the scarred tissues do not allow the blood vessels to function in the organ and cause weakening of the muscles associated with the digestive tract.
These GI problems can be classified in various forms and organs in the digestive tract:
Scleroderma United
Spring 2024 Intern Articles
*These symptoms can last for hours, days, or even weeks at a time and can also be very long term.
Treatments for GI related symptoms of scleroderma oftentimes are long term and do not offer long term results to alleviate GI problems. There are also little to no FDA approved treatments for conditions like gastroparesis that are long term (not extending 12 weeks), as described in the podcast. This is why people with scleroderma have such hard times dealing with this chronic issue.
Treatment plan & tips to alleviate various GI related issues
There are current treatment plans that are being introduced through clinical trials, but none have been approved by the FDA for long term treatment. For immediate, short term relief, pain killers, and other pharmaceutical drugs can be purchased over the counter or prescribed.
For some, these issues can also cause post traumatic stress related disorders (PTSD), where these GI issues can cause eating disorders or a fear of eating in general. Many are scared of secondary issues (like malnutrition) that stem from having one GI related problem, so it is important to create a daily plan for those experiencing these issues, as explained in the podcast.
It is becoming increasingly important that awareness of these issues needs to be projected in order to possibly allow for new treatments to combat and alleviate these GI symptoms experienced by those with systemic scleroderma. Patients, caregivers, physicians, friends, and family of those who are educated on GI symptoms in regards to systemic scleroderma should advocate for further research in this topic as well as offer support to those who are battling these problems.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma’s Impact on Mental Health and Overall Health
By Mya Silveyra from Chicago, Illinois, USA
What is scleroderma?
The concept of scleroderma doesn’t usually ring a bell in people’s minds. In fact, most people have never even heard of it. However, the often-unspoken reality for around 300,000 people in the United States alone is extremely difficult, as scleroderma’s impact on mental health as well as overall health is oftentimes extreme. For context, scleroderma is an autoimmune disease that causes the skin to inflame and thicken. The body tricks its tissue into thinking an injury was sustained, causing itself to produce excess collagen as well as inflame the skin, leading to scleroderma.
Many patients suffer from a large range of symptoms, from complicated diseases (Raynaud’s Disease, arthritis, etc.) and physical deterioration (heartburn, loss of movement, skin discoloration, etc.) to mental decline (memory loss, heightened anxiety/depression, etc.). Not all patients experience every single possible symptom, and each symptom has unique effects on different patients, but the majority of scleroderma patients reported poorer mental health after their diagnosis.
This article will tell the stories of scleroderma patients, and how their diverse experiences have uniquely impacted their lives, with a focus on the mental health aspect. It’s important to understand how living with such an impactful disease affects these patients; as it is, not many people understand their
Scleroderma United
Spring 2024 Intern Articles
situation, so it’s up to us to educate ourselves to, through sympathy, better help these people, who aren’t as fortunate to have good health.
Impact of Scleroderma on Mental Health
As previously mentioned, scleroderma patients are often able to sympathize with one another when it comes to mental health struggles caused by their diagnosis. Many hadn’t ever heard of the disease, much less knew how to treat it or handle it. Because of this, many felt lost and lonely at first.
In an interview, Shirley Alvarez, a scleroderma patient, recalls how her family and friends didn’t really show up for her following her diagnosis. She speculates it’s likely because they didn’t know how to handle the diagnosis, but also admits that she somewhat hid herself from them for the first few years. It isn’t to say they didn’t care; Shirley said everyone treated her very well, and that her loved ones slowly learned more about her condition and how to approach it. Jayda Anastasia, a fellow scleroderma patient, also said her loved ones suddenly became distant after her diagnosis.
Scleroderma includes so many complications, symptoms, and lifestyle changes that it becomes hard to continue making room for the people in your circle that were there long before the disease, so it’s a common experience for patients to struggle with loneliness as a result.
With all the complications that scleroderma patients face, it also gets hard to continue maintaining your own well-being on your own.
Luisa Ruiz Kulig has lost her mobility as a result of her scleroderma diagnosis, and needs assistance to walk. She said it’s extremely hard not being able to rely on herself. Silvia Petrozza had a similar experience, recounting how she felt like a burden to her family because she was in the hospital so often. She felt “trapped in her skin,” since her scleroderma caused her chronic pain that held her back from carrying out her normal duties.
This is something even I have struggled with; when I was a young teen, I was struck by a car while I was biking. I broke my pelvis as well as a few ribs, which left me temporarily unable to walk on my own. The month following my accident, I couldn’t even get out of my bed without help, much less go up a flight of stairs or shower. I felt extremely guilty that my family had to take time to help me do such meaningless things, especially since I’d already burdened them with such expensive medical bills. It was one of the lowest points of my life, honestly.
Though I can’t fully sympathize with those like Luisa and Silvia who suffer from scleroderma, I do understand how scleroderma’s impact on mental health is so severe that patients often feel like a burden to their loved ones, and it’s unfortunate that so many people struggle with it.
Scleroderma United
Spring 2024 Intern Articles
Treatments
Common treatments for scleroderma patients include monthly/bi-annual infusions. Silvia takes monthly prostaglandin infusions, and Luisa takes Rituxan infusions. They both have said that that’s one of the only treatments they take, and that while they don’t cure their scleroderma, the infusions definitely have helped their symptoms/pain management.
Many patients take over-the-counter medicines and other prescribed drugs, however it’s common for patients to not respond to these treatments or not like them. Silvia recounted how being on pain medications sent her into a really dark place and felt that it robbed her of her personality. She also has tried hyperbaric oxygen, stem cell, and sympathetic treatments, all of which were extremely long and painful processes that she couldn’t handle. Jayda mentioned how she grew tired of medications and switched to natural approaches and maintaining her overall health, which is also the same path Shirley took.
Overall, it seems that scleroderma patients find the most comfort in minimal amounts of medicine and increased self-care, especially in fitness and clean eating habits.
Methods of Coping
An extremely common theme amongst how scleroderma patients maintain their senses of self are through creative endeavors. With little to no room for flexibility in handling scleroderma, feelings become harder to express and become more bottled up. Because of this, having a creative outlet helps patients express themselves when words fail to do so.
Shirley said she found a lot of comfort in music and fashion, as she is a visual person who thought it to be therapeutic to be able to connect to things like that. Angela Fernandez, a fellow scleroderma patient, likes to paint and color, as it helps her de-stress.
Another common method of relaxation is exercise. Jayda discusses how she put more energy into the gym when her scleroderma got bad, and how even just a little bit of exercise per day does wonders for her. She also says healthy eating paired with fitness makes her feel good about herself, which contributes to an overall more positive mindset. Elodie Allen says similar things have helped with her scleroderma; as a circus arts trainer, she has found community in the art, and she says working out helps her feel better overall. Luisa had a similar experience; after meeting her mentor online, she learned how to work out safely after thinking she couldn’t, which helped her remember how much she loved sports.
Focusing on your own personal development improves your overall mindset,
Scleroderma United
Spring 2024 Intern Articles
which helps ease scleroderma’s impact on mental health.
Beyond personal endeavors, the family and friends of patients have also made tremendous impacts on their scleroderma journeys. Jayda emphasized that her friends and loved ones grew to be as supportive as possible in helping her through her situation as time passed. During the pandemic, because she was high-risk, they would get her food, take notes for her in classes, and wash their hands around her, all which really helped her keep herself safe and make adjustments to her lifestyle to do so. Luisa, coming from a family with medical backgrounds, had an extra push from them reminding her that things do get better and that she could still live with scleroderma. Her father gifted her a wheelchair when he noticed her mobility became limited.
It’s important to find community in the people you already have, especially family, because having as many people as you can by your side makes it a little easier to feel less alone when coping with a disease like scleroderma.
Conclusion
Knowing what scleroderma is is just the beginning of expanding your mindset to helping those who may be suffering alone. It’s important to understand and sympathize with scleroderma’s impact on mental health, and to show support and kindness through it all. You already know how lonely it gets for patients following their diagnoses; help them by being the one who does stay close through the difficult times. Educating ourselves is the best we can do to help better the quality of lives of people with scleroderma.
Bibliography
“Angela Fernandez - Scleroderma United.” Scleroderma United, 1 Aug. 2023,
www.sclerounited.us/angela-fernandez-post/.
Baron, Manouchka. “(PDF) Prostaglandin E1 Therapy for Digital Ulcers in Scleroderma.”
ResearchGate, PubMed, 1 Feb. 1982,
www.researchgate.net/publication/16000469_Prostaglandin_E1_therapy_for_digial_ulcer
“Elodie Allen - Scleroderma United.” Scleroderma United, 1 Aug. 2023,
www.sclerounited.us/elodie-allen/.
“Jayda Anastasia - Scleroderma United.” Scleroderma United, 1 Aug. 2023,
www.sclerounited.us/jayda-anastasia-post/.
Kuzumi A, Ebata S, Fukasawa T, et al. Long-term Outcomes After Rituximab Treatment for
Scleroderma United
Spring 2024 Intern Articles
Patients With Systemic Sclerosis: Follow-up of the DESIRES Trial With a Focus on
Serum Immunoglobulin Levels. JAMA Dermatol. 2023;159(4):374–383.
doi:10.1001/jamadermatol.2022.6340
“Luisa Ruiz Kulig - Scleroderma United.” Scleroderma United, 23 Sept. 2023,
www.sclerounited.us/luisa-ruiz-kulig/.
Markus, Y. M., Bell, M. J., & Evans, A. W. (2006). Ischemic scleroderma wounds successfully
treated with hyperbaric oxygen therapy. The Journal of rheumatology, 33(8), 1694–1696.
“Raynaud’s Phenomenon.” National Institute of Arthritis and Musculoskeletal and Skin
Diseases, U.S. Department of Health and Human Services, 27 July 2023,
www.niams.nih.gov/health-topics/raynauds-phenomenon.
“Scleroderma.” National Institute of Arthritis and Musculoskeletal and Skin Diseases, U.S.
Department of Health and Human Services, 15 Dec. 2023,
www.niams.nih.gov/health-topics/scleroderma.
“Scleroderma.” Yale Medicine, 6 July 2023,
www.yalemedicine.org/conditions/scleroderma#:~:text=Scleroderma%20is%20a%20rare
%20condition,about%20100%2C000%20have%20systemic%20scleroderma.).
“Shirley Alvarez - Scleroderma United.” Scleroderma United, 1 Aug. 2023,
www.sclerounited.us/shirley-alvarez/.
“Silvia Petrozza - Scleroderma United.” Scleroderma United, 1 Aug. 2023,
www.sclerounited.us/silvia-petrozza/.
“Stem Cell Transplant for Severe Scleroderma Improves Survival, Quality of Life.” National
Institutes of Health, U.S. Department of Health and Human Services, 3 Jan. 2018,
www.nih.gov/news-events/news-releases/stem-cell-transplant-severe-scleroderma-improv
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Scleroderma’s Effect on Childhood
By Nathan Morales from Converse, Texas, USA
According to the Journal of Clinical Medicine, Scleroderma, also known as systemic sclerosis or linear scleroderma, is a rare autoimmune disease that causes hardening and tightening of the skin in areas such as the hands, feet, forearms, and in certain cases an internal organ. Despite the unknown matter of a specific occurrence on how Scleroderma is caused in a person, what is for certain is that systemic sclerosis is favorable to women and minorities, typically in adulthood (Cherim, Aifer, et al.). However, despite its rarity, what is even more scarce is scleroderma being diagnosed in children. This leads to the main perspective of this article, which is how children’s lives and childhood are affected by being diagnosed with scleroderma and how different they must live compared to others. Thus, through the exploration of the life stories of Jayda Anastasia and Wyatt Wright, systemic sclerosis's effect on youth development will be analyzed as symptoms and changes in daily life will be brought to light compared to an average child.
Jayda Anastasia was diagnosed with Scleroderma when she was only 5 years old, although her symptoms began to appear when she was 3. Yet, it wasn’t until her highschool years that Jayda was impacted the most by her disease. In school, she was an athlete that specialized in rowing, however, was forced to make a shift to the gym after symptoms like pain in her body, particularly joints, made it too hard for her to continue her sport. But sports
Scleroderma United
Spring 2024 Intern Articles
isn’t the biggest thing that was taken from her, when asked if scleroderma affected her ability to attend school Jayda commented “Yes. My junior year in high school was the worst I had ever gotten that I could remember. I could barely move, I kept fainting, and I stopped eating like I was – which made me extremely anemic” (2). Since Jayda was unable to fully function, she consequently ended up missing a lot of which some would say is an important milestone in a person’s life as junior year sparks the transfer from an adolescent to an adult. Therefore, a child that is diagnosed with scleroderma ends up missing out on important aspects of their education and childhood due to the fact that they are unable to attend school as needed as a result of their symptoms from systemic sclerosis.
Alongside Jayda, thirteen-year-old Wyatt Wright is currently experiencing similar setbacks in his youth as well. Wyatt was diagnosed with scleroderma when he was eight years old, but what is particular about his case is that he has six other diseases alongside systemic sclerosis. Although instead of missing time in school, Wyatt is missing time on the playground. To further elaborate, a childhood memory of a typical person is running and playing with other kids, but due to Wyatt’s linear scleroderma his knees and joints were weakened and Wyatt was barely able to walk. When asked about his knee surgery experience, Wyatt responded by saying “It was hard because I couldn’t walk and could only stay sitting and watch” (3). The inability to walk affects a kid’s childhood. Due to his knee surgery, Wyatt was unfortunately impaired for a while and lost possible memories as a child. Thus, scleroderma is hard on children because of the sudden life changes they face when dealing with their treatments and symptoms.
All things considered, systemic sclerosis impacts youth tremendously despite its uncommon occurrence by withholding childhood experiences. Nonetheless, those diagnosed with scleroderma are maturing a lot faster and learning how to deal with real world problems. In addition, people that are in similar situations to Wyatt and Jayda and are dealing with scleroderma are receiving better treatments, more become available and are prospering in life.
Works Cited
Scleroderma United
Spring 2024 Intern Articles
“Wyatt Wright - Scleroderma United.” Wyatt Wright- Scleroderma Stories Issue 2, Scleroderma United, 1 Aug. 2023, www.sclerounited.us/wyatt-wright/.
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Revolutionizing Scleroderma Treatment: The CONQUEST Trial Platform's Journey
By Navya Dubey from Frisco, Texas, USA
I. Introduction
Scleroderma, a complex autoimmune disease affecting millions worldwide, has long presented a formidable challenge to the medical community. However, recent strides in research and collaboration have birthed promising initiatives such as the CONQUEST Trial Platform, heralding a new era in scleroderma treatment. This article delves into this groundbreaking endeavor's transformative impact and potential.
II. Background on Scleroderma and Its Treatment Challenges
Scleroderma, characterized by excessive collagen production leading to skin thickening and internal organ damage, poses significant treatment challenges due to limited therapeutic options and a pressing unmet medical need. Its global prevalence, impacting individuals across diverse demographics, underscores the urgency for innovative solutions. Organizations like the Scleroderma Research Foundation (SRF) have been pivotal in advancing research and support for affected individuals.
III. The CONQUEST Trial Platform: A Game-Changing Initiative
Scleroderma United
Spring 2024 Intern Articles
The CONQUEST Trial Platform emerges as a beacon of hope in the landscape of scleroderma treatment. Originating from a strategic partnership between SRF and pharmaceutical giants Sanofi and Boehringer Ingelheim, this initiative aims to revolutionize scleroderma treatment paradigms. With a primary focus on advancing treatments for Interstitial Lung Disease Secondary to Scleroderma (SSc-ILD), the platform holds immense promise for the scleroderma community.
IV. Boehringer Ingelheim's Involvement and Contribution
As a leading biopharmaceutical company renowned for its commitment to innovation, Boehringer Ingelheim's involvement in the CONQUEST Trial Platform is significant. Their experimental agent contribution marks a pivotal step towards developing targeted therapies for scleroderma, underscoring the collaborative spirit driving this initiative forward.
V. Global Reach and Enrollment Efforts of the CONQUEST Trial Platform
Central to the success of the CONQUEST Trial Platform is its extensive global network of centers and countries participating in clinical trials. Including diverse patient populations is crucial for ensuring the efficacy and accessibility of emerging treatments. Challenges in enrollment efforts are met with strategic solutions, emphasizing the importance of global collaboration in expediting drug development.
VI. Ensuring Funding and Execution of the Vision
The SRF's pivotal role in facilitating funding and execution underscores the importance of committed partnerships in realizing the CONQUEST Trial Platform's vision. With sustained support and collaborative efforts, the platform holds immense potential for expansion, promising continued advancements in scleroderma treatment.
VII. Conclusion
The CONQUEST Trial Platform is a beacon of hope for those affected by scleroderma, offering a glimpse into a future where effective treatments are within reach. Its implications extend beyond patient care, resonating profoundly within the scientific community and among caregivers. Reflecting on its significance, a resounding call to action emerges for continued support
Scleroderma United
Spring 2024 Intern Articles
and awareness of scleroderma research initiatives.
VIII. Further Exploration
In dedicated articles, readers are invited to explore more detailed aspects of the CONQUEST Trial Platform's journey and its impact on scleroderma treatment through articles and information published by renowned scleroderma organizations.
Works Cited
“About CONQUEST SSc Therapy Research.” Scleroderma Research Foundation, srfcure.org/research/conquest/about-conquest/. Accessed 29 Mar. 2024.
“Boehringer Ingelheim Joins Scleroderma Research Foundation’s Conquest Trial Platform.” Applied Clinical Trials, 6 Oct. 2023, www.appliedclinicaltrialsonline.com/view/boehringer-ingelheim-joins-scleroderma-research-foundation-s-conquest-trial-platform. Accessed 30 Mar. 2024.
“CONQUEST Platform Clinical Trial.” Scleroderma Research Foundation, srfcure.org/research/conquest/. Accessed 31 Mar. 2024.
Scleroderma Research Foundation, Inc., et al. “Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.” Clinicaltrials.gov, 29 Feb. 2024, classic.clinicaltrials.gov/ct2/show/NCT06195072. Accessed 31 Mar. 2024.
Scleroderma United
Spring 2024 Intern Articles
The Scleroderma Experience: Hope for our Warriors
By Nichu Shibu from Melbourne, VIC, AU
What is scleroderma?
Scleroderma, a rare autoimmune disease that results in thickening of the skin and various other parts of the body. This condition presents itself in different forms with the primary forms being systemic sclerosis and localised scleroderma. Depending on the type, the disease can target limited areas such as the arms and legs or it can widely spread to areas including the face. Though it has been suggested that scleroderma arises due to the overproduction of collagen, the exact cause of the condition remains unknown. The lack of definitive understanding of the cause creates uncertainties among health professionals, family and the individual itself on how to best tackle and receive a cure from this life-changing disease. scleroderma.org
Scleroderma symptoms
Different individuals present with different symptoms but a common symptom indicating the presence of scleroderma is the Raynaud’s phenomenon. Patients with Raynaud’s exposure to cold conditions can cause fingers to turn pale or blue and red upon warming up.scleroderma.org As this change in the colour of the skin also occurs in individuals without scleroderma upon exposure to cold environments, it can often lead to misdiagnosis or misinterpretation of the condition. So, to be on the safe side,
Scleroderma United
Spring 2024 Intern Articles
just get it checked out! Better to be safe than sorry!
Further, it’s important to look out for symptoms of scleroderma as outlined by CREST (see below for more details). Other symptoms that people with scleroderma can present with includes digestive problems (e.g., heartburn, bloating), hypertension (high blood pressure), fatigue, swelling and itchiness. Mayo Clinic.
Image from: Penn Medicine
Common experiences and how you can support
Whether you are officially diagnosed or not, scleroderma can have a detrimental and sudden impact on your life. Scleroderma United’s scleroderma stories of individuals from a variety of backgrounds, have highlighted some sudden life changes experienced as a result of this disease. Although these changes differ from individual to individual, understanding similarities enables us to help those in need.
There is hope!
This section is mainly for those of you living with scleroderma right now (or please share if you know someone with scleroderma). You are not alone and there are many individuals going through the same right now. Scleroderma stories have mentioned some helpful tips that you can incorporate into your everyday life.
Scleroderma United
Spring 2024 Intern Articles
ones. Keeping yourself busy is the best way to get your mind off things.
This is not the end of your story. It’s a new chapter where you are still discovering the new version of yourself. So hold on tightly to hope and keep fighting forward. Those of you who are caregivers, health professionals, friends or family reading this, encourage them to keep fighting.
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Uncovering New Paths in Scleroderma Treatment: Insights from Cancer-like Mutations
By Nithusha Ranjith from Ajax, Ontario, Canada
Introduction
Scleroderma, also known as systemic sclerosis, is an uncommon autoimmune disorder characterized by dermal and connective tissue fibrosis, which results in skin and tissues becoming hard and tight. This debilitating disease affects approximately 100,000 individuals in the United States and can lead to life-threatening complications. Despite the severity of scleroderma, current treatment options remain limited and often yield suboptimal outcomes. However, a recent discovery of cancer-like mutations in scleroderma patients holds promise for transforming treatment approaches and improving patient outcomes.
The Discovery of Cancer-like Mutations
A recent study conducted by researchers at the University of Alberta has identified cancer-like genetic mutations in individuals with scleroderma. The mutations in question were detected through the use of a next-generation sequencing platform which facilitated the sequencing of all the exons in the genome. The study revealed the existence of nearly 2,000 mutations, some of which were identified as "clock-like" mutations that have the potential to drive premature aging and cancer. Additionally, the researchers identified 25 oncogenes that have the potential to cause cancer. These findings underscore the significance of genetic mutations in the development of
Scleroderma United
Spring 2024 Intern Articles
scleroderma and the importance of early detection and treatment.
These observations carry great significance as they offer valuable insight into the progression of scleroderma and may help clarify why traditional treatments have not been successful. Scleroderma is generally classified as an inflammatory autoimmune disease, but treatments that suppress the immune system, which are typically employed for other autoimmune conditions, are not as effective for scleroderma. The detection of these mutations that resemble cancer could open up the possibility of developing more effective treatment approaches.
Immunotherapy as a Promising Avenue
An interesting treatment approach that has shown success in cancer treatment is immunotherapy, which may also be a promising option for treating scleroderma. As part of a 13-year clinical study focused on identifying an immunotherapy treatment for scleroderma-related pulmonary arterial hypertension (PAH), promising results were obtained. The study evaluated the safety and effectiveness of rituximab, an immunotherapy agent that has been known to deplete B-cells and reduce tissue scarring, in patients who were afflicted with scleroderma-associated PAH.
Boosting specific parts of the immune system with this method has the potential to target the root mechanisms of the illness. By focusing on the autoimmune response that triggers collagen overproduction, a protein that causes skin and connective tissues to harden and tighten, immunotherapy could provide a promising avenue for more effective treatments.
Conclusion
Overall, the identification of cancer-like mutations in scleroderma patients and the potential use of immunotherapy as a treatment approach have the potential to significantly improve outcomes for those afflicted with scleroderma. These discoveries emphasize the necessity of ongoing research and collaboration in unravelling the complexities of this disease and developing more precise and effective therapies. As we continue to deepen our understanding of scleroderma, we are drawing nearer to transforming the lives of those affected by this debilitating condition.
Scleroderma United
Spring 2024 Intern Articles
No One-Size-Fits-All: Exploring the Variability of Systemic Sclerosis Fibrosis
By Nuzhat Azim from Toronto, Ontario, Canada
Fibrosis in SSc Patients
Systemic Sclerosis (SSc) is a type of Scleroderma affecting the internal organ systems such as the esophagus, stomach and kidneys and may cause pulmonary hypertension and telangiectasia. Patients suffering from systemic sclerosis have varying symptoms, some patients experience different internal organ issues more than others. Fibrosis is one of many symptoms that SSc patients suffer from; it is the excessive accumulation of collagen tissues affecting the skin and impairs organ function. In SSc patients who suffer from fibrosis, the TGF-B (transforming growth factor beta) primarily promotes fibrosis-causing pathways by stimulating the fibroblasts and matrix synthesis. Other factors include the immune cell function of profibrotic messages such as the platelet-derived growth factor (PDGF) and tumour necrosis factor-alpha (TNF-a) which imbalances the pathological fibroblast activity and causes excessive ECM deposition.
Ajit Tolani: SSc Fibrosis Case Study
Ajit Tolani was one of many patients who suffered from fibrosis due to SSc. Ajit was diagnosed with Scleroderma at age 15 in India. At the time, his only symptom was enlarged fingers due to cold temperatures. Ajit continued to lead a normal life; he became an International Tax lawyer and stayed healthy
Scleroderma United
Spring 2024 Intern Articles
otherwise. However, 20 years after his diagnosis his wife noticed that he would be getting fevers and pneumonia, which greatly affected his lungs. Doctors believed that his lungs would return to normal until on his second visit, doctors informed him that he only had a few months to live as he was at the end stage of pulmonary fibrosis. Ajit was then taken to the Cleveland Clinic as a Global Patient where he received a lung transplant. Ajit was also experiencing stomach acid issues, which was damaging his new lungs and had to be fed through a tube in the abdomen. Ajit could not consume anything through his mouth for a few months until he had a Laparoscopic Antireflux Surgery to tighten his esophagus to reduce acid reflux. Today, Ajit takes immunosuppression medications that keep his lungs under control. Physically, and mentally, Ajit is in good shape; he stays active doing various exercises, still works as a Tax Lawyer and can consume anything he wishes.
What We Can Learn From Ajit’s Story:
Therapeutic Interventions of SSc Fibrosis
Recently, researchers have focused on cellular therapeutic interventions which balance the anti-fibrotic factors and profibrotic factors balancing physiological fibroblast activity that intervenes in homeostatic ECM deposition. A research team at the Medical University of South Carolina investigated levels of the antifibrotic protein Cathepsin L. Reduced levels of this antifibrotic protein are redundant to the onset of fibrosis. Findings suggest that Cathepsin L releases endostatin, which reduces fibrosis effects. Currently, researchers are
Scleroderma United
Spring 2024 Intern Articles
working towards a therapeutic approach which restores Cathepsin L and aids in releasing endostatin at normal levels, which will decrease the chance of fibrosis to occur.
Other Therapeutic and Treatment Interventions include:
No One-Size-Fits-All
In conclusion, someone who is diagnosed with Scleroderma may not have the same experience, diagnosis, symptoms and treatment approaches. Fibrosis is one of many symptoms that SSc patients are diagnosed with and treatment can range from oral supplements to possible lung transplants. It is also important to keep raising awareness in hopes of more research that potentially leads to better medical interventions and quicker diagnosis.
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Empowering Mental Well-being: Interventions for Scleroderma Patients
By Nuzhat Azim from Toronto, Ontario, Canada
Scleroderma is a chronic, rare autoimmune disease that hardens the skin and connective tissues through inflammation and overproduction of collagen, affecting various parts of the body, such as the skin, blood vessels and internal organs. The consequences of this diseases however, is beyond physical impact alone. A scleroderma diagnosis can impact daily activites such as education, work and even relationships and interactions correlating to depletion in quality of life and mental health in those a struggle with scleroderma. Accordingly, Psychiatric Symptoms and Quality of Life in Systemic Sclerosis researchers found that patients with scleroderma reported significant increases in depression, anxiety and OCD and are 4.5 times more likely to receive psychiatric diagnosis than the general population. Negative psychological affects occur due to the “burden of living with a chronic and painful illness, the fatigue, difficulty in daily activities leading to demoralization, loss of self-worth and hopelessness. (Mura et al. 2012)”
Amy Gietzen’s Story:
Amy Gietzen is a Scleroderma patient advocate who discusses her story and challenges she faced since her diagnosis in 2001, and highlights the importance of empowerment and improving quality of life. In her story, Amy
Scleroderma United
Spring 2024 Intern Articles
reflects on how her diagnosis caused loss of independence, financial burden, ending of relationships and the lack of encouragement, support and self worth as a young woman. Gietzen hit a “pivotal point,” where she decided to take initiative to mentally support not herself and others through work of advocacy by:
How Can We Help?
From Gietzen’s story we learned the importance of community support and finding adversity. To improve mental health, interventions that are important to implement for Sclerodrma patients:
- Psychotherapy (either individualized, with family or groups) which help identify and change varying thoughts and behavior due to Scleroderma
- Additionally, implications for rehabilitation for people with rare diseases should be accessible in the future where professionals can support
Scleroderma United
Spring 2024 Intern Articles
Scleroderma patients through facilitating patient support networks.
In conclusion, Scleroderma not only present physical challenges but significant mental health impacts on indiviudals diagnosed as scleroderma patients are likely to experience various psychiatric symptoms than the general population. Gietzen’s story and advocacy works provides valuable insight into coping with the emotional toll of having the disease and empowering others to maximize the quality of life despire the challenges faced through education, having a support system and maintaining a positive outlook. Mental health Interventions and rehabilitation involving self care, awareness and social support can provide a better mental well-being amongst patients and can help navigate challenges of Scleroderma with greater resilience.
Resources:
Angelopoulos NV, Drosos AA, Moutsopoulos HM. Psychiatric symptoms associated with scleroderma. Psychother Psychosom. 2001 May-Jun;70(3):145-50. doi: 10.1159/000056240. PMID: 11340416.https://pubmed.ncbi.nlm.nih.gov/11340416/
G, M., Bhat, K. M., A, P., G, L., & MG, C. (2012). Psychiatric Symptoms and Quality of Life in Systemic Sclerosis. Clinical Practice and Epidemiology in Mental Health : CP & EMH, 8, 30-35. https://doi.org/10.2174/1745017901208010030
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339425/
Milette K, Thombs BD, Maiorino K, Nielson WR, Körner A, Peláez S. Challenges and strategies for coping with scleroderma: implications for a scleroderma-specific self-management program. Disabil Rehabil. 2019 Oct;41(21):2506-2515. doi: 10.1080/09638288.2018.1470263. Epub 2018 May 9. PMID: 29741963. https://pubmed.ncbi.nlm.nih.gov/29741963/
https://www.youtube.com/watch?v=Ntw3llBNSCI
https://sclerodermanews.com/columns/how-advocacy-work-helps-me-embrace-living-scleroderma/
https://scleroderma.org/virtual-groups/
Scleroderma United
Spring 2024 Intern Articles
Unveiling the Hidden Faces of Scleroderma
By Prisha Bhatnagar from Tung Chung, Hong Kong, SAR
Scleroderma is a disease of vascular and connective tissue where the skin and many other parts of the body can become thick and hard, restricting mobility of the individual. Scleroderma is a rare, chronic autoimmune disease. This can also cause potential damage to internal organs such as the lungs, heart, and digestive system. This disease can have a profound impact on the lives of those affected, causing physical discomfort, emotional distress, and significant lifestyle changes. Even though knowledge and treatment of this illness have advanced significantly, certain patients of scleroderma are still poorly understood and particularly face difficulties in receiving proper treatment due to no proper access to healthcare facilities.
There is strong evidence that people of darker race are more likely than people with lighter race to suffer from systemic sclerosis (SSc, scleroderma). According to (Silver et al., 2012), Black Americans have a higher risk than White Americans of developing Scleroderma, as well as higher morbidity and lower survival rates and racial Differences in the expression levels of various pro- and anti-fibrotic factors may make people with darker skin more susceptible to fibrotic diseases such as scleroderma (systemic sclerosis). This suggests that some are at a higher risk of Scleroderma than others and this information also allows us to draw conclusions about the potential root causes of Scleroderma. Additionally, Scleroderma is really easily
Scleroderma United
Spring 2024 Intern Articles
misdiagnosed due to its symptoms being really similar to other medical conditions. Diagnostic mistakes account for around 10% of adverse occurrences in hospital practice. However, very few studies have been conducted to investigate methods for improving diagnostic mechanisms according to the Royal College of Physicians.
Some factors that affect the risk of Scleroderma and discussed in the article could include cultural differences, genetics of individuals, environmental factors of certain regions on the earth and disparities in local healthcare systems.
Cultural Considerations:
The considerations about the cultural background of an individual are very significant when looking at what affects them more than others in terms of developing Scleroderma. According to research in the National Library of Medicine, Hispanics in the North American population are considered to be the ones with the more strong perception on diseases, medical conditions and their treatments. A neurology journal suggests that Scleroderma (and other medical conditions) may be seen as the result of supernatural causes, curses, or powerful emotions in some cultures, resulting in stigma and a reluctance to seek medical care. However as much as beliefs are important as responsible individuals we should try to seek proper consultation from a certified medical professional whenever the body asks for it.
Genetics of Individuals based on different regions and Environmental Factors:
The book about Genes, Behavior, and the Social Environment: Moving Beyond the Nature/Nurture Debate states that
Although there are numerous potential causes of human disease, family history is frequently one of the most powerful risk factors for prevalent disease complexes.
The Mendelian paradigm, which focuses on researching genes to better understand diseases, has failed to explain why some people are predisposed to common chronic diseases. Researchers understand that these diseases run in families and have a hereditary component, but examining genes has not fully explained the disparities in disease rates between groups.Environmental and social factors such as nutrition, exercise, and stress, on the other hand, have been shown in studies to influence the likelihood of developing specific diseases. Even after accounting for these factors, disparities in disease rates remain unexplained.
Scleroderma United
Spring 2024 Intern Articles
Disparities in Healthcare:
Limitations in healthcare quality and unequal access to services can both influence citizen’s overall health. Access to healthcare can be impacted by variables like financial situation, racial or cultural background, gender, and place of residence. Inadequate access to early detection, treatment, and preventative care can result in delayed diagnosis, inadequate chronic illness management, and ultimately inferior health outcomes.
Image 1: (Scleroderma Therapeutics Market Size | Industry Report, 2019-2026, 2019)
The pie chart shows the regions that have treatment for scleroderma and North America and Europe regions are the areas with the most treatment options and opportunities which is reflected in the highest % area of market share, on the other hand, Asia Pacific region which has the two most populated countries (China and India) is third in the treatment opportunity for scleroderma. The data in the chart can be affected by the socio economic situation of the region itself or lack of awareness about the rare chronic diseases like Scleroderma. This also links into accessing healthcare by travelling to a foreign country where the patient might experience language barriers and financial burden.
Unveiling the hidden faces of Scleroderma can be a real struggle with it being a rare chronic autoimmune condition. In order to ensure treatment to every patient of Scleroderma, the proper diagnosis and treatment is crucial. This is only possible through research on finding the cause of Scleroderma and funding proper treatment globally to make healthcare accessible. Scleroderma research relies heavily and should continue to rely on inclusive
Scleroderma United
Spring 2024 Intern Articles
research approaches. Researchers can acquire a greater awareness of illness processes and differences among ethnic, racial, and geographic groupings by involving a varied population base. This understanding is critical for accurate diagnosis, tailored therapy, and better patient outcomes. Inclusive research also contributes to reducing healthcare inequities, promoting equal access to care, encouraging community participation, and empowering individuals to take an active role in their medical choices. Embracing inclusive research has the potential to improve scleroderma support and treatment for all patients.
References
Dobson, R., Rice, D. R., D’hooghe, M., Horne, R., Learmonth, Y., Mateen, F. J., Marck, C. H., Reyes, S., Williams, M. J., Giovannoni, G., & Ford, H. L. (2022). Social determinants of health in multiple sclerosis. Nature Reviews Neurology, 18(12). https://doi.org/10.1038/s41582-022-00735-5
Grand View Research. (n.d.). Scleroderma Therapeutics Market Size | Industry Report, 2019-2026. Www.grandviewresearch.com. Retrieved April 12, 2024, from https://www.grandviewresearch.com/industry-analysis/scleroderma-therapeutics-market#:~:text=The%20global%20scleroderma%20therapeutics%20market
Hernandez, L. M., Blazer, D. G., & Institute of Medicine (US) Committee on Assessing Interactions Among Social, B. (2006). Genetics and Health. In www.ncbi.nlm.nih.gov. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK19932/#:~:text=3Genetics%20and%20Health
Mayes, M. D., Lacey, J. V., Beebe-Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., & Schottenfeld, D. (2003). Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis & Rheumatism, 48(8), 2246–2255. https://doi.org/10.1002/art.11073
Neale, G., Hogan, H., & Sevdalis, N. (2011). Misdiagnosis: analysis based on case record review with proposals aimed to improve diagnostic processes. Clinical Medicine, 11(4), 317–321. https://doi.org/10.7861/clinmedicine.11-4-317
Obiwuru, O., Joseph, S., Liu, L., Palomeque, A., Tarlow, L., Langer-Gould, A. M., & Amezcua, L. (2017). Perceptions of Multiple Sclerosis in Hispanic Americans. International Journal of MS Care, 19(3), 131–139. https://doi.org/10.7224/1537-2073.2015-081
Silver, R. M., Bogatkevich, G., Tourkina, E., Nietert, P. J., & Hoffman, S. (2012). Racial differences between blacks and whites with systemic sclerosis. Current Opinion in Rheumatology, 24(6), 642–648. https://doi.org/10.1097/bor.0b013e328356d9dc
Scleroderma United
Spring 2024 Intern Articles
Coping Mechanisms in Scleroderma
By Sarika Rahman from Valdosta, Georgia, United States
What is scleroderma?
Scleroderma is an autoimmune disease in which cells incorrectly overproduce collagen in the skin, which results in the hardening of the skin. There are mainly two types of scleroderma; limited which affects mainly physically and systemic which affects both physically and internally. Many difficulties can arise within the body because of the hardening of the skin, including pain and difficult mobility in the joint system, legs, and arms, as well as internal organ damage (systemic).However, a key factor or effect that is not always taken into consideration are the mental and social effects of scleroderma.
Effects of Scleroderma
Oftentimes, scleroderma has a significant impact on patients' lives and their ability to do things that they would have normally done. Many patients experience depression and increased anxiety, resulting from scleroderma. For instance, the Beyond Blue Chronic and Pain Illness, Anxiety and Depression website mentions that people who have chronic illnesses are more likely to suffer from depression and anxiety than those who do not have
Scleroderma United
Spring 2024 Intern Articles
chronic illnesses. Specific reasons why patients may encounter depression range from a wide variety of reasons including job-loss, low-self esteem, and low hope and fear of the future. On the other hand, medications and psychological therapy can be used to treat depression and anxiety if one can afford it.
Coping Mechanisms
While medicine and therapy can be used to treat depression and anxiety, many patients find rejoice and satisfaction in activities that they are interested in. For some, that may be through art and others through physical activity.
For instance, Elodie Allen was a woman who had undergone lethargy and emotional hardship after being advised not to do strenuous exercise because of scleroderma. While it was challenging to listen to the advice, she seeked other ways that she could still do physical activity whilst enjoying it. She later on found circus arts which allowed her to swing through new perspectives and be able to express herself within her community.
Also, another key figure to highlight is Amy Gietzen who has scleroderma and Telangiectasias (red blotches around her body). Physical appearance was the biggest difficulty for her in her 20s since her body underwent rapid changes through that time. Gietzen’s self esteem dropped and became self-conscious in a world of unrealistic beauty standards. However, she realized the magic that could help her look “artificially pretty;” makeup. Although Gietzen used makeup to alter her looks at the time, she came to accept her conditions over time and use makeup as an art expression to represent herself.
Coping mechanisms do not always have to be a very distinct activity that you do such as the ones mentioned above because it can vary by person. To give an example for some people, a very common coping mechanism may be surrounding themselves with loved ones, while others by doing more for the people around. Coping mechanisms are shaped by an individual in order for them to successfully accept their circumstances and live their best life!
Scleroderma United
Spring 2024 Intern Articles
Scleroderma Warriors
By Sehrish Hirani from Visalia, California, USA
When it comes to researching autoimmune diseases that can cause high-risk factors and even death, you can rarely see one. However, is this because most of these diseases don’t exist, or is it because they haven’t been researched or talked about enough? Could you identify the autoimmune disease seen in the picture? Scleroderma is one of the rarest autoimmune diseases that sadly doesn’t have a known cause, but it does impact many lives each year. But what is scleroderma? The truth is, taking the time to explain each variant and cycle of scleroderma will not make any sense as the tree of scleroderma has many branches. If you would like to read more about this disease, I suggest clicking on this link because this article's purpose is to promote scleroderma warriors. A great way of learning and seeking the effort to make an impact is by reading stories of true scleroderma warriors who have persevered despite all the challenges that they faced. All the following stories of warriors are from Scleroderma United. Let us go through some of the strongest scleroderma warriors who fought for themselves!
Stories: The Warriors Who Fought
First, I read Emily Grace Romero's interview. Emily started noticing symptoms when she was working a full-time job, being a young mother, and trying to do
Scleroderma United
Spring 2024 Intern Articles
everything she could all at once. Her hands would turn purple and white out of nowhere. At one point, her body gave up, and she simply could not push through the struggles of everyday life. However, some of her best decisions have been made since that day. When she was misdiagnosed and had to do all her research on her own, she decided that she wanted to go into holistic and functional medicine. Ever since then, she has not let scleroderma stop her from living out her dream. She still enjoys her hobbies and has the same love that she had before. Her motivation has pushed her so far. As a scleroderma patient, she recommends searching and exploring more about scleroderma and to be curious. You can make a big difference out of something that was meant to harm you.
Then, I decided to explore another scleroderma warrior. I like reading about people and their experiences from their perspective which is why I love reading these interviews. Alayna’s story attracted me because she is also a data scientist which is a field that is very interesting to me. She had an attack back in 2015 where she was told that she had to be amputated. She started noticing some pigmentation, and that’s when she thought she had scleroderma. Furthermore, she ended up finding out in 2021 that she did have scleroderma. Being a data scientist, she knew nothing about medical studies, and her brain mainly worked with data which is why she signed up for a Scleroderma newspaper so she could get different information. Despite all the pain she went through, especially with Rauyaund’s disease, she still pushed through, and she can do everything she used to before the pandemic. However, with all that she has been through, she does have her fears for the future. She is scared that her scleroderma may stop her from working, and in a country with widespread poverty, this is a terrifying thought. ¨I need to do everything that I can, everything that’s available to me to try to be able to get ahead of this and start being able to think of how to plan my financial future if the worst were to happen,” is her main concern with her disease. However, she has learned that this disease isn’t any type of course. Her best advice is: “The best thing I can do for myself is to keep working through and keep fighting for myself.”
Making A Difference: Research
After reading and finally understanding what scleroderma is, that’s when we get to make a choice. We can either move on, or we can choose to learn more about how we can help the cause and the community of scleroderma warriors. So, I decided to find a research foundation that devotes its time to learn more about scleroderma and finding ways to help all the warriors across the world. Research is the investigation and study of materials to
Scleroderma United
Spring 2024 Intern Articles
establish facts and reach new conclusions. After researching, I found the Scleroderma Research Foundation. This is the United States’ largest non-profit for Scleroderma. They not only mention stories of scleroderma warriors, but they also conduct research on scleroderma and raise money that goes towards that research. They are now introducing CONQUEST which is a clinical trial that will rapidly produce treatments for scleroderma. This amazing journey started with a woman named Sharon who was a scleroderma warrior. She knew that a cure wouldn’t come in her lifetime, but she dedicated her time to starting the process of finding a cure, so the future of scleroderma would be much brighter. The main goal of the Scleroderma Research Foundation is to raise awareness of scleroderma and to find a cure. This foundation can be explored by more in-depth research, but overall, the cause of scleroderma and the fight to raise awareness can be found in multiple sources.
Stand Up For The Cause
There is one thing that all these scleroderma warriors have in common: their strength. They all share their immense courage and the experiences they have used to fight against scleroderma. It's not easy living with an autoimmune disease. Many people still don't understand what scleroderma is. But taking the time to learn more and understand the stories of scleroderma warriors can only be done by a person who wants to make a difference. Even if you don't have any connection with scleroderma, you can still make a difference, simply by devoting your time to the stories and the research done for scleroderma. So join me and many others in standing up for scleroderma warriors.
Scleroderma United
Spring 2024 Intern Articles
Differentiating between Scleroderma and Related Diseases
By Shria Ajay from Princeton, New Jersey, USA
Scleroderma is a rare group of disorders that is often difficult to diagnose. Scleroderma is characterized by the development of hard skin. Scleroderma is often categorized into localized and systemic scleroderma. Localized scleroderma can be in patches or lines on the skin, while systemic scleroderma affects the organs. One symptom of the condition is the Raynaud phenomenon, which is where the fingers turn red in warmth and blue in the cold. This symptom is found in both forms of scleroderma. People with SSc often have acid reflux because of issues with their esophagus. Localized scleroderma is less severe, although the linear version can cause one limb to be shorter than the other. The cause of scleroderma is unknown, although we know that the thickened skin is caused by excessive collagen formation by fibroblasts. Issues with the blood vessels, immune system response, silica exposure, and some medications could contribute to causing scleroderma. Scleroderma is very rare, with only 1 in every 10,000 people affected, according to this article from the Rare Disease Organization. The article "The Global Role of Patients, Advocates, and Caregivers in Rare Diseases" by Mukund Nori details the importance of PACs (patients, advocates, and caregivers) in ensuring that patients with rare disorders get correctly diagnosed and treated. Because of the importance of PACs, it is incredibly valuable for them to be able to differentiate systemic scleroderma
Scleroderma United
Spring 2024 Intern Articles
from similar diseases. This article aims to explain key differences in these diseases in a way that is accessible to the public. Dr. Kathy Katella from Yale Medicine argues that since scleroderma symptoms often vary and appear at different times, the disease can be difficult to diagnose. It is often confused with systemic lupus erythematosus and rheumatoid arthritis.
Rheumatoid arthritis is an inflammatory disorder that targets the joints, as well as the eyes, skin, heart, and lungs. It is an autoimmune disease where the body attacks the joints. One study by Alex Magno Coelho Horimoto and Izaias Pereira da Costa found that 32.8% of clinical patients with scleroderma had also been diagnosed with arthritis. However, their study found that the true overlap of the two diseases should be 6.6%. Clearly, the two diseases are commonly confused. VeryWell Health explains that an antibody nuclear test is extremely useful in differentiating arthritis from scleroderma. This process tests for elevated levels of antibodies in the blood. According to one MedLine website article, ANA tests are also called “antinuclear antibody panel, fluorescent antinuclear antibody, FANA, ANA, ANA reflexive panel.” While patients with scleroderma usually have high levels of these antibodies, arthritis patient results vary greatly between patients. Therefore, the ANA test could potentially be useful in this differential diagnosis. However, the most clear difference between the two diseases is the presence of Raynaud’s phenomenon. This phenomenon, present in scleroderma but not arthritis patients, causes a patient's fingers and toes to become painfully cold and numb.
Lupus is an autoimmune disorder that causes inflammation in the skin, joins, and organs. Scleroderma is often confused with lupus because they have similar features, and patients sometimes have both diseases. In fact, according to one article from the Scleroderma News Organization, 20% of scleroderma patients also have lupus. Medical News Today explains that if a patient has high levels of anti-topoisomerase I, which is an antinuclear antibody, they are more likely to have scleroderma. However, the presence of a different antibody, like anti-dsDNA, anti-smith, anti-Ro/SSB, or anti-La/SSB is more likely to be lupus, according to the Scleroderma News Organization. Finally, a complete blood count (CBC) test may be helpful in the diagnosis, since lupus often lowers the level of blood in a patient. CBC tests measure the amount of red blood cells, white blood cells, hemoglobin, hematocrit, and platelets.
Tests like the ANA and CBC tests might help differentiate scleroderma from
Scleroderma United
Spring 2024 Intern Articles
similar diseases like rheumatoid arthritis and lupus. With close inspection from medical professionals, with the help of patients, advocate, and caregiver groups, scleroderma patients can be correctly diagnosed as much as possible.
Bibliography
ANA (Antinuclear Antibody) Test: MedlinePlus Medical Test. (n.d.). Retrieved March 25, 2024, from https://medlineplus.gov/lab-tests/ana-antinuclear-antibody-test/
“Complete Blood Count (CBC).” Mayo Clinic, January 14, 2023. https://www.mayoclinic.org/tests-procedures/complete-blood-count/about/pac-20384919.
Horimoto, A. M. C., & da Costa, I. P. (2016). Overlap between systemic sclerosis and rheumatoid arthritis: A distinct clinical entity? Revista Brasileira De Reumatologia, 56(4), 287–298. https://doi.org/10.1016/j.rbre.2014.12.011
Eustice, Carol. “Other Diseases to Consider before Diagnosing Rheumatoid Arthritis.” https://www.aafp.org/pubs/afp/issues/2018/0401/p455.html#:~:text=%E2%80%A0%E2%80%94Differential%20diagnoses%20differ%20in,expert%20rheumatologist%20should%20be%20consulted.
Flavell, Laura. “Lupus and Scleroderma.” Scleroderma News, May 14, 2018. https://sclerodermanews.com/lupus-and-scleroderma/.
Thomas, Liji. “What Is a Diagnosis?” News, September 1, 2021. https://www.news-medical.net/health/What-is-a-diagnosis.aspx.
Paknikar, S. S., Crowson, C. S., Davis, J. M., & Thanarajasingam, U. (2021). Exploring the Role of Antinuclear Antibody Positivity in the Diagnosis, Treatment, and Health Outcomes of Patients With Rheumatoid Arthritis. ACR open rheumatology, 3(6), 422–426. https://doi.org/10.1002/acr2.11271
“Rheumatoid Arthritis.” Mayo Clinic, January 25, 2023. https://www.mayoclinic.org/diseases-conditions/rheumatoid-arthritis/symptoms-causes/syc-20353648.
“Scleroderma.” Mayo Clinic, January 27, 2022. https://www.mayoclinic.org/diseases-conditions/scleroderma/symptoms-causes/syc-20351952.
Scleroderma United
Spring 2024 Intern Articles
Medication Affordability and Access to Healthcare
By Sonal Jain from Brisbane, Queensland, Australia
Scleroderma is a rare and chronic autoimmune disease that involves hardening and tightening of the skin. It also causes problems in the gastrointestinal tract, internal organs and blood vessels. This complex disease can be difficult to diagnose as the symptoms vary from person to person and are similar to those of other diseases. There is no single test to diagnose scleroderma, and doctors usually use a combination of tests to diagnose patients. This complexity makes scleroderma a very expensive disease to manage, often requiring a combination of medications and specialised care.
Importance of medication affordability for scleroderma patients:
Effective disease management often hinges on the affordability of medications. Consistent and appropriate medication use is vital for maintaining health and preventing complications associated with scleroderma, such as Raynaud's phenomenon, gastro-oesophageal reflux, pulmonary hypertension and calcinosis. High medication costs can lead to non-adherence, where patients either skip doses or stop taking medications altogether, resulting in worsening symptoms and increased hospitalisations. The financial burden of medication expenses can also lead to significant economic strain, contributing to increased debt and reduced quality of life.
Scleroderma United
Spring 2024 Intern Articles
Ensuring medication affordability is crucial for achieving equity in healthcare.
Barriers to Medication affordability:
Patent Laws and Market Exclusivity
Patents and market exclusivity can limit the availability of generic drugs, keeping prices high. These patents, which encourage innovation, can also delay the introduction of more affordable generic versions of medications, impacting scleroderma patients who rely on expensive, patented drugs.
Insurance Coverage
Inadequate insurance coverage and high out-of-pocket costs can prevent individuals from accessing necessary medications. Insurance plans may have high copayments or restrictive formularies, limiting access to effective treatments. For scleroderma patients, this often means choosing between high-cost, effective treatments and more affordable, less effective options.
The lack of regulation and transparency in drug pricing by pharmaceutical companies often leads to high medication costs. Without clear pricing policies, patients and healthcare providers face unpredictability in drug costs.
Access to Healthcare:
Access to healthcare is a fundamental right, and these barriers hinder the ability of individuals, particularly those with chronic illnesses like scleroderma, to receive timely and effective treatment. This exacerbates health disparities and negatively impacts their quality of life. Scleroderma often requires care from specialists, such as rheumatologists, dermatologists, and pulmonologists and accessing these specialists can be very costly. Moreover, effective treatment for scleroderma involves a multidisciplinary approach, including medications, physical therapy, occupational therapy, and mental health support. Financial constraints can disrupt comprehensive care as the high cost of specialist consultations, diagnostic tests and ongoing treatments can be prohibitive for many patients. Furthermore, geographical barriers - rural and remote areas often have limited healthcare facilities and providers, making it difficult for individuals to access necessary care. Specialised treatments for scleroderma are usually concentrated in urban centres, making healthcare a significant challenge for those living in less accessible regions.
Scleroderma United
Spring 2024 Intern Articles
Case Study: Alanya Roberts
One such scleroderma patient is Alayna Roberts, whose case highlights the critical issues of medication affordability and access to healthcare, emphasising the need for comprehensive strategies to improve the quality of life and health outcomes for those affected by scleroderma. Alayna Roberts is one of many individuals diagnosed with scleroderma disease who struggles with the high costs of medications and limited access to healthcare. Her story, highlighted in Issue 5 of Scleroderma Stories underscores Alayna’s journey with scleroderma and her battle with medication affordability.
For years, Alayna relied on Dexilant, a proton pump inhibitor (PPI) that effectively managed her gastroesophageal reflux disease (GERD), a common complication of scleroderma. However, after losing her job, Alayna could no longer afford Dexilant, even with a manufacturer coupon reducing its cost to $300 a month. Her current job offers no coverage for PPIs, forcing her to switch to cheaper alternatives like Omepraxole and Famotidine, which are less effective. This switch has negatively impacted her health, as the cheaper medications do not control her GERD symptoms as well as Dexiland did.
Alayna’s situation highlights several key issues, such as the economic burden of medication costs, forcing her to choose less effective treatments and lack of insurance coverage for necessary medications in managing chronic illnesses. This has led to a negative health impact, demonstrating the direct effect of medication affordability on patient health.
Alayna’s story underlines the importance of addressing medication affordability and access to healthcare. By tackling these issues, individuals with chronic illnesses like scleroderma can receive the necessary care and treatment.
Addressing medication affordability and access to healthcare for scleroderma patients requires comprehensive strategies:
Policy Reforms - Implementing policies to regulate drug prices, increase transparency and promote the use of generic medications can help reduce costs. Advocating for these reforms can make medications more affordable for patients.
Scleroderma United
Spring 2024 Intern Articles
Expanding Insurance Coverage - Enhancing public insurance programs and subsidies to reduce out-of-pocket costs for medications and healthcare services can improve access. Expanding insurance coverage ensures that more individuals can afford necessary effective treatments.
Innovative Healthcare Models - Adopting telemedicine and mobile health clinics that can reach under-served populations and improve access to care. These models can provide remote consultations and follow-up care, especially for those in rural or remote areas.
Patient Support Programs: Developing patient assistance programs to provide financial aid and access to necessary medications and treatments is also crucial. Such programs can offer relief to patients struggling with medication costs, ensuring they receive the required treatments.
In conclusion, medication affordability and access to healthcare are essential for managing chronic illnesses like scleroderma and improving overall health outcomes. Alayna Roberts’ case illustrates the significant challenges faced by individuals with scleroderma in accessing effective and affordable treatments. Comprehensive strategies, including policy reforms, expanded insurance coverage, and innovative healthcare models, are necessary to address these challenges. Collaboration among policymakers, healthcare providers, patient advocacy groups and the broader community is crucial in ensuring that all patients receive the affordable medications and quality healthcare they need. By working together, we can improve the lives of those affected by chronic illnesses and ensure better health outcomes for all.
Scleroderma United
Spring 2024 Intern Articles
How to blog safely: The Power of Social Media Blogging and Managing Scleroderma Disease
By Sonia Lee from Clayton, Victoria, Australia
“Hello welcome to my blog! Today I will be sharing with you what my first day in school was like!” As a child growing up with the internet, an entry such as this would be an embarrassing past but it was normal for us. It may not be written as words on the internet that would never be erased now, but it is still something that happens for children of today. The only difference is that these (slightly embarrassing pasts) are posted on Tiktok and Instagram instead. However, there is in fact nothing to be embarrassed of about these. In fact, there are multiple benefits of these forms of journaling and blogging!
Blogging can help improve ones writing and reflecting skills, expression of ones thoughts and creativity, communication abilities, independence in learning, and online safety. Journaling can also observe similar benefits by managing one’s emotions and fears, recognising symptoms and its impact on us, acknowledging the ruminative thoughts, and promoting positive thinking. In finding a space to record our thoughts, experiences, and journey through life, we are able to be more aware of our own feelings and thus understand ourselves more. This can lead to one finding the courage to reach out for help and especially for those who are suffering and battling an illness, it can help in the healing process.
Scleroderma United
Spring 2024 Intern Articles
There are scientific evidences that can support how journaling can be a good treatment tool for individuals facing mental illnesses. And of course, the same can apply to physical illnesses. Individuals with physical illness may not share the same degree of emotional problems that individuals with mental illness do, yet we are all humans and having a physical disease can be teriffying and have a huge emotional toll on anyone. This can apply to any type of disease; chronic illnesses, diabetes, cardiovascular disease, and even autoimmune diseases such as scleroderma.
Scleroderma is an autoimmune disease which results in the inflammation and thickening of one’s skin. There are different types of scleroderma, with two main types: localised scleroderma and systemic scleroderma. It can result in physical patching of skin, thickenign of skin in specific areas, tightening of eseophagus, digestive issues, kidney diseases, progressive lung diseases, heart fibrosis, and more. It can also cause fatigue, headaches, mood disorders, and change in ones cognition.
Thetubefedwife, Chanel White, had used a popular blogging social networking site, Blogspot, as a space to record her diagnosis story with Scleroderma and her daily or monthly experiences. Chanel records her experiences in the clinic, her daily life, and activities she partakes in ever since her diagnosis in 2015.
Similarly, Elaine uses YouTube, a social media platform, to share her life with scleroderma. Her channel, Elaine’s Autoimmune Adventure, has more than a thousand subscribers with weekly videos and updates on her experiences to clinics, sharing insights, and answering questions related to her disease.
We find that having a space to share ones experiences related to illnesses can have a healing effect on an individual. By sharing their own experience as a patient, they feel supported when like individuals find their shared words, they are able to access more health information, they experience improved behaviour and relationships with others. This is as social media use can infact promote online spaces for patients to interact with other patients, individuals who have completely healed, and also professional clinicians.
Additionally, blogging on social media and sharing experiences, confronting misconceptions, and providing health education can result in raising awareness of the particular illness, in this case scleroderma, to the general public. This can help in improving and changing the public opinion towards
Scleroderma United
Spring 2024 Intern Articles
certain diseases, promoting a healthy and safe space both online and in the real world for patients. Hence, blogging and sharing on social media is in fact a hero in disguise for individuals with illnesses.
However, we all know the fears and dangers that social media can pose: internet trolls with negative comments, exposure to cyberbullying and cyberthreats, increased self-comparison, and potential addiction. Hence, it is important that one adopts good practices when using social media. Some recommendations include recognising fake information and photos on social media, practising mindfulness and self-compassion, clearing ones feed by selecting which accounts or communities to not follow, finding a good balance between social media and being offline, and also recognising when one has become a victim of cyberbullying.
Chanel, otherwise known as thetubefedwife, has since stopped posting with her latest post dating June 2021, but for a good reason. She writes in her final post, “As of now, I am no longer, 'the tube-fed wife.' ...You know, getting rid of your lifeline is actually quite frightening. My head was swimming with the, 'what ifs.' What if this treatment suddenly fails? What if I need my J tube again? Remember how terrible that surgery was!? But, I have decided I cannot live in the 'what ifs,' all I can do is move forward. So here I am, marching forward with one less tube, ready to take on whatever comes next.”
Chanel’s story is very inspiring and a journey well spent, sharing her experience with medical devices and clinic visits, and her emotions and feelings which had its up and downs. Like many other scleroderma patients, she displayed her optimism, encouraging others who have stayed with her journey that there will always be a better day and something to look forward to in life.
Scleroderma United
Spring 2024 Intern Articles
The Challenges of Scleroderma and Helpful Coping Mechanisms
By Sophia Neuenhaus from Mountain Lakes, New Jersey, United States
What is Scleroderma?
Scleroderma is an autoimmune disease which can be categorized into systemic and localized scleroderma. Systemic scleroderma affects the internal organs and the skin, while localized scleroderma affects specific parts of the skin. Despite patients having the same diagnosis, they still have different challenges and coping mechanisms.
Challenges of Scleroderma
Scleroderma presents itself differently for everyone, causing individuals to experience the disease’s challenges in their unique way. Despite this, it is still important for patients to share their stories so that they can empower each other, create a community, and educate others. Many patients have come forward and shared to help the greater population of scleroderma patients.
Natasha Sisodiya explained that her physical symptoms of scleroderma included skin tightening, joint pain, and stiffness. Meanwhile, she experienced the mental challenges of depression, anger, and fear. Her life was thrown upside down, making it difficult for her to be intimate with her husband, to maintain friendships, and to stay active. Natasha's Story
Scleroderma United
Spring 2024 Intern Articles
Evamarie Gilbes-Cole shared her challenges of losing teeth, GI issues, ulcers, calcinosis, skin tightening, joint pain, and hand curling. Despite these symptoms, it took a year for her to be diagnosed with scleroderma. All of these challenges forced her to relearn daily functions such as eating and drinking. Evamarie Gilbes-Cole Story
Tameka Nelson noted that when she was originally diagnosed, she fell into a deep depression because she was not ready to accept that her whole life would change. She was not prepared for this severe disease to take over. Tameka Nelson's Story
In Living With Scleroderma Can Affect Your Sense of Self, Women Say, scientists researched experiences of women with scleroderma. It was discovered that most women felt that their sense of self was forced to completely change. Their body changed significantly, causing many features, such as their nose, lips, and cheekbones, to become unrecognizable. Their physical capabilities were also challenged, as they could not perform many of the activities they were previously able to.
As it can be seen, each patient experiences their challenges differently, but they are each affected mentally and physically. Receiving a serious diagnosis is not easily accepted by anyone, and so coping mechanisms must be developed.
Coping Mechanisms to Maintain Physical and Mental Health
There are many different ways in which each patient copes with scleroderma, ranging from social forms of coping mechanisms to individual activities or thought processes.
For Natasha, she noted that joining a support group has been a major way in which she can eliminate the feeling of isolation. She talks to others who share her feelings and can relate to her challenges. In an individual sense, she said that over time she has learned that acceptance and focusing on enjoying life has helped her mentally. Until she learned acceptance, she was unable to conquer the idea that scleroderma was controlling her life. Natasha's Story
Regarding Evamarie, she has chosen to focus on building a community and building friendships through scleroderma, making an effort to visit others with this disease. Spreading awareness has been a way to take an unexpected disease and turn it into something positive. She also has recognized that
Scleroderma United
Spring 2024 Intern Articles
although she has lost certain parts of her life such as her job, this has allowed her to spend more time with her son. Overall, Evamarie has turned her diagnosis into a positive impact on the scleroderma community as a coping mechanism. Evamarie Gilbes-Cole Story
Tameka has also worked to positively impact the scleroderma community by sharing her story and encouraging others to do the same. She has done this through her Itcouldabeenworse foundation, based on the coping mechanism of looking at the bright side and realizing that there was a worse possible outcome. Tameka Nelson's Story
From Living With Scleroderma Can Affect Your Sense of Self, Women Say, scientists learned that the women that lost their sense of self have learned to take their identity back in other ways. They reclaim their identity by accepting the changes and practicing gratitude to develop a stronger sense of inner self.
Each individual finds their peace through different coping mechanisms, whether it be by finding community, helping others, or strengthening mental health. It is important to find what coping mechanism works best for each person to make living with scleroderma more manageable.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma: Gender discrimination & Awareness
By Sophie Choi from Fremont, California, USA
What is scleroderma?
Imagine you feel that there is something wrong with your fingers. The skin is thicker than usual. You go to the hospital to figure out what is happening to your body. The doctor explains to you that you have a disease called scleroderma and it cannot be cured. What would you do if you were in that situation?
Scleroderma is an autoimmune disease where the immune system is unable to distinguish invaders from itself and attacks the body’s tissue. The two primary forms of scleroderma are systemic sclerosis and localized scleroderma. Systemic sclerosis affects the internal parts of the body such as organs as well as the skin. There are two major types of systemic sclerosis (SSc): limited cutaneous SSc and diffuse cutaneous SSc. Limited SSconly involves the hands and forward, lower legs, and feet. However, diffuse SSc affects the hands, forearms, upper arms, thighs, or trunk. In both forms, the face can be affected. It is important to distinguish the two forms as they can reflect the state and involvement of the internal organs. Systemic sclerosis can be deadly because it affects the internal organs and systems. Localized scleroderma only affects the skin and is usually not as life-threatening compared to systemic sclerosis. The cause of scleroderma is still unknown but there is some knowledge about the biological processes involved. In
Scleroderma United
Spring 2024 Intern Articles
localized scleroderma, the problem is the overproduction of collagen in some areas of the skin. In systemic sclerosis, the causes are blood vessel abnormalities, fibrosis, and autoimmunity. It has been found that SSc is more common among people who have had family members with other autoimmune diseases. Localized scleroderma is more common in children while SSc is more common in adults. A possible reason for someone to get scleroderma is an injury from an external agent such as a bacterial infection or something in the environment.
Scleroderma’s impact on women
Between 24 and 50 million Americans have an autoimmune disease and four out of five of them are women. Stanford Medicine scientists have found that the cause of this is because of the X-chromosome in females. “Women have too much of a good thing: It's called the X chromosome” (News Medical). Having two X-chromosomes means that there are twice the myriad proteins produced than the Y-chromosome which can be lethal. That is why in embryogenesis, each cell shuts down the activity of one or the other of its two X-chromosomes so that the same amount of protein is made as in a male cell. The inactivation of the X-chromosome is a factor that can cause autoimmune disorders. When Xist, a molecule that helps with X-chromosome inactivation, attaches with the extra X-chromosome, it generates odd combinations of IncRNA which can trigger a strong immune response.
Women who share their story
Aneila Vargas is a 28-year-old scleroderma patient born in Puerto Rico and later moved to Florida. She recently graduated with a bachelor’s degree in Health Services Administration. The first symptom she noticed was skin discoloration. Then, she discovered that she was sleepier than usual and was developing patches on her face that resembled rough crocodile skin. She visited three primary care centers but they all did nothing to help her. They said the problems were because of her weight. Since her diagnosis did not solve any of the problems was feeling, she visited a rheumatologist and got diagnosed with scleroderma. To manage her mental health emotions, she learned how to enjoy life. She created an Instagram page where she posts her drawings to express how she feels. (Scleroderma United).
Aneila’s story is one of many women who got diagnosed with scleroderma. They all experience problems with mental health and when finding out about their disease. In many stories, doctors do not recognize scleroderma, and women especially, get diagnosed with the wrong disease or just get dismissed.
Gender Discrimination
Scleroderma United
Spring 2024 Intern Articles
An article by Duke Health presents a survey conducted in early 2019 by TODAY. It shows the statistics in which women believe there is gender discrimination in patient care. 20% of women say they have felt that a healthcare provider has ignored or dismissed their symptoms, and 17% say they feel that they have been treated differently because of their gender. This is a much higher percentage than men which is 14% and 6% respectively. Also, studies have shown that compared to men, women who present the same condition may not receive the same care. Many women get different treatments that lead to poorer outcomes. Most likely, this discrimination is not intended but is caused by more research on male animals and male cells which are different from females.
What can we do to help solve this problem?
The most important thing you can do is to gain awareness on this problem. There has always been discrimination towards women, such as lower pay and less opportunities. Thankfully, there have been advancements in providing equal treatment to men and women. However, many times, the discrimination goes unnoticed to the general public. Most people don’t know that there is discrimination in the healthcare system. If people don’t know, they can’t change. In addition to being aware of this situation yourself, spread the awareness to other people and let them know the problem too!
Scleroderma United
Spring 2024 Intern Articles
Mental Health and Self-Esteem While Living With Scleroderma
By Sophie Citron from Greenwich, Connecticut, USA
An autoimmune disease is a condition where an individual’s immune system attacks their body. Typically, the immune system fights viruses and toxins. However, for individuals with autoimmune diseases, the immune system cannot distinguish between healthy and dangerous cells, and causes damage. Scleroderma, or systemic sclerosis, is an example of an autoimmune disease. In patients with scleroderma, the immune system produces too much collagen, a protein found in skin and other connective tissues. This can result in thickened skin, as well as many other symptoms, including fatigue, joint pain, and other localized symptoms. There are different types of scleroderma that can present themselves differently, resulting in many different symptoms.
Mental health is a topic that is important for individuals of all ages and conditions. In individuals with autoimmune diseases, mental health is a crucial topic that is often overlooked due to the physical issues that are constantly being addressed. According to research done by the University of Cambridge and King’s College London, over half of patients with autoimmune diseases have mental health conditions, yet the majority of patients are not asked about their mental health during appointments. Many of the symptoms involved with scleroderma and other autoimmune diseasese are also symptoms of mental health conditions like depression,
Scleroderma United
Spring 2024 Intern Articles
which can result in these symptoms being attributed to the physical condition and being widley overlooked in terms of mental health.
Self-esteem is how an individual views themself and they amount of value they place on their wellbeing. Mental health and self-image are connected, as high self-esteem can help indivduals cope with mental disorders and low self-esteem is linked with mental health issues and poor quality of life. Some of the benefits of high self-esteem can include stronger relationships, increased success at work and at school, and less anti-social behavior. While self-esteem is just one aspect of the ways that individuals can work towards a better quality of life long-term, research has demonstrated that self-esteem can make large positive changes. Therefore, promoting high self-esteem in individuals living with autoimmune diseases such as scleroderma can result in improved mental health.
Amy Gietzen is a columnist at Scleroderma News that talks about her experience with self-esteem while living with scleroderma. Scleroderma, and many other autoimmune diseases, can cause drastic physical changes. This can result in low self-esteem, but it doesn’t have to. Gietzen explores how wearing makeup can make her feel beautiful in the body that she is living in without resenting herself for the struggles that she is facing. She does not reject her identity - instead, she leans into it, and does what she can to make herself comfortable.
In summary, mental health and self-esteem are concepts that are prevalent for people of all ages and all conditions. While having an autoimmune disease is incredibly challenging, it doesn’t mean that you can’t love yourself and the body that you are in. There are still ways to embrace your newfound identity while struggling and doing what you can to value yourself for who you are and what you can do.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma and Low Self-Esteem
By Tharmitha Ramkumar from Toronto, Ontario, Canada
Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening of the skin due to excess production of collagen. This condition can be caused by one genetic makeup, the environment the person resides in, changes in immune system and hormones. Some of the physical effects that derive from those who have scleroderma are skin thickening, telangiectasia which are small red spots on their face and face and Raynaud's phenomenon. These physical conditions can cause those with scleroderma to feel less confident and have a lower self-esteem. Low self-esteem can stem from issues such as health issues, depression or trauma. From the perspective of scleroderma which is a health issue can lead to one having a lower self-esteem which can be due to things as to the physical conditions of the disease. When most think of the impacts of a disease, they mostly think of the mental distress and disorders that come with it but it is important to note that there can be mental distress that can arise due to the physical conditions of the disease.
Scleroderma and Self-Esteem
One of the biggest physical insecurities that come with scleroderma is the thickening of the skin. Self-Manage Scleroderma has written that people
Scleroderma United
Spring 2024 Intern Articles
perceive the physical changes that come with scleroderma are seen as undesirable and attractive which can be very distressing. A study had researched how scleroderma affects one's self-esteem. They had discovered that skin thickening from scleroderma lowers their self-esteem which later affects their psychological distress. The effects of low self-esteem does not only take a physical toll on one's body but can also lead to other health problems such as depression anxiety, eating disorders, social phobia, attention deficit disorder and substance abuse. It can be seen that scleroderma can have many effects on one's physical and mental health.
How to overcome Low Self-Esteem with Scleroderma
As scleroderma can affect those who have it by lowering self-esteem, is it important that they prioritise their health and seek health so they can increase their self-esteem. One of the things people with scleroderma can do to increase their self-esteem is to reflect on themselves and think about their strengths and positive things. This can help forget about the insecurities and bring out their best characteristics. Another thing that can help improve one's self-esteem is to exercise. Exercise can help increase the mood of the person, so they can avoid further mental distress such as anxiety and depression and overall feel happier. Lastly, those who have scleroderma and low self-esteem should seek help from their family doctors. Doctors can help seek help and access a health treatment plan that could help with the physical scars, mental distress and improving your mood. These resources are important in helping to improve one's mood and increase their self-esteem.
Conclusion
In conclusion, scleroderma is a physical condition that has many effects including physical effects such as scars and the thickening of the skin. These physical conditions can cause one to have physical insecurities and lower self-esteem. Lower self-esteem can lead to other mental problems such as anxiety and depression. It is important that those who have scleroderma and low self-esteem seek help such as meeting with their doctors, self reflecting and exercising. It can be upsetting if one has physical insecurities but it is important to know that scars and marks on the outside do not define who you are.
Scleroderma United
Spring 2024 Intern Articles
Photo Source here
Scleroderma: The Full Story
By Tisya Mahajan from Waxhaw, North Carolina, USA
Introduction
Scleroderma is a formidable adversary in the realm of autoimmune disorders, spinning an intricate web of symptoms and challenges for those it ensures. Consider a morning when the gentle touch of sunlight on your skin is replaced by an unfamiliar sensation of rigidity and tightness, as if your body is gradually turning to stone. Individuals suffering from scleroderma, a condition known for its relentless assault to the body’s connective tissues, face a harsh reality. In this article, we will take a journey through the complexities of scleroderma, from clinical manifestations to its profound impact on quality of life. Through the lens of understanding, empathy, and knowledge, we will delve deeply into the nuances of scleroderma, exploring its etiology, epidemiology, management, and personal narratives. I hope to shed light on this misunderstood condition, highlighting the struggles and triumphs of those affected.
Understanding Scleroderma
Scleroderma, a complex autoimmune disorder, remains a puzzle that medical science is still grappling with. Its cause is the complex interplay of genetic predisposition and environmental triggers, in which the body’s immune system mistakenly attacks its own tissues, particularly the connective tissues. This assault causes abnormal collagen production and
Scleroderma United
Spring 2024 Intern Articles
Scleroderma is classified into various subtypes, such as localized and systemic forms, which heps unravel its complexities and tailor treatment strategies to individual patients.
Scleroderma’s clinical manifestations are diverse, including not only the characteristic skin thickening and joint stiffness, but also internal organ involvement. Scleroderma can disrupt multiple organ systems, including the skin, lungs, heart, kidneys, and gastrointestinal tract, posing a slew of challenges for both patients and healthcare providers.
Scleroderma diagnosis can be difficult because the symptoms can mimic those of other conditions and vary greatly from patient to patient. Distinguishing between different types of scleroderma and ruling out other autoimmune diseases necessitates a thorough evaluation by experienced clinicians, which frequently includes a combination of clinical assessments, laboratory tests, and imaging studies.
Epidemiology and Risk Factors
While scleroderma can affect people of all ages, genders, and ethnicities, epidemiological studies consistently show a bias toward certain demographic groups. Scleroderma affects women more than men, with a female to male ratio ranging from 3:1 to 9:1, depending on the subtype and population studied. The reason for this gender disparity remains unknown, necessitating further investigation into hormonal, genetic, and environmental factors.
Scleroderma patients’ age of onset varies greatly, with peak incidence occurring between the ages of 30 and 50. However, scleroderma is not limited to middle-aged adults; cases have also been reported in children and older adults. Understanding age related patterns of scleroderma incidence and prevalence is critical in developing diagnostic and management strategies for different age groups.
Ethnicity also plays an important role in scleroderma epidemiology, as disease prevalence and clinical characteristics differ between racial and ethnic groups. Scleroderma is more commonly reported in people of African descent in the United States, but some subtypes, such as diffuse cutaneous scleroderma, are more common in people of European ancestry. These ethnic disparities highlight the importance of considering both genetic and environmental factors unique to diverse populations.
Scleroderma United
Spring 2024 Intern Articles
Environmental exposures have long been linked to autoimmune diseases including scleroderma. Occupational hazards, such as silica exposure in the mining or construction industries, as well as environmental toxins like organic solvents and pesticides, have been linked to an increased risk of scleroderma development. Furthermore, viral infections, particularly those caused by cytomegalovirus and Epstein-Barr virus, have been proposed to play a role in scleroderma pathogenesis, though the exact mechanisms are unknown.
Scleroderma’s complex etiology is also influenced by genetic factors, with familial aggression and genetic susceptibility playing a role in disease pathogenesis. Twin studies have shown that monozygotic twins have a higher concordance rate for scleroderma than dizygotic twins, indicating a genetic predisposition to the disease. Genome-wide association studies (GWAS) have identified several susceptibility loci for scleroderma, providing important insights into the disease’s genetic architecture.
Scleroderma management necessitates a multidisciplinary approach that focuses on symptom relief, organ function preservation, and quality of life enhancement. Right now, there is not cure for this autoimmune disease but there are some treatment options to reduce the severity. These include immunosuppressive medications, vasodilators, and physical therapy. Non-pharmacological interventions, such as lifestyle changes and psychological support, work alongside pharmacotherapy to address the multifaceted challenges posed by scleroderma.
Despite advances in treatment, challenges remain, necessitating continued research and innovation.
Scleroderma has far-reaching consequences for mental, emotional, and social well-being. Individuals deal with chronic pain, disfigurement, and disability, which can lead to anxiety, depression, and social isolation. Coping mechanisms, such as support groups and adaptive strategies, are lifelines for those navigating the complexities of scleroderma, providing hope and camaraderie in the face of adversity.
Impact on Quality of Life
Scleroderma's impact on quality of life is primarily characterized by the burden of physical symptoms as well as functional limitations. Skin thickening, joint stiffness, and muscle weakness can reduce mobility and dexterity, making even simple tasks difficult and tiring. Scleroderma-related
Scleroderma United
Spring 2024 Intern Articles
complications, such as Raynaud’s phenomenon, digital ulcers, and gastrointestinal dysfunction, exacerbate patients’ physical challenges, jeopardizing their independence and overall well-being.
Scleroderma’s effects extend beyond the individual to interpersonal relationships, social interactions, and participation in daily activities. Social isolation and withdrawal are common among scleroderma patients, as the disease’s physical limitations and associated complications limit mobility and participation in social activities. Stigma and misconception about scleroderma can also impede social integration and acceptance, exacerbating feelings of loneliness and isolation.
Despite the formidable challenges posed by scleroderma, patients show remarkable resilience and adaptability in their journey. Patients find comfort in sharing their experiences, exchanging knowledge, and cultivating a sense of belonging through peer support groups, online communities, and advocacy organizations. Engaging in meaningful activities, pursuing hobbies, and cultivating a sense of purpose can all serve as coping mechanisms, allowing people to reclaim their agency and resilience in the face of hardship.
Complications and prognosis
Scleroderma can affect almost any organ system in the body, resulting in a wide range of complications that present significant challenges for patients and healthcare providers alike. One of the most common and serious complications of scleroderma is pulmonary involvement, which includes interstitial lung disease and pulmonary arterial hypertension, resulting in respiratory compromise and cardiovascular morbidity. Gastrointestinal compilations such as esophageal dysmotility, gastroparesis, and intestinal pseudo obstruction can impair nutritional status, worsen reflux and dysphagia symptoms, and increase the risk of aspiration pneumonia. Renal complications, such as scleroderma renal crisis, are another potentially fatal manifestation of the disease, with symptoms including acute renal failure, hypertension, and microangiopathic hemolytic anemia. Scleroderma complications can also include digital ulcers, calcinosis, cardiomyopathy, and musculoskeletal manifestations like arthritis.
Organ involvement, which can range from pulmonary fibrosis to renal crisis, has a significant impact on scleroderma prognosis. Identifying prognostic factors and implementing targeted interventions is critical for minimizing complications and improving long-term outcomes. Despite the challenges
Scleroderma United
Spring 2024 Intern Articles
posed by scleroderma, research advances offer hope for improved prognosis and personalized treatment approaches.
In scleroderma, prognostic factors include a variety of clinical, serological, and histopathological parameters that provide information about disease severity, progression, and treatment response. The disease subtype, extent of skin involvement, and presence of internal organ involvement are all important clinical factors influencing scleroderma prognosis. Serological markers, such as the presence of specific autoantibodies (like anti-centromere, anti-topoisomerase 1), may also have prognostic value, correlating to different clinical phenotypes and outcomes. Histopathological features found on skin or internal organ biopsy, such as fibrosis, inflammation, and vascular changes, can help to predict prognosis and guide treatment decisions.
Sclerodema’s long term prognosis varies greatly between individuals, reflecting the disease’s heterogeneity as well as the range of clinical presentations and outcomes. While some patients may have a relatively stable disease course with mild symptoms and minimal organ involvement, others may face progressive disease progression, debilitating complications, and a shorter life expectancy. Scleroderma mortality rates are higher than in the general population, with pulmonary complications and renal crisis being major causes of morbidity and mortality. However, advances in early detection, aggressive management, and targeted therapies have resulted in longer-term outcomes and higher survival rates in recent years.
Personal Experiences
Behind every statistic is a personal story of bravery, resilience, and optimism. Through intimate accounts and real-life experiences, we gain insight into the daily struggles and triumphs of scleroderma patients.
Christaine Haines’s journey demonstrates the human spirit’s resilience in the face of adversity. Chrstine was diagnosed at the age of 28 and initially struggled with fear and uncertainty about her future. However, armed with a supportive network of loved ones and health care professionals, she set out on a journey of self-discovery and empowerment. Christine, a small business owner and mother, faces the daily challenges of scleroderma with grace and determination. From dietary changes to proactive medical management, she takes a holistic approach to wellness, striving to improve her quality of life
Scleroderma United
Spring 2024 Intern Articles
while inspiring others through her advocacy and resilience.
Another personal story example is Sarah Mederios. Scleroderma, for Sarah, is more than a diagnosis; it serves as a catalyst for advocacy, awareness, and community building. Sarah was diagnosed with Raynaud’s syndrome at the age of 2 and now works as a lead recruiter in the healthcare industry, channeling her experiences as a patient. Through social media advocacy and online support networks, she finds solace in connecting with others who share her journey, offering mutual support, encouragement, and camaraderie in the face of adversity. Despite the difficulties of living with an invisible illness, Sarah remains committed to raising awareness and fostering understanding in their community, serving as a source of hope and inspiration for those affected by scleroderma.
Their stories are a testament to the human spirit, emphasizing the importance of empathy, understanding, and advocacy in the pursuit of better care and support for all people affected by scleroderma.
Research Advances and Emerging Trends
Recent research has shed light on the complex interplay of genetic, environmental, and immunological factors in the development and progression of scleroderma. GWAS have identified key genetic variants linked to scleroderma susceptibility, providing important insights into the diseas’s underlying molecular pathways. Furthermore, advances in molecular profiling technologies have revealed distinct molecular signatures and immune dysregulation patterns in different subtypes of scleroderma opening the door to personalized therapeutic strategies tailored to individual patient’s needs.
In addition to genetic factors, environmental triggers such as viral infections, occupational exposures, and lifestyle choices have been linked to the onset and progression of scleroderma. Ongoing research aims to better understand the complex interplay between genetic predisposition and environmental influences, with the ultimate goal of identifying modifiable risk factors and preventive interventions.
On the treatment front, significant advances have been made in the development of targeted biologic therapies, immunomodulatory agents, and disease modifying drugs for sclerosis. Biological agents that target key proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha)
Scleroderma United
Spring 2024 Intern Articles
and interleukin-6(IL-6) have shown promising results in clinical trials, suggesting potential therapeutic options for patients with refractory disease. Furthermore, novel small molecule inhibitors targeting fibrotic pathways and profibrotic signaling cascades are being investigated, with the potential to develop more effective and targeted therapies for scleroderma.
Emerging trends in scleroderma research include the study of regenerative medicine approaches such as stem cell therapy, tissue engineering, and gene editing. These novel approaches offer exciting opportunities for tissue repair, regeneration, and organ function restoration in scleroderma patients, ushering in a new era of regenerative medicine based interventions for autoimmune diseases.
Scleroderma United
Spring 2024 Intern Articles
Shining a Light on Scleroderma: Raising Awareness and Promoting Understanding
By Tonique Swaby from May Pen, Clarendon, Jamaica
Introduction
Scleroderma, a rare autoimmune disorder, presents a complex array of symptoms ranging from skin thickening to organ involvement. Despite its rarity, the impact on those affected is profound, often leading to significant challenges in daily life. Raising awareness about scleroderma is crucial not only to facilitate early diagnosis and access to appropriate treatment but also to foster understanding and support within communities. By shining a light on this condition, we can empower individuals living with scleroderma to navigate their journey with greater resilience and access the resources they need to thrive.
Understanding Scleroderma
Scleroderma, according to Johns Hopkins Medicine and PMC encompasses localized and systemic forms, and is a chronic connective tissue disorder characterized by skin thickening and, in systemic cases, involvement of internal organs. Immune system dysfunction, highlighted by T-cell activation, macrophage infiltration, and autoantibody production, contributes to inflammation and tissue damage. Abnormal collagen production by activated fibroblasts leads to fibrosis, while vascular abnormalities and oxidative stress further exacerbate tissue injury. Endothelial dysfunction,
Scleroderma United
Spring 2024 Intern Articles
dysregulated cytokine signaling, and reactive oxygen species production play pivotal roles in the disease's pathogenesis. Understanding these mechanisms is crucial for developing targeted therapies to manage scleroderma effectively.
Prevalence and Impact
Systemic sclerosis (SSc) presents a significant health burden globally, with a pooled prevalence of 17.6 per 100,000 individuals and an incidence rate of 1.4 per 100,000 person-years, as revealed by a recent systematic review and meta-analysis, according to PMC and Mayo Clinic suggests that this chronic autoimmune disorder profoundly impacts individuals' lives due to its diverse array of symptoms and complications affecting multiple organs. Scleroderma's manifestations vary widely, encompassing skin hardening, Raynaud's phenomenon, digestive issues, and cardiovascular and pulmonary complications. Such multi-organ involvement underscores the complexity of scleroderma and its profound effects on patients' quality of life, necessitating comprehensive management strategies to address its diverse clinical manifestations and mitigate its impact on affected individuals.
Signs and Symptoms
Recognizing the signs and symptoms of scleroderma is vital for prompt diagnosis and intervention, according to NIH. Common manifestations include skin thickening, which can lead to restricted mobility and a shiny, taut appearance. Raynaud's phenomenon, characterized by pale fingers that become numb and tingle in response to cold or stress, is often an early indicator. Johns Hopkins Medicine also states that joint pain, digestive issues such as heartburn and difficulty swallowing, and respiratory problems like shortness of breath due to lung scarring are also typical. Identifying these early symptoms is crucial, as scleroderma can progress rapidly, potentially leading to significant organ involvement and complications. Early diagnosis allows for timely medical intervention, which can help manage symptoms, slow disease progression, and improve overall outcomes for individuals affected by this condition.
Challenges Faced by Patients
Living with scleroderma presents a multitude of challenges across physical, emotional, and social domains,as stated by NIH . Additionally, Karger provides that the unpredictable course of the disease, coupled with chronic pain and visible symptoms, significantly impacts the quality of life and
Scleroderma United
Spring 2024 Intern Articles
mental well-being of affected individuals. Physically, scleroderma manifests as progressive fibrosis of the skin and internal organs, leading to fatigue, limitations in daily activities, and discomfort. Emotionally, patients grapple with distress over the unpredictable nature of the disease, fear of disease progression, and anxiety about the future. Socially, visible symptoms such as skin thickening and joint contractures can lead to stigmatization, social exclusion, and decreased self-esteem. These challenges underscore the importance of comprehensive support and care to address the complex needs of individuals living with scleroderma, emphasizing both medical management and psychosocial support to improve overall well-being.
Diagnostic Process
The diagnostic process for scleroderma typically involves a multifaceted approach to confirm the presence of the disease and assess its extent, according to Johns Hopkins. Physicians rely on a combination of physical examination, blood tests, imaging studies, and tissue biopsies to make an accurate diagnosis. During the physical examination, rheumatologists and other specialists look for characteristic signs such as skin tightening, swelling, and nailfold capillaroscopy abnormalities. Blood tests, including antibody nuclear (ANA) tests, help identify autoantibodies associated with scleroderma, although they do not solely determine diagnosis. Imaging studies such as CT scans and echocardiograms may be ordered to evaluate internal organ involvement, while tissue biopsies provide definitive evidence of skin fibrosis. Consulting with rheumatologists and other specialists familiar with scleroderma is crucial throughout the diagnostic process to ensure comprehensive evaluation and appropriate management. Healio maintains that their expertise and experience help navigate the complexities of scleroderma, leading to accurate diagnosis and tailored treatment plans for improved patient outcomes.
Treatment and Management
Scleroderma treatment encompasses a range of options aimed at managing symptoms and improving quality of life for patients. Medications play a central role, with corticosteroids, immunosuppressants, and vasodilators among the pharmaceutical interventions utilized to address inflammation, skin tightening, and blood vessel abnormalities according to Yale Medicine. Immunomodulatory therapies such as methotrexate and mycophenolate mofetil target underlying autoimmune processes, while vasodilators like calcium channel blockers enhance blood flow to alleviate
Scleroderma United
Spring 2024 Intern Articles
symptoms such as Raynaud's phenomenon. In addition to pharmacological approaches, physical therapy helps maintain joint mobility and muscle strength, while lifestyle modifications, including skin moisturization, temperature management, and dietary adjustments, can mitigate symptoms and improve overall well-being. However, given the heterogeneous nature of scleroderma, treatment plans must be individualized, taking into account the specific symptoms and disease progression of each patient. This personalized approach, which Cedars Sinai swears by, ensures that therapeutic interventions are tailored to address the unique needs and challenges faced by individuals living with scleroderma, ultimately optimizing treatment outcomes and enhancing patient quality of life.
Raising Awareness
Raising awareness about scleroderma is crucial among the public, healthcare professionals, and policymakers for several reasons. Firstly, increased awareness helps to educate people about the signs, symptoms, and risks associated with scleroderma, enabling individuals to recognize the disease early and seek appropriate medical attention as shown by World Scleroderma Foundation. Healthcare professionals need to be informed about scleroderma to ensure timely diagnosis and access to specialized care for patients. Additionally, policymakers play a vital role in allocating resources for research funding and improving access to care and support services for individuals living with scleroderma. Awareness campaigns, advocacy efforts, and community support initiatives are essential in achieving these goals by promoting early diagnosis, facilitating access to care, and advocating for research funding to advance understanding and treatment options for scleroderma according to The Importance of Health Awareness Campaigns. Through these collective efforts, we can enhance patient outcomes, quality of life, and ultimately work towards finding a cure for this debilitating disease.
Getting Involved
Individuals can actively participate in raising awareness about scleroderma by engaging in various initiatives and activities, such as ones at TRACC-R Center
They can participate in awareness events organized by scleroderma organizations, attend fundraising activities such as charity runs or virtual events, and share educational resources about the condition with their communities. By joining patient support groups or becoming involved in peer
Scleroderma United
Spring 2024 Intern Articles
mentoring programs, like ones at Simply Meds Online,individuals can contribute to fostering a supportive network for those affected by scleroderma. Additionally, readers are encouraged to support scleroderma organizations, research initiatives, and patient support groups through donations, volunteering, or spreading awareness about their work. Together, through collective efforts and advocacy, we can increase awareness, support research, and provide invaluable assistance to individuals living with scleroderma.
Conclusion
In conclusion, shining a light on scleroderma is essential for improving outcomes and quality of life for individuals affected by this complex autoimmune disorder. Through understanding its mechanisms, recognizing its signs and symptoms, and addressing the challenges faced by patients, we can better support those living with scleroderma. Raising awareness among the public, healthcare professionals, and policymakers is crucial for promoting early diagnosis, facilitating access to specialized care, and advocating for research funding. By actively participating in awareness initiatives, supporting scleroderma organizations, and engaging in fundraising activities, we can make a tangible difference in the lives of those affected by scleroderma. Let us join together in this effort, spreading awareness, offering support, and advocating for better resources and treatments to ultimately improve outcomes and bring hope to individuals living with scleroderma.
References
“Advances in Scleroderma Treatment: FAQ.” Cedars-Sinai, www.cedars-sinai.org/blog/treating-scleroderma.html.
Angelopoulos, Nikiforos V., et al. “Psychiatric Symptoms Associated with Scleroderma.” Psychotherapy and Psychosomatics, vol. 70, no. 3, Jan. 2001, pp. 145–50. https://doi.org/10.1159/000056240.
Bairkdar, Majd, et al. “Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis.” Rheumatology, Feb. 2021, https://doi.org/10.1093/rheumatology/keab190.
Scleroderma United
Spring 2024 Intern Articles
Bellocchi, Chiara, et al. “Predicting the Progression of Very Early Systemic Sclerosis: Current Insights.” Open Access Rheumatology : Research and Reviews, vol. Volume 14, Sept. 2022, pp. 171–86. https://doi.org/10.2147/oarrr.s285409.
Csg, Team. “The Importance of Health Awareness Campaigns.” Communications Strategy Group, 7 Mar. 2023, wearecsg.com/blog/importance-of-health-awareness-campaigns.
February is Raynaud’s Awareness Month - Education and Empowerment for Better Understanding. www.simplymedsonline.co.uk/blog/february-is-raynauds-awareness-month-education-and-empowerment-for-better-understanding.
“Joint Ventures in Complicated Patients: Advent of Derm-rheum Clinics.” Healio.com, 22 May 2019, www.healio.com/news/rheumatology/20190514/joint-ventures-in-complicated-patients-advent-of-dermrheum-clinics.
Ogden, Olivia. “World Scleroderma Day Emphasizes the Importance of Disease Awareness.” National Scleroderma Foundation, 29 June 2023, scleroderma.org/world-scleroderma-day-emphasizes-the-importance-of-disease-awareness.
“Scleroderma.” Yale Medicine, 6 July 2023, www.yalemedicine.org/conditions/scleroderma.
“Scleroderma - Symptoms and causes - Mayo Clinic.” Mayo Clinic, 27 Jan. 2022, www.mayoclinic.org/diseases-conditions/scleroderma/symptoms-causes/syc-20351952.
“Scleroderma Diagnosis.” Johns Hopkins Medicine, 19 Nov. 2019, www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/scleroderma-diagnosis.
“Scleroderma Symptoms.” Johns Hopkins Medicine, 8 Aug. 2021, www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/scleroderma-symptoms.
Sierakowska, Matylda, et al. “Factors associated with quality of life in systemic sclerosis: a cross-sectional study.” Quality of Life Research, vol. 28, no. 12, Sept.
Scleroderma United
Spring 2024 Intern Articles
2019, pp. 3347–54. https://doi.org/10.1007/s11136-019-02284-9.
“Types of Scleroderma.” Johns Hopkins Medicine, 19 Nov. 2019, www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/types-of-scleroderma.
Types of scleroderma. (2019, November 19). Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/types-of-scleroderma#:~:text=Localized%20scleroderma%3A%20often%20affects%20only,%2C%20heart%2C%20lungs%20or%20kidneys
Yamamoto, Toshiyuki. “Autoimmune Mechanisms of Scleroderma and a Role of Oxidative Stress.” Self/Nonself, vol. 2, no. 1, Jan. 2011, pp. 4–10. https://doi.org/10.4161/self.2.1.14058.
Bairkdar, Majd, et al. “Incidence and Prevalence of Systemic Sclerosis Globally: A Comprehensive Systematic Review and Meta-analysis.” Rheumatology, Feb. 2021, https://doi.org/10.1093/rheumatology/keab190.
Bellocchi, Chiara, et al. “Predicting the Progression of Very Early Systemic Sclerosis: Current Insights.” Open Access Rheumatology : Research and Reviews, vol. Volume 14, Sept. 2022, pp. 171–86. https://doi.org/10.2147/oarrr.s285409.
“Joint Ventures in Complicated Patients: Advent of Derm-rheum Clinics.” Healio.com, 22 May 2019, www.healio.com/news/rheumatology/20190514/joint-ventures-in-complicated-patients-advent-of-dermrheum-clinics.
Scleroderma United
Spring 2024 Intern Articles
Understanding Pulmonary Involvement in Scleroderma: Navigating the Impact on Lung Health
By Tonique Swaby from May Pen, Clarendon, Jamaica
Introduction
Scleroderma is a systemic autoimmune disease characterized by the hardening and thickening of skin and connective tissues. However, its effects extend beyond the skin, potentially impacting various organs such as the lungs, heart, kidneys, and gastrointestinal tract. Pulmonary involvement, particularly interstitial lung disease and pulmonary arterial hypertension is common in scleroderma patients and can significantly impact their quality of life and prognosis. Understanding the complexities of pulmonary manifestations in scleroderma is vital for both patients and healthcare providers to ensure timely diagnosis, appropriate management, and improved outcomes. Early recognition and intervention can make a significant difference in managing pulmonary complications and optimizing the overall care of individuals living with scleroderma.
Understanding Scleroderma Lung Disease
Scleroderma, a systemic inflammatory disorder, can profoundly impact the lungs, leading to various complications such as interstitial lung disease (ILD), pulmonary hypertension (PH), and other respiratory issues as provided by Science Direct and PMC.The mechanisms underlying lung involvement in scleroderma are multifaceted, involving inflammation, fibrosis, and vascular
Scleroderma United
Spring 2024 Intern Articles
abnormalities. Inflammation triggers immune cell activation and fibroblast hyperplasia, leading to increased collagen production and turnover, ultimately resulting in fibrotic lung tissue. Additionally, vascular damage contributes to the development of pulmonary hypertension, further exacerbating respiratory dysfunction. This complex interplay of inflammatory processes, fibrotic changes, and vascular abnormalities underscores the diverse manifestations of lung disease in scleroderma and highlights the importance of comprehensive management strategies targeting these underlying mechanisms.
Types of Lung Involvement
Lung involvement in scleroderma can manifest in various forms, each with distinct characteristics and implications for patient health. Science Direct, Cleveland Clinic, UPMC & PMC state that interstitial lung disease (ILD) stands out as a prominent complication, marked by scarring and inflammation within the lung tissue. This fibrotic process diminishes lung function, leading to breathing difficulties and decreased exercise capacity. Pulmonary hypertension (PH) represents another significant concern, characterized by elevated blood pressure in the arteries of the lungs. PH can precipitate heart failure and respiratory symptoms, further complicating the management of scleroderma patients. Additionally, less common pulmonary manifestations include pulmonary fibrosis, characterized by progressive scarring of lung tissue, and pulmonary artery involvement, which may exacerbate PH and respiratory compromise. Furthermore, scleroderma patients face an increased risk of developing lung cancer, adding another layer of complexity to their respiratory health management. Thus, a comprehensive understanding of these diverse pulmonary complications is crucial for effective management and improved outcomes in scleroderma patients.
Symptoms and Diagnosis
Scleroderma-related lung disease presents with a variety of symptoms, including shortness of breath, cough, fatigue, and chest pain. These manifestations, according to Very Well Health and PMC often arise due to complications such as interstitial lung disease (ILD) and pulmonary hypertension (PH). However, diagnosing lung involvement in scleroderma poses significant challenges. The symptoms are often nonspecific and can mimic those of other respiratory conditions, making differential diagnosis crucial. Specialized tests such as pulmonary function tests (PFTs), high-resolution CT scans, and echocardiography are essential for accurate
Scleroderma United
Spring 2024 Intern Articles
diagnosis. PFTs help assess lung function, while CT scans provide detailed images of lung tissue, facilitating the identification of characteristic features like interstitial changes. Echocardiography is vital for detecting pulmonary hypertension, a common complication of scleroderma-related lung disease. Despite these challenges, early and comprehensive evaluation using these specialized tests is crucial for timely diagnosis and management of lung involvement in scleroderma.
Treatment and Management
The comprehensive management of scleroderma-related lung disease necessitates a multidisciplinary approach involving rheumatologists, pulmonologists, and other specialists. Treatment strategies are tailored to address various aspects of the condition, aiming to alleviate symptoms, slow disease progression, and improve overall quality of life. Immunosuppressive therapy forms a cornerstone of treatment, utilizing medications such as corticosteroids, methotrexate, or mycophenolate mofetil to dampen inflammation and modify the immune response. These agents help mitigate the underlying autoimmune process and reduce the risk of fibrosis progression within the lungs.
In addition to pharmacotherapy, pulmonary rehabilitation programs are recommended to optimize lung function and enhance exercise tolerance according to PMC
These programs typically include a combination of aerobic exercises, strength training, and respiratory exercises tailored to individual needs. By engaging in structured physical activity under the guidance of trained professionals, patients can strengthen respiratory muscles, improve lung capacity, and enhance overall physical fitness.
For individuals experiencing significant respiratory impairment, Johns Hopkins , Cleveland Clinic and PMC provide that supplemental oxygen therapy may be prescribed to alleviate dyspnea and improve oxygenation. This involves the use of portable oxygen delivery systems to ensure adequate oxygen levels in the bloodstream during daily activities and rest. Oxygen therapy is particularly beneficial for individuals with scleroderma-related interstitial lung disease (ILD) or pulmonary arterial hypertension (PAH), where impaired gas exchange and reduced oxygen saturation levels are common.
Moreover, PMC states that specific therapies targeting pulmonary hypertension, a frequent complication of scleroderma, are integral to the
Scleroderma United
Spring 2024 Intern Articles
management approach. These include endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs, which help alleviate pulmonary vasoconstriction, improve pulmonary blood flow, and reduce pulmonary artery pressure. By addressing the underlying vascular abnormalities associated with PAH, these medications aim to improve symptoms, enhance exercise capacity, and prolong survival in affected individuals.
The treatment and management of scleroderma-related lung disease require a comprehensive and individualized approach, incorporating a range of therapeutic modalities to address the complex pathophysiology of the condition. Through collaborative efforts and close monitoring, healthcare providers strive to optimize outcomes and enhance the quality of life for patients living with scleroderma-related pulmonary manifestations.
Prognosis and Outlook
Understanding the prognosis of scleroderma-related lung disease according to PMC
involves considering various factors that influence disease progression and survival rates. Patients with this condition often face challenges due to the progressive nature of the disease and its impact on lung function. Factors such as the extent of lung involvement, the severity of pulmonary fibrosis, the presence of pulmonary hypertension, and comorbidities can significantly affect prognosis. Regular monitoring of lung function through pulmonary function tests (PFTs), high-resolution computed tomography (HRCT) scans, and other imaging modalities is crucial for detecting changes early and guiding treatment decisions. Early intervention with immunosuppressive therapy, pulmonary rehabilitation, and oxygen therapy can help slow disease progression and improve quality of life. Adherence to treatment plans, including medication regimens and lifestyle modifications, is essential for optimizing outcomes. Despite advancements in treatment options, the prognosis for patients with scleroderma-related lung disease remains variable, emphasizing the importance of individualized care plans and multidisciplinary management to achieve the best possible outcomes.
Lifestyle and Coping Strategies
Patients with scleroderma-related lung disease can take proactive steps to manage symptoms and improve lung health. First and foremost, quitting smoking is crucial to prevent further damage to the lungs and enhance overall respiratory function. Engaging in regular exercise within personal
Scleroderma United
Spring 2024 Intern Articles
limits, such as walking or gentle yoga, can help maintain lung capacity and promote cardiovascular health. Adopting a healthy diet rich in fruits, vegetables, and lean proteins, while maintaining a healthy weight, can support optimal lung function and overall well-being. Additionally, avoiding environmental triggers such as air pollution, dust, and allergens can reduce respiratory symptoms and prevent exacerbations. Coping with the emotional and psychological impact of lung involvement in scleroderma may require support from mental health professionals, support groups, and loved ones. Developing coping strategies such as mindfulness techniques, relaxation exercises, and seeking social support can help individuals manage stress and maintain emotional resilience throughout their journey with the disease.
Conclusion
In conclusion, scleroderma-related lung disease presents a complex and challenging clinical scenario characterized by various pulmonary manifestations such as interstitial lung disease and pulmonary hypertension. The impact of these conditions extends beyond respiratory symptoms, significantly affecting patients' quality of life and prognosis. However, through a comprehensive and multidisciplinary approach involving rheumatologists, pulmonologists, and other specialists, effective management strategies can be implemented to mitigate symptoms, slow disease progression, and improve outcomes. Early detection through specialized tests, personalized treatment plans tailored to individual needs, and ongoing support are paramount in optimizing the care of individuals with scleroderma-related lung disease. By addressing the diverse aspects of this condition and empowering patients with lifestyle modifications and coping strategies, healthcare providers can strive to enhance the overall well-being and resilience of those living with scleroderma-related pulmonary manifestations.
Resources
Almaaitah, Saja, et al. “<p>Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis</p>” Integrated Blood Pressure Control, vol. Volume 13, Mar. 2020, pp. 15–29. https://doi.org/10.2147/ibpc.s232038.
Chowaniec, Małgorzata, et al. “Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management.” Reumatologia, vol. 56, no. 4, Aug. 2018, pp. 249–54. https://doi.org/10.5114/reum.2018.77977.
---. “Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management.” Reumatologia, vol. 56, no. 4, Aug. 2018, pp. 249–
Scleroderma United
Spring 2024 Intern Articles
54. https://doi.org/10.5114/reum.2018.77977.
Cueto-Robledo, Guillermo, et al. “Systemic Scleroderma: Review and Updated Approach and Case Description to Addressing Pulmonary Arterial Hypertension and Idiopathic Pulmonary Fibrosis - A Dual Challenge in Treatment.” Current Problems in Cardiology, vol. 49, no. 4, Apr. 2024, p. 102404. https://doi.org/10.1016/j.cpcardiol.2024.102404.
---. “Systemic Scleroderma: Review and Updated Approach and Case Description to Addressing Pulmonary Arterial Hypertension and Idiopathic Pulmonary Fibrosis - A Dual Challenge in Treatment.” Current Problems in Cardiology, vol. 49, no. 4, Apr. 2024, p. 102404. https://doi.org/10.1016/j.cpcardiol.2024.102404.
Hickman, Ruth Jessen, MD. “Lung Problems From Scleroderma (Systemic Sclerosis).” Verywell Health, 15 Jan. 2024, www.verywellhealth.com/lung-problems-in-systemic-sclerosis-5185668.
Jin, Li, et al. “Pulmonary rehabilitation training for improving pulmonary function and exercise tolerance in patients with stable chronic obstructive pulmonary disease.” PubMed Central (PMC), 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC8340261.
---. “Pulmonary rehabilitation training for improving pulmonary function and exercise tolerance in patients with stable chronic obstructive pulmonary disease.” PubMed Central (PMC), 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC8340261.
Johns Hopkins Scleroderma Center. “Scleroderma Treatment Options : Johns Hopkins Scleroderma Center.” Johns Hopkins Scleroderma Center, 2 Feb. 2023, www.hopkinsscleroderma.org/patients/scleroderma-treatment-options.
Kumar, Pankaj, et al. “Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection.” The Journal of Thoracic and Cardiovascular Surgery, vol. 125, no. 6, June 2003, pp. 1321–27. https://doi.org/10.1016/s0022-5223(03)00028-x.
---. “Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection.” The Journal of Thoracic and Cardiovascular Surgery, vol. 125, no. 6, June 2003, pp. 1321–27. https://doi.org/10.1016/s0022-5223(03)00028-x.
Nakayama, Yoichi, et al. “Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study.” Scientific Reports, vol. 13, no. 1, June 2023, https://doi.org/10.1038/s41598-023-37141-w.
---. “Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study.” Scientific
Scleroderma United
Spring 2024 Intern Articles
Reports, vol. 13, no. 1, June 2023, https://doi.org/10.1038/s41598-023-37141-w.
National Academies Press (US). “Scleroderma.” Selected Immune Disorders and Disability - NCBI Bookshelf, 24 May 2022, www.ncbi.nlm.nih.gov/books/NBK584477.
---. “Scleroderma.” Selected Immune Disorders and Disability - NCBI Bookshelf, 24 May 2022, www.ncbi.nlm.nih.gov/books/NBK584477.
Professional, Cleveland Clinic Medical. “Interstitial Lung Disease.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/17809-interstitial-lung-disease.
---. “Interstitial Lung Disease.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/17809-interstitial-lung-disease.
---. “Oxygen Therapy.” Cleveland Clinic, my.clevelandclinic.org/health/treatments/23194-oxygen-therapy.
Roofeh, David, et al. “Management of systemic sclerosis-associated interstitial lung disease.” Current Opinion in Rheumatology, vol. 31, no. 3, May 2019, pp. 241–49. https://doi.org/10.1097/bor.0000000000000592.
---. “Management of systemic sclerosis-associated interstitial lung disease.” Current Opinion in Rheumatology, vol. 31, no. 3, May 2019, pp. 241–49. https://doi.org/10.1097/bor.0000000000000592.
“Scleroderma-Associated Pulmonary Hypertension | UPMC.” UPMC | Life Changing Medicine, www.upmc.com/services/pulmonology/conditions/pulmonary-hypertension/scleroderma-ph.
“---.” UPMC | Life Changing Medicine, www.upmc.com/services/pulmonology/conditions/pulmonary-hypertension/scleroderma-ph.
Suliman, Sally, et al. “Scleroderma-related interstitial lung disease.” Respiratory Medicine Case Reports, vol. 22, Jan. 2017, pp. 109–12. https://doi.org/10.1016/j.rmcr.2017.07.007.
---. “Scleroderma-related interstitial lung disease.” Respiratory Medicine Case Reports, vol. 22, Jan. 2017, pp. 109–12. https://doi.org/10.1016/j.rmcr.2017.07.007.
Scleroderma United
Spring 2024 Intern Articles
Reports, vol. 13, no. 1, June 2023, https://doi.org/10.1038/s41598-023-37141-w.
National Academies Press (US). “Scleroderma.” Selected Immune Disorders and Disability - NCBI Bookshelf, 24 May 2022, www.ncbi.nlm.nih.gov/books/NBK584477.
---. “Scleroderma.” Selected Immune Disorders and Disability - NCBI Bookshelf, 24 May 2022, www.ncbi.nlm.nih.gov/books/NBK584477.
Professional, Cleveland Clinic Medical. “Interstitial Lung Disease.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/17809-interstitial-lung-disease.
---. “Interstitial Lung Disease.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/17809-interstitial-lung-disease.
---. “Oxygen Therapy.” Cleveland Clinic, my.clevelandclinic.org/health/treatments/23194-oxygen-therapy.
Roofeh, David, et al. “Management of systemic sclerosis-associated interstitial lung disease.” Current Opinion in Rheumatology, vol. 31, no. 3, May 2019, pp. 241–49. https://doi.org/10.1097/bor.0000000000000592.
---. “Management of systemic sclerosis-associated interstitial lung disease.” Current Opinion in Rheumatology, vol. 31, no. 3, May 2019, pp. 241–49. https://doi.org/10.1097/bor.0000000000000592.
“Scleroderma-Associated Pulmonary Hypertension | UPMC.” UPMC | Life Changing Medicine, www.upmc.com/services/pulmonology/conditions/pulmonary-hypertension/scleroderma-ph.
“---.” UPMC | Life Changing Medicine, www.upmc.com/services/pulmonology/conditions/pulmonary-hypertension/scleroderma-ph.
Suliman, Sally, et al. “Scleroderma-related interstitial lung disease.” Respiratory Medicine Case Reports, vol. 22, Jan. 2017, pp. 109–12. https://doi.org/10.1016/j.rmcr.2017.07.007.
---. “Scleroderma-related interstitial lung disease.” Respiratory Medicine Case Reports, vol. 22, Jan. 2017, pp. 109–12. https://doi.org/10.1016/j.rmcr.2017.07.007.
Scleroderma United
Spring 2024 Intern Articles
Reports, vol. 13, no. 1, June 2023, https://doi.org/10.1038/s41598-023-37141-w.
National Academies Press (US). “Scleroderma.” Selected Immune Disorders and Disability - NCBI Bookshelf, 24 May 2022, www.ncbi.nlm.nih.gov/books/NBK584477.
---. “Scleroderma.” Selected Immune Disorders and Disability - NCBI Bookshelf, 24 May 2022, www.ncbi.nlm.nih.gov/books/NBK584477.
Professional, Cleveland Clinic Medical. “Interstitial Lung Disease.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/17809-interstitial-lung-disease.
---. “Interstitial Lung Disease.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/17809-interstitial-lung-disease.
---. “Oxygen Therapy.” Cleveland Clinic, my.clevelandclinic.org/health/treatments/23194-oxygen-therapy.
Roofeh, David, et al. “Management of systemic sclerosis-associated interstitial lung disease.” Current Opinion in Rheumatology, vol. 31, no. 3, May 2019, pp. 241–49. https://doi.org/10.1097/bor.0000000000000592.
---. “Management of systemic sclerosis-associated interstitial lung disease.” Current Opinion in Rheumatology, vol. 31, no. 3, May 2019, pp. 241–49. https://doi.org/10.1097/bor.0000000000000592.
“Scleroderma-Associated Pulmonary Hypertension | UPMC.” UPMC | Life Changing Medicine, www.upmc.com/services/pulmonology/conditions/pulmonary-hypertension/scleroderma-ph.
“---.” UPMC | Life Changing Medicine, www.upmc.com/services/pulmonology/conditions/pulmonary-hypertension/scleroderma-ph.
Suliman, Sally, et al. “Scleroderma-related interstitial lung disease.” Respiratory Medicine Case Reports, vol. 22, Jan. 2017, pp. 109–12. https://doi.org/10.1016/j.rmcr.2017.07.007.
---. “Scleroderma-related interstitial lung disease.” Respiratory Medicine Case Reports, vol. 22, Jan. 2017, pp. 109–12. https://doi.org/10.1016/j.rmcr.2017.07.007.
Scleroderma United
Spring 2024 Intern Articles
The Gut-Skin Connection in Systemic Scleroderma: A Novel Perspective
By Tonique Swaby from May Pen, Clarendon, Jamaica
The Gut Skin-Axis
According to the National Library of Medicine, the gut-skin axis shows how the gut and skin interact with each other, affecting overall health. In this relationship, the gut microbiome and skin health influence each other. Systemic sclerosis (SSc), a long-term autoimmune disease causing skin hardening and potentially affecting other organs, highlights how problems in the gut can affect the skin. SSc's immune system issues and skin fibrosis reflect how changes in gut bacteria can impact skin problems. Understanding this connection can help find new ways to treat SSc and other skin issues by fixing gut health, balancing the immune system, and keeping the skin healthy.
The Role of The Microbiome in SSc
Emerging research from Arthritis Research & Therapy and NCBI, National Library of Medicine suggests a potential link between alterations in the gut microbiome and the development of systemic sclerosis. Dysbiosis, characterized by an imbalance in the gut microbial community, is increasingly recognized in individuals with SSc compared to healthy controls. Studies have identified specific gut microbiota associated with the severity of gastrointestinal (GIT) symptoms in SSc patients. Elevated levels of
Scleroderma United
Spring 2024 Intern Articles
Lactobacillus, Blautia, and Coprococcus, alongside reduced levels of Roseburia and Faecalibacterium, are observed in SSc patients with GIT symptoms. Additionally, dysbiosis in SSc is linked to increased pro-inflammatory bacteria, such as Desulfovibrio, correlating with elevated pro-inflammatory metabolites and intestinal damage. Furthermore, dysbiosis is prevalent in SSc patients and is associated with gastrointestinal dysfunction, malnutrition risk, and several inflammatory, fibrotic, and vascular extraintestinal features of the disease. These findings highlight the potential significance of gut microbiome alterations in the pathogenesis and progression of SSc, warranting further investigation into their role and therapeutic implications.
Immune Dysregulation and Fibrosis
According to ScienceDirect, changes in the gut microbiome can significantly impact immune function and fibrotic processes, both of which are central to the pathogenesis of systemic sclerosis . Dysbiosis can initiate a cascade of events leading to immune dysregulation and fibrosis in various organs, including the skin.
One mechanism by which dysbiosis contributes to immune dysregulation is through the disruption of the gut epithelial barrier. Intestinal dysbiosis can compromise the integrity of the gut barrier, leading to increased permeability and leakage of bacterial products, such as lipopolysaccharides (LPS), into the bloodstream. These microbial components activate pattern recognition receptors (PRRs) on immune cells, such as Toll-like receptors (TLRs), triggering the release of pro-inflammatory cytokines and chemokines.
The systemic inflammation resulting from dysbiosis can drive immune cell infiltration into affected tissues, including the skin. Inflammatory cells release cytokines and growth factors that stimulate fibroblasts, the primary producers of extracellular matrix (ECM) components like collagen. Dysregulated activation of fibroblasts leads to excessive ECM deposition, disrupting tissue architecture and function, ultimately resulting in fibrosis.
Moreover, dysbiosis can directly influence the balance of cytokines and growth factors in the local tissue microenvironment, favoring the upregulation of pro-fibrotic mediators such as transforming growth factor-beta (TGF-β) and connective tissue growth factor (CTGF). These factors promote fibroblast activation and ECM synthesis while inhibiting ECM
Scleroderma United
Spring 2024 Intern Articles
degradation, perpetuating the fibrotic process.
Additionally, dysbiosis-induced alterations in the gut microbiota can impact the production of metabolites with immunomodulatory properties, such as short-chain fatty acids (SCFAs). SCFAs produced by gut bacteria have been shown to regulate immune cell function and inflammatory responses. Changes in SCFA production may contribute to immune dysregulation and fibrosis in SSc.
Clinical Implications and Therapeutic Opportunities
According to Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis. The intricate relationship between the gut and skin in systemic sclerosis underscores both diagnostic opportunities and therapeutic strategies. SSc manifests with diverse cutaneous symptoms, including localized and systemic scleroderma, characterized by thickened and hardened skin patches, often extending to internal organs. The immune-mediated pathogenesis of SSc, involving excessive collagen production and tissue fibrosis, further complicates its clinical landscape. Biomarkers such as chemokines CCL18, CX3CL1, CXCL4, and IL-6 offer valuable insights into disease progression and organ involvement, aiding in timely diagnosis and prognostication. Moreover, the gut microbiome emerges as a modifiable factor influencing SSc outcomes. Dietary interventions, including probiotics and prebiotics, present promising avenues for restoring microbial equilibrium, attenuating inflammation, and mitigating fibrosis. By leveraging these therapeutic opportunities, clinicians can potentially enhance treatment response and alleviate disease burden in SSc patients. Furthermore, Scleroderma Information | Mount Sinai - New York. maintains that holistic approaches integrating lifestyle modifications, such as antioxidant-rich diets and regular exercise, alongside traditional medications, offer comprehensive management strategies to improve quality of life and mitigate long-term complications associated with SSc, including pulmonary fibrosis and cardiovascular comorbidities. Thus, the gut-skin connection in SSc not only underscores the complexity of its pathogenesis but also unveils novel avenues for personalized therapeutic interventions aimed at optimizing patient outcomes and mitigating disease progression.
Challenges and Future Directions
Current research on the gut-skin axis in systemic sclerosis faces several challenges and limitations, including the complexity of microbiome analysis and the need for larger longitudinal studies. (Current Methods for Studying the Human Microbiome). The intricate interplay between the gut microbiome and skin manifestations of SSc requires sophisticated analytical techniques
Scleroderma United
Spring 2024 Intern Articles
that are still evolving, making it challenging to fully elucidate the underlying mechanisms. (Gastrointestinal involvement in systemic sclerosis: Pathogenesis, assessment, and treatment - PMC). Additionally, the heterogeneity of SSc and its gastrointestinal involvement necessitate comprehensive longitudinal studies with large cohorts to capture the variability and progression of gut microbiome alterations over time.( The significance of microbiome in personalized medicine - PMC). Despite these challenges, future research directions hold promise for advancing our understanding and management of SSc. Exploration of personalized microbiome-based therapies tailored to individual patients' microbiota profiles offers exciting potential for targeted interventions (Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease - ScienceDirect.). Furthermore, integrating gut health assessments into SSc management protocols may provide valuable insights into disease progression and treatment response, ultimately improving patient outcomes. Embracing these future research directions can pave the way for more effective strategies in combating the debilitating effects of SSc on both the gut and skin.
A Holistic Approach To Scleroderma Care
The article underscores the importance of adopting a holistic approach to scleroderma (SSc) care, recognizing the diverse clinical manifestations of the disease and the need for comprehensive management strategies. Key points include the prevalence of gastrointestinal (GI) involvement in SSc patients, ranging from laryngo-esophageal symptoms to gastroparesis, and the challenges in diagnosis and management due to the variability of symptoms. It emphasizes the limited evidence-based treatment options for SSc-GI complications, highlighting the urgent need for disease-modifying therapies. Importantly, the article advocates for considering the gut microbiome as a critical factor in SSc management. Given the emerging understanding of the gut-skin axis in SSc pathogenesis, interdisciplinary collaboration between gastroenterologists, rheumatologists, and dermatologists is essential to optimize patient care. By integrating gut health assessments and personalized microbiome-based therapies into SSc management protocols, healthcare teams can address the complex interplay between gut dysbiosis and skin manifestations, ultimately improving patient outcomes and quality of life.
Scleroderma United
Spring 2024 Intern Articles
References
1. PubMed Central. “Chronic Periodontitis and Rheumatoid Arthritis: A Review.” National Center for Biotechnology Information, U.S. National Library of Medicine, 19 Jan. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916842/.
2. Shi, J, et al. “Inflammatory Markers in Blood and Serum Progression in Rheumatoid Arthritis: a Comprehensive Review.” Arthritis Research & Therapy, vol. 18, no. 1, 2016, doi:10.1186/s13075-016-1182-z.
3. PubMed Central. “Systemic Sclerosis: Current Concepts in Pathogenesis and Therapeutic Aspects of Dermatological Manifestations.” National Center for Biotechnology Information, U.S. National Library of Medicine, 4 Jan. 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853331/#:~:text=Specific%20gut%20microbiota%20may%20be,to%20healthy%20controls%20%5B133%5D.
4. Ruofeng, Y, et al. “Biological Mechanisms in the Pathogenesis of Systemic Sclerosis: Role of T Cells and Stromal Cells.” ScienceDirect, vol. 30, no. 1, 2010, doi:10.1016/j.autrev.2010.05.008.
5. Bellando-Randone, S, et al. “Biomarkers in the Pathogenesis, Diagnosis and Treatment of Systemic Sclerosis.” Dove Medical Press, vol. 2015, 2015, doi:10.2147/jir.s45214.
6. Bellando-Randone, S, et al. “Biomarkers in the Pathogenesis, Diagnosis and Treatment of Systemic Sclerosis.” Dove Medical Press, vol. 2015, 2015, doi:10.2147/jir.s45214.
7. National Center for Biotechnology Information. "Chapter 1: Introduction to Molecular Testing." Molecular Testing in Cancer, 2018, https://www.ncbi.nlm.nih.gov/books/NBK481559/#:~:text=However%2C%20there%20are%20also%20some,lower%2Dthroughput%20than%20molecular%20techniques%2C.
8. Lebre, M, et al. “Biomarkers in Rheumatoid Arthritis.” National Center for Biotechnology Information, U.S. National Library of Medicine, 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547962/.
9. Sakthiswary, R, and Y W Foo. “Infections and Systemic Lupus
Scleroderma United
Spring 2024 Intern Articles
Erythematosus.” National Center for Biotechnology Information, U.S. National Library of Medicine, 2019, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512898/.
10. Lerner, AM, et al. “The Gut Microbiome in Systemic Autoimmune Disease.” ScienceDirect, vol. 3, no. 1, 2015, doi:10.1016/j.jaut.2014.11.007.
Scleroderma United
Spring 2024 Intern Articles
Beyond the Skin: Navigating the Mental Health Challenges of Scleroderma
By Tonique Swaby from May Pen, Clarendon, Jamaica
Introduction
Scleroderma is an autoimmune disease characterized by the hardening and thickening of skin and connective tissues, often affecting multiple organs such as the lungs, heart, kidneys, and gastrointestinal tract. Beyond its physical manifestations, scleroderma can profoundly impact mental health. The chronic nature of the disease, its unpredictable course, and the potential for disfigurement and disability can lead to increased levels of stress, anxiety, depression, and overall emotional distress. Addressing the mental health aspect of scleroderma is crucial as it not only affects the well-being and quality of life of patients but also influences disease management and treatment outcomes. By recognizing and addressing the mental health challenges associated with scleroderma, healthcare providers can offer more holistic care and support to individuals living with this condition.
Understanding Scleroderma
Scleroderma is a chronic autoimmune disease characterized by the hardening and thickening of skin and connective tissues, with potential systemic involvement. There are two main types of scleroderma: localized scleroderma, which primarily affects the skin, and systemic sclerosis, which involves internal organs in addition to the skin. Systemic sclerosis can
Scleroderma United
Spring 2024 Intern Articles
manifest in various forms, affecting organs such as the lungs, heart, kidneys, and gastrointestinal tract. The disease process involves abnormal activation of the immune system, leading to inflammation, fibrosis, and vascular damage in affected tissues. This can result in a wide range of physical symptoms, including skin tightening, joint stiffness, Raynaud's phenomenon (characterized by color changes in the fingers and toes in response to cold or stress), digestive problems, and respiratory issues. Individuals with scleroderma often face significant challenges due to these symptoms, which can impact mobility, daily activities, and overall quality of life. Moreover, systemic involvement of scleroderma poses additional complexities and potential complications, requiring comprehensive management and multidisciplinary care to address the diverse manifestations of the disease and optimize patient outcomes.
Impact on Mental Health
The prevalence of psychiatric symptoms and hostility factors in patients with scleroderma is a topic of clinical interest, yet it remains poorly studied. In a study done by PMC involving thirty female scleroderma patients and thirty-three healthy women for comparison, various psychometric instruments were utilized, including the Hostility and Direction of Hostility Questionnaire (HDHQ), the Delusions Symptoms States Inventory/states of Anxiety and Depression (DSSI/sAD), and the Symptom Check List-90R (SCL-90R). The results revealed that scleroderma patients reported significantly increased levels of depression, anxiety, somatization, interpersonal sensitivity, and obsessive-compulsiveness. Additionally, scores for paranoid ideation and psychotic symptoms were elevated, with higher levels of guilt observed in the hostility domain. These findings indicate a notable presence of psychiatric symptomatology among scleroderma patients, encompassing various emotional and cognitive domains, emphasizing the need for further research and tailored interventions to address their mental health needs.
Factors Contributing to Mental Health Challenges
Factors contributing to mental health challenges in individuals with scleroderma encompass a complex interplay of physical and psychological factors. The debilitating symptoms of scleroderma, including chronic pain, persistent fatigue, social isolation due to physical limitations, and changes in physical appearance such as skin thickening and disfigurement, all contribute significantly to psychological distress. Moreover, the uncertainty surrounding the progression of the disease and the effectiveness of available
Scleroderma United
Spring 2024 Intern Articles
treatments further exacerbates mental health issues, leading to anxiety and depression among patients. The study examining mental health service utilization among those with systemic sclerosis provides valuable insights into the prevalence of mental health service use and its association with various factors. Despite the substantial psychosocial implications of scleroderma, PMC states that only 18% of participants sought mental health services in the three months preceding enrollment, indicating potential gaps in addressing the emotional distress experienced by this population. This underscores the urgent need for comprehensive support systems tailored to the unique challenges faced by individuals with scleroderma, addressing both their physical symptoms and psychological well-being. By addressing these multifaceted aspects of the disease, healthcare providers can better support patients in managing their condition and improving their overall quality of life.
Coping Strategies and Support
Living with scleroderma presents numerous challenges, both physical and psychological, requiring effective coping strategies and robust support systems, according to Cleveland Clinic.Coping mechanisms play a crucial role in helping individuals manage the mental health implications of the disease. Therapy, including cognitive-behavioral interventions and relaxation techniques, can provide valuable tools for addressing anxiety, depression, and stress associated with scleroderma. Additionally, support groups offer a sense of community and understanding, allowing individuals to share experiences and gain emotional support from others facing similar challenges. Mindfulness techniques and self-care practices, such as meditation, nature walks, and engaging in hobbies, can also promote mental well-being by reducing stress and enhancing resilience. Furthermore, the importance of a strong support network cannot be overstated, with close relationships providing emotional, informational, and instrumental support crucial for navigating the complexities of living with scleroderma. Healthcare professionals play a vital role in addressing mental health needs by offering educational resources, connecting patients with support organizations and resources, and providing compassionate care tailored to individual needs. By incorporating these coping strategies and accessing support systems, individuals with scleroderma can better manage the psychological impact of the disease and improve their overall quality of life.
Raising Awareness and Advocacy
Raising awareness about the mental health impact of scleroderma is
Scleroderma United
Spring 2024 Intern Articles
crucial within the medical community, among patients, and the general public; according to PMC and National Scleroderma Foundation. Given the high levels of emotional distress reported by individuals with systemic sclerosis (SSc), advocacy efforts aimed at improving access to mental health resources and support are essential. Patients with SSc often experience a range of negative emotions, including depression, anxiety, fear about disease progression, and body image concerns, which can significantly affect their functional status and quality of life. Psychosocial factors, such as fatigue and concerns about disability, may even surpass clinical parameters in predicting distress and depression. Additionally, physical disabilities associated with SSc, particularly changes in facial and hand appearance, contribute to body image distress and psychological impact. Therefore, non-pharmacological treatments and behavioral interventions, including Mindfulness-Based Stress Reduction (MBSR) programs, hold promise in alleviating emotional distress and improving well-being for individuals with SSc. Efforts to raise awareness and advocate for better access to such interventions can significantly enhance the mental health outcomes and overall quality of life for those affected by scleroderma.
Conclusion
In conclusion, the mental health challenges associated with scleroderma are multifaceted and significant, encompassing emotional distress, anxiety, depression, and concerns about body image and disease progression. These challenges often go beyond the physical symptoms of the disease, impacting the overall well-being and quality of life of individuals living with scleroderma. However, by recognizing the importance of addressing mental health needs in conjunction with medical management, healthcare providers can offer more comprehensive care and support to patients. Effective coping strategies, such as therapy, support groups, mindfulness techniques, and self-care practices, play a crucial role in helping individuals navigate the psychological impact of scleroderma. Additionally, raising awareness and advocating for better access to mental health resources and support are essential steps in improving the overall quality of life for those affected by scleroderma. By prioritizing mental health support and integrating it into the management of scleroderma and other chronic illnesses, we can better meet the needs of patients and enhance their resilience and well-being.
Scleroderma United
Spring 2024 Intern Articles
References
Angelopoulos, Nikiforos V., et al. “Psychiatric Symptoms Associated With Scleroderma.” Psychotherapy and Psychosomatics, vol. 70, no. 3, Jan. 2001, pp. 145–50. https://doi.org/10.1159/000056240.
Becetti, Karima, et al. “Mental Health Care Use and Associated Factors in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study.” ACR Open Rheumatology, vol. 4, no. 8, May 2022, pp. 647–57. https://doi.org/10.1002/acr2.11439.
Aoufy, Khadija El, et al. “Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life.” International Journal of Environmental Research and Public Health, vol. 20, no. 3, Jan. 2023, p. 2512. https://doi.org/10.3390/ijerph20032512.
National Scleroderma Foundation. “Advocacy and Awareness - National Scleroderma Foundation.” National Scleroderma Foundation, 25 Mar. 2022, scleroderma.org/tri-state-chapter/advocacy-and-awareness.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma
Diagnosis and Everyday Challenges
By Uday Kandi from Aldie, Virginia
INTRODUCTION
Scleroderma, a disease known for more than just its impact beneath the skin; it affects the very lives of those it touches. Its birth, though silent, is pronounced through its relentless progress of symptoms: each person’s experience is as unique as their fingerprint, yet it is universally taxing. Its impact goes far beyond the confines of a medical textbook, digging deep into what it means to live with a condition that transforms your daily life in unpredictable ways.
Visualize waking up every morning with the body being wrapped tightly around, not in skin, but in a cocoon that is stiff and unexplainably painful. It’s there in every step of their way, creating a barrier between those impacted and their dreams. Our duty is to bring these stories into lives, combining the scientific with the personal tales. We’re not just retelling the journey of scleroderma through a lens of medical research but also through the eyes and hearts of those who pushed through its limits everyday. Every aspect of scleroderma is proof of human resilience and determination.
UNDERSTANDING THE DISEASE
The word scleroderma derives from the Greek words “sclero” meaning hard and “derma” meaning skin, also known as systemic sclerosis, it is a chronic autoimmune disease known for its hardening and tightening of the skin and
Scleroderma United
Spring 2024 Intern Articles
connective tissues. It is a condition which effectuates an accelerated production of collagen, leading to skin and internal fibrosis.
Fibrosis: a medical term that refers to the formation of excess connective tissue in an organ of tissue. Imagine a jammed finger for example, when a basketball hits your finger causing noticeable swelling but in case of scleroderma, it is far worse.
Scientifically, scleroderma is the result of an overactive immune system that falsely attacks the body’s tissues. This abnormal immune system response leads to an overproduction of collagen, a protein that is the main component of connective tissues which provides structure, strength, and support throughout the body, and can affect internal organs including the heart, lungs, kidneys, and gastrointestinal tract.
mage shows Cat Davis, a previous scleroderma patient, suffering from the effects of scleroderma. This is one of the most common signs of scleroderma, where the skin appears swollen, shiny, and feels tight. This is due to the overproduction of collagen, leading to a fibrotic response in the skin.
This type primarily affects the skin and muscular structures beneath it. It is generally considered to be a milder version of scleroderma and has been known to rarely affect internal organs.
Localized Scleroderma can also be divided into two categories:
Morphea is a form of localized scleroderma known for its hard waxy patches
Scleroderma United
Spring 2024 Intern Articles
on the skin in many different sizes and shapes. The National Scleroderma foundation states that this form typically affects the ages of 20 and 50, but is often seen in young children.
Linear Scleroderma persists as lines or streaks of hard thickened skin, typically on arms, legs, or face. This form of scleroderma, usually developed at a young age, can affect the growth of involved limbs as it can also affect muscles and bones.
This form of scleroderma affects the skin, esophagus, gastrointestinal tract, lungs, kidneys, heart and other internal organs. It may also affect blood vessels, muscles, joints, and connective tissues in various parts of the body. The effect of Systemic sclerosis may harden the internal systems involved and lead to its decreased function affecting the health of the individual.
Systemic Sclerosis can also be divided into two categories based on the degree of skin involvement:
Limited cutaneous systemic sclerosis is gradual and progresses slowly. It affects the skin on your fingers, hands, face, forearms, and legs below the knees. This form of sclerosis is less widespread as there is less skin involvement and it was also previously known to be called the CREST Syndrome
Scleroderma United
Spring 2024 Intern Articles
Diffuse cutaneous systemic sclerosis causes widespread thickening and hardening of the skin and can also affect the internal organs like the heart, lungs, and kidneys.
“Scleroderma tends to have a mind of its own. In general, autoimmune disease does not discriminate. They do not care who you are, your age, your sex, race or religion. They will get you no matter who you are” - Cat Davis
Scleroderma is a confusing and often overlooked disease that makes the skin feel tight and hard. It’s more than just skin; it can mess with your internal organs and make daily tasks really tough. Imagine waking up one day and finding that what used to be simple, like buttoning your shirt or walking up stairs, suddenly feels like climbing a mountain.
Take Rashmi Bhasin from Mumbai, India, for instance. Her journey to diagnosis was a long one filled with pain and misunderstanding. It all started with a terrible pain in her fingers and was wrongly informed that she had carpal tunnel syndrome. The frustration of knowing something is off but not being able to get the right help, shows that difficulty of diagnosis. It took years before she finally met a doctor who understood that it was scleroderma, not just a minor issue.
“ I told my doctor my symptoms for about 40 minutes and when he said “child, I understand,” I think I cried for 30 minutes because finally someone was not telling me to see a therapist! Instead, someone was telling me “I understand what you’re going through.” - Rashmi Bhasin
Then there’s Nayanshree from Karnataka, whose symptoms started with something as odd as her fingertips turning blue in the warm Indian climate. She was a teenager, and her doctors thought it was due to stress. It wasn’t until much later that she was properly diagnosed. By then, scleroderma has already harmed her body and her dreams. These aren’t just sad stories. They’re real struggles of people who face a disease that’s hard to sport and even harder to explain. Hearing about Rashmi and Nayanshree reminds us of the urgent need to spread the word about scleroderma. It shows us why doctors and everyone else need to take such symptoms seriously , so no one else has to wait years for the right diagnosis.
DAILY LIVES
“The symptoms started with a lot of pain in my fingertips, like someone was trying to put a nail through my thumb. The pain was excruciating, and my skin started turning very hard, dry, and itchy”( Rashmi Bhasin). This pain made simple tasks like cooking and writing very difficult for her”. Similarly, Nayanshree R. Sainkop found that her hands changed noticeably, “My fingers and entire palm started to turn blue and numb, and I couldn't hold my pen”.
Scleroderma United
Spring 2024 Intern Articles
The Problem with her hands was so bad that her friends had to help warm them up so she could use her pen. Cheryll Iddon, a Scleroderma patient, also faced major issues, especially with swelling that changed how she looked and moved: “my ankles were swelling up and my socks were getting so tight that my ankles were spilling over my socks and my trainers! It was really unattractive, because I'm actually quite tall and slim naturally.” The swelled affected how she views herself, It brought negative thought in her head and this shows how far Scleroderma can really go. Angelina Fernandez, who was diagnosed as a kid, experienced many symptoms that made her life tough: “This has affected me in many ways, including movement in my fingers, difficulty with opening my mouth, fatigue, difficulty concentrating, and insomnia.” The hardness of her skin even made injections very difficult.
Living with scleroderma can be really tough, but the difficulties can be reduced through a good support system and by also finding ways to adapt can make a big difference. From the personal stories, it’s clear that each person has found their own unique ways to handle their condition and get support. Rashmi Bhasin, for example, finds a lot of strength in a foundation she has started called Scleroderma India. This group helps her connect with many others who have scleroderma, just like her, and it gives her a way to help others understand the disease better, so they don't have to go through what she had. She talks about her foundation with a lot of passion: "Right now, my foundation (Scleroderma India) is very important to me. It is my passion. I live and breathe my foundation." Nayanashree R. Sanikop also talks about how much her doctor helps her, not just with her health, but also by giving her emotional support that is needed. She feels less alone because her doctor sets aside a special time just for scleroderma patients, which helps her learn more about her condition and how to manage it, through his guidance. Cheryl Iddon is taking steps to create her own support network. She is organizing regular meet-ups with other scleroderma patients at her hospital to share stories and advice on how to deal with sclerosis. She plans to hold these gatherings once a month: "I'm organizing with the hospital to try and sort out a room to maybe meet and invite other patients once a month for a coffee morning, you know, just to chat about themselves and how they're feeling." Angela Fernandez, who was diagnosed as a child, finds great support from her family and her medical team. Even though her treatments can be tough because of how hard her skin is, having supportive doctors and therapies that meet her needs helps her handle her symptoms. These stories show how important it is to have support from doctors, family, groups, or friends. This support can help manage the physical challenges of scleroderma and also offer emotional support and a sense of community, which are crucial when living with a long-term illness.
Scleroderma United
Spring 2024 Intern Articles
Flow-Mediated Dilation: Promising Predictive Test for Vascular Complications in Systemic Sclerosis
By Valeria Bianchi from Clayton, Victoria, Australia
Scleroderma is a complex autoimmune disorder characterised by excessive collagen deposition and fibrosis, posing a significant challenge in both diagnosis and management. Some commonly associated symptoms of scleroderma are vascular conditions such as Reynaud’s disease or endothelial dysfunction, which is the narrowing of blood vessels in different sections of the body. While these complications are seen in different types of scleroderma, it is most commonly associated with systemic sclerosis (SSc).
There is a promising non-invasive test called flow-mediated dilation (FMD) that has shown to be useful for monitoring these changes in blood vessels, and predicting vascular complications within people with systemic sclerosis (SSc).
Flow-mediated dilation is a form of ultrasound test involving a blood pressure cuff. It is a non-invasive procedure where doctors cut off blood flow, and watch through imaging software as the circulation restores itself, checking vessels for abnormalities. If an artery does not increase in diameter, it typically indicates endothelial dysfunction or vascular issues.
Scleroderma United
Spring 2024 Intern Articles
2. What is the importance of FMD? How does it relate to SSc?
Though it does not directly predict the development and progression of systemic sclerosis, just focusing on the endothelial cells in vessels gives a lot of insight. Systemic sclerosis is associated with widespread endothelial dysfunction, leading to impaired vasodilation, inflammation, and fibrosis. Flow-mediated dilation allows one to assess the health and condition of the endothelial cells, allowing for predictions into what complications can occur. For example, if the test shows dysfunction in vessels near the heart, it is very likely that cardiovascular complications will arise during the systemic sclerosis’ progression.
Also, while there exist tests that can study microvascular damage, such as the nailfold video-capillaroscopy, detecting macrovascular damage is less common. Flow mediated dilation allows for this in a non-invasive way, providing more information on the morbidity and mortality of the person’s condition.
3. Limitations
There are several things to consider before getting a test done however. The testing is heavily dependent on the doctor’s technique, as the images and analysis can change massively depending on the person. This test can also be skewed when done on patients who are obese, have anatomical abnormalities or people on medication for blood pressure. Another thing to note is that changes in blood pressure, heart rate, body position, time of day, the last time they did exercise and emotional state can influence measurements, potentially introducing variability and bias into the results.
4. Conclusion
Overall, while flow-mediated dilation is a promising tool in testing vascular conditions, especially when applied to systemic sclerosis which has many vascular complications, its limitations should be considered when interpreting results. Do not rely solely on the test, but use it as a basis for further testing and precautions. Continued efforts are needed to standardise procedures, improve techniques, and address the earlier factors to amplify its clinical utility.
Scleroderma United
Spring 2024 Intern Articles
Hormonal Cycle and Scleroderma: Estrogen, Sexual life and Menopause
By Valeriia Svyrydova from Kremenchuk, Poltava Oblast, Ukraine
People with scleroderma and accompanying conditions may encounter issues with their sexual life, hormones, and skin tightening during menopause. These are complex and often challenging moments, so in this article, we will delve into research and the main problems faced by individuals with this disease.
Scleroderma, also known as systemic sclerosis, is a group of rare autoimmune diseases that involve the hardening and tightening of the skin. It can also affect blood vessels, muscles, and internal organs and can indeed be influenced by hormonal factors.
Estrogen Levels and Scleroderma:
Estrogen, the quintessentially female hormone, plays a role in scleroderma. The study conducted by the Medical University of South Carolina (MUSC) found that older men with scleroderma have higher levels of estradiol, a type of estrogen, compared to postmenopausal women with the same condition. The MUSC team, funded by the National Institutes of Health (NIH), also discovered that men with elevated estradiol levels had more severe disease and heart involvement. Furthermore, those with the Scl-70 autoantibody and higher estradiol levels faced a greater risk of mortality. Female hormones,
Scleroderma United
Spring 2024 Intern Articles
particularly estrogen, play a role in autoimmune diseases. While estrogen can boost the immune system, it can also increase the risk of autoimmune disease.
Scleroderma predominantly affects women during their child-bearing years when estrogen levels are high. Researchers speculate that estrogen may play a role in the disease and other autoimmune conditions. Hormone replacement therapy trials showed that women’s skin thickened during therapy, returning to normal afterward.
Sexual life and Scleroderma:
Women with scleroderma may experience vaginal dryness due to Sjögren’s syndrome or sicca syndrome, which often accompanies systemic sclerosis. These conditions cause dryness of mucous membranes, including the vagina. Reduced lubrication during arousal can make sex uncomfortable or even painful for women with scleroderma. Treatment options include vaginal lubricants, relaxation techniques, local anaesthetic jelly, and smooth plastic dilators to gradually improve comfort during intercourse
Sexual Dysfunction:
Both men and women with scleroderma commonly experience sexual dysfunction.
For men, erectile dysfunction (ED) is a significant concern. Studies have reported ED prevalence of 76.9% to 81.4% in male patients with scleroderma. Women’s sexual dysfunction is complex and often related to psychological health. Clinicians should pay attention to sexual function, as it significantly affects patients’ quality of life.
Menopause and Scleroderma:
Menopause is the natural process when levels of the female hormone oestrogen gradually decline, leading to the cessation of menstrual cycles. The perimenopause refers to the time from when menopausal symptoms first begin until after periods have stopped. Common menopausal symptoms include period changes, hot flushes, headaches, night sweats, vaginal dryness, mood changes, joint pain, and an increased risk of developing osteoporosis.
Studies show that menopausal women with scleroderma may experience increased skin thickening.
Changes in hormones during menopause can lead to a worsening of the patient's condition. An example of a complication of scleroderma during menopause is Pulmonary Arterial Hypertension. Pulmonary Arterial
Scleroderma United
Spring 2024 Intern Articles
Hypertension (PAH) is a serious condition that affects the heart, lungs, and blood vessels. It is a type of high blood pressure that specifically impacts the arteries in the lungs and the right side of the heart. The development of PAH may be more common after menopause in scleroderma patients.
Hormone Replacement Therapy (HRT):
HRT can help relieve menopausal symptoms. However, for women with scleroderma, individualized advice is essential. Some forms of HRT may be considered safe, while others containing estrogen could worsen symptoms. Oestrogen-based creams and pessaries for the genital area are generally safe for women with SSc2.
In conclusion, it is worth noting that not every person with scleroderma may experience symptoms related to hormonal changes or their sexual life. Research indicators show that estrogen can exacerbate health issues in both women and men with scleroderma. Women with scleroderma may experience vaginal dryness, which can lead to discomfort in their sexual life. It is crucial for each patient that their doctor tailors suitable treatments involving medication and mental support.
Scleroderma United
Spring 2024 Intern Articles
Scleroderma and Anxiety: Dermatillomania, OCD and IBS
By Valeriia Svyrydova from Kremenchuk, Poltava Oblast, Ukraine
Scleroderma is an autoimmune disease that affects skin, blood vessels, muscles, and internal organs. The symptoms are thickened skin, stiffness, fatigue, and poor blood flow to fingers or toes. Anxiety is a common experience for many people with chronic illnesses, including scleroderma. The most common include pounding heartbeat, shallow breathing, sweaty palms, muscle tensions, tightening in the stomach, and trembling of the body.
Dysfunctional anxiety goes beyond normal nervousness and fear. It interferes with daily life, causing excessive dread, unease, and uncontrollable fear. After having a couple of really good days (with excellent energy levels and manageable pain), some individuals with scleroderma may experience heightened anxiety. The fear of their health deteriorating again can keep them awake at night, leading to a cycle of worry and exhaustion. This type of anxiety doesn’t serve any purpose and can be distressing.
Functional Anxiety:
Functional Anxiety is not a recognized mental health diagnosis, but it refers to individuals who experience anxiety while still managing daily life quite well.
Scleroderma United
Spring 2024 Intern Articles
They may appear put-together and accomplished on the outside, yet internally, they experience excessive worry, self-doubt, and stress. People with scleroderma can experience excessive anxiety, self-doubt and stress, but still cope well with everyday life.
Dermatillomania:
Dermatillomania, also known as excoriation disorder, is a mental health condition characterized by compulsive skin picking. Individuals with dermatillomania repeatedly pick at their skin, leading to tissue damage, scarring, and distress. The symptoms are persistent skin picking, often in response to anxiety or stress and difficulty controlling the urge to pick.
Individuals with scleroderma may also experience dermatillomania due to the impact of the disease on their skin and overall well-being. Treatment for dermatillomania often involves a combination of medication and therapy.
OCD:
Obsessive-Compulsive Disorder (OCD) is a mental and behavioral disorder characterized by intrusive thoughts (obsessions) and the need to perform certain repetitive routines (compulsions). These compulsions are carried out repeatedly to relieve the distress caused by the obsessions, to the extent that they impair general function. Dealing with a chronic illness like scleroderma can be emotionally challenging. The stress, anxiety, and lifestyle adjustments associated with the disease may contribute to the development or exacerbation of OCD symptoms. The physical and emotional impact of scleroderma may indirectly influence the development or exacerbation of OCD symptoms in some individuals.
IBS:
While IBS and scleroderma are distinct conditions, individuals with scleroderma may experience gastrointestinal symptoms similar to those seen in IBS due to the impact of the disease on the digestive system. Gastrointestinal involvement occurs only in systemic sclerosis but is a prominent feature of both diffuse scleroderma and limited scleroderma. IBS is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits (diarrhea, constipation, or both). Patients who have scleroderma and anxiety disorder also experience Irritable Bowel Syndrome.
In conclusion, it is worth noting that patients with scleroderma may
Scleroderma United
Spring 2024 Intern Articles
experience anxiety, followed by OCD, dermatillomania, and IBS. If you suspect an anxiety disorder, seeking consultation with a doctor is advisable.
Scleroderma United
Spring 2024 Intern Articles